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"Theories come and go. The frog remains." 
Jean Rostand, 1960 
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Summary 
XrelA is a maternally expressedXenopus member of the rel family of 
transcription factors which includes the Drosophila dorsal-ventral patterning gene 
dorsal. During the blastula stages XrelA becomes differentially localised to the nuclei 
of the animal hemisphere and marginal zone. Another rel family member, known as 
Xrel.2, which is also expressed maternally has been cloned recently, and is a likely 
endogenous heterodimerisation partner for XrelA. Various attempts have been made 
· previously to investigate the developmental role of XrelA. Over-expression of XrelA 
in embryos has dramatic phenotypic effects, but these are probably largely due to 
transcriptional squelching. The effects of over-expressing a dominant inhibitory 
variant ofXrelA lacking the transactivation domain, which acts by saturating DNA 
binding sites for XrelA homodimers, have also been characterised. However, the 
DNA binding specificity of XrelA present in XrelA!Xrel.2 heterodimers is likely to 
differ from this. 
To avoid this problem, dominant inhibitory variants deficient in DNA binding 
activity, which act by sequestering wild-type protein into inactive complexes, were 
constructed from XrelA (XrelMSP) and human NFKB 1 (p50.:iSP). Both clones are 
capable of inhibiting DNA binding and transactivation by exogenous XrelA and do not 
possess the squelching activity of wild-type XrelA. Three 1eB binding complexes 
have been detected in embryos, none of which contains XrelA. The activity of one of 
these complexes is inhibited by p50.:iSP, but not by XrelA.:iSP. Expression of XrelA 
.:iSP in embryos has dramatic phenotypic effects. This phenotype has been analysed 
in detail and exhibits some similarities to that caused by the dominant negative FGF 
receptor. The fact that expression of p50.:iSP, or of a deletion of XrelMSP (XrelM 
SP222), which lacks the transactivation domain, have no phenotypic effects suggests 
that the phenotype probably arises by some mechanism other than inhibition of XrelA, 
and that the transactivation domain is necessary to this mechanism. Future work 
might concentrate on the identification of factors interacting with this domain. 
2 
1. Introduction 
1.1. The Rel Family of DNA binding proteins 
The aim of this section is to review the current state of understanding the 
activities of mamalian rel family members and their control. I aim, in doing so, to 
provide essential background to understanding the strategy used to investigate the roles 
of rel family members in Xenopus early development. 
1.1.1. Overview of the rel and IKB families. 
The rel gene family encodes a group of dimeric DNA binding proteins (see 
figure 1 for nomenclature and relationships) containing a highly conserved domain of 
about 300 amino acids known as the 'rel homology domain' (RHD). The RHD 
contains regions necessary for DNA binding and for dimerisation with other family 
members. In fact conservation is such that all of the known mammalian rel family 
members can heterodimerise with all the others, with the exception of relB, which 
does not homodimerise and forms heterodimers with p50 and p52 only (Bours et al., 
1993). The family can be subdivided into two groups, one of which includes rel 
family members with C-terminal transactivation domains. The known mammalian 
members of this group are Re/A, c-rel, and RelB. The other group, so far consisting 
of two genes called NFKBJ and NFKB2, have no transactivation domains but are 
transcribed as large precursors with C-terminal inhibitory domains. In order to be 
active (i.e.:- able to translocate to the nucleus and to bind DNA) these gene products 
require proteolytic processing, which removes and degrades the inhibitory domain 
(Pallombella et al., 1994 ). However they can dimerise in their unprocessed state and 
so sequester other rel family members into inactive complexes. As might be 
expected, the promiscuity of dimerisation of rel family members is significant as a 
source of variation with respect to control of activation, DNA binding specificity and 
affinity, and transactivation activity. The current state of knowledge of the 
differences in activities between rel family dimers is summarised in figure 4. Rel 
family dimers can be activated by a wide range of stimuli, including tumour necrosis 
factor a. (TNF-a.), interleukin-I (IL-1), lipopolysaccaride (LPS), and phorbol 
myristate actetate (PMA). Models of the mechanism of activation are discussed later 
(see section 1.1.2.). 
3 
A further complexity arises from the fact that activation, and in some cases 
transactivation activity, of rel family members is controlled by a family of interacting 
proteins, which differ in their specificity and affinity for the various rel dimers (see 
figure 4), and in means of activation. These related proteins, referred to as the IKB 
family, all contain ankyrin-like repeat domains (ARD's) which are common motifs 
involved in protein-protein interaction (see Blank et al., 1992 for review). The 
prototypical member of this family, IKBa, is specific for p65, Rel, and relB 1 
containing dimers (Duckett et al., 1993; Dobrzanski et al., 1994) which it binds to 
and retains in the cytoplasm. Phosphorylation of11eBa is thought to act as a signal 
which marks it for degradation (possibly involving the proteasome) while still bound 
to the rel dimer (Didonato et al., 1995). The loss ofIKBa from the complex unmasks 
nuclear localisation signals present on the rel dimer (Beg et al., 1992) and so allows 
the dimer to translocate to the nucleus where it can activate or repress transcription of 
target genes. As well as being able to retain certain rel complexes in the cytoplasm, I 
KBa can inhibit their DNA binding activity in vitro (Nolan et al., 1991). 
Interestingly the IKBa gene itself is under the positive control of NF-KB (Le Bail et 
al., 1993). This may be a negative feedback mechanism which allows a short burst of 
activation ofNF-KB before active dimers are sequestered by resynthesised IKBa. 
This provides a neat explanation of the function oflKBa's ability to inhibt DNA 
binding. 
Another member of the family, IKBP, has identical specificity and inhibitory 
functions to IKBa (as far as has been tested), but its degradation is induced by only a 
subset of the factors which can induce I1eBa degradation. For example, IL-1 and 
LPS treatment cause degradation of both whereas TNFa and PMA cause degradation 
of only IKBa (Thompson et al., 1995). The major difference in the activation ofNF-
KB involving IKBP as well as IKBa is that it is sustained for much longer (hours rather 
than minutes) than activaton involving IKBa alone. Unlike IKBa, the IKBP gene is 
not under autoregulatory control by NF-KB. Interestingly, even in cells which 
contain both isoforms, activation of NF-KB from a pool bound to IKBP is sustained 
for much longer than that from the IKBa bound pool (Thompson et al., 1995). If IKB 
a is indeed involved in negative feedback inhibition of active, nuclear NF-KB, 
activation ofIKBP bound NF-KB must include modification (e.g.-phosphorylation) of 
NF-KB itself to somehow make it insensitive to inhibition by IKBa. 
1 Note the interaction of IKBa. with p52/relB is much weaker than that with p50/relB (Dobrznaski et al., 
1994). 
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FIG.1:- A. Table of nomenclature for the rel family. 
Gene Product(s) 
RelA p65, p65~ 
RelB relB 
c-rel Rel 
NFKBJ p 105, p50 (p 105 cleavage product), Ild3y, lld3y-1 
and lld3-y-2 (alternative splicing products) 
NFKB2 pl 00, P52 (plOO cleava~e product) 
v-rel v-Rel 
XrelA XrelA 
Xrel.2 Xrel.2 
dorsal dorsal 
The first five of these genes have homologues which have been cloned in humans, 
mice and chicks. It is these genes which are concentrated on for most of this section 
(1.1) of this section v-rel is a viral oncogene from avian reticulovirus. The Xenopus 
members of the rel family, XrelA and Xrel. l are dealt with in a separate section 
(1.1.7.). Dorsal is a Drosophila member of the rel family member. Its developmental 
function is disscussed in detail in section 1.2. 
B. Sequence analysis of the rel family. 
NFKBl 
NFKB2 
Che-rel 
v-rel 
Mu.c-rel 
The above figure shows relationships between sequences of members of the rel family, 
reproduced from a pileup sequence comparison on GCG. 
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The C-terminal inhibitory domains of NFKB 1 and NFKB2 mentioned 
previously are actually quite closely related in sequence to members of the IKB family, 
and in fact differential splicing of the NFKBl transcript produces an IKB protein in its 
own right, known as hcBy. lKBy protein is capable of inhibiting nuclear localisation 
ofhomodimers ofp50 and Rel, and p50/p65 heterodimers2 (Grumont and Gerondakis, 
1994). It has recently been shown that the NFKB 1 gene has two further products 
resulting from alternative splicing (Grumont and Gerondakis, 1994). These products, 
known as hcBy-1 and IKBy-2, are smaller isoforms of IKBy which lack IKBy's putative 
Protein kinase A (PK.A) phosphorylation site, suggesting their activity may be 
controlled differently. hcBy-1 and -2 are also more limited in their specificity for rel 
dimers, only inhibiting DNA bindng by p50 containing dimers. Unlike other IKB 
proteins with inhibitory functions, IKBy-2 is found predominantly in the nucleus. 
A further member of the IKB family has a completely different function. Bcl3 
operates in the nucleus, where it binds to p50 and p52 homodimers in a 
phosphorylation dependent manner (Nolan et al., 1993). Bcl3 has transactivating 
activity which becomes functional when Bcl3 is bound to p503 or p52 homodimers 
(which alone are not transactivating) bound to a relevant site (Bours et al., 1993; 
Fujita et al., 1994). Bc13 does not bind to p65 homodimers, or to NF-KB (p65/p50) 
(Nolan et al., 1993). 
1.1.2. Activation of NF-KB 
The rel family dimer whose mechanism of activation has been most thoroughly 
investigated is the dimer ofp50 and p65, known as NF-KB. NF-KB is activated by a 
wide range of factors, but most is known about activation by the cytokines IL-1 and 
TNF-a.. Evidence has gradually been accumulating that ceramide produced as a result 
of signal-dependent hydrolysis of sphingomyelin, acts as a second messenger 
involved in a pathway leading to activation of NF-KB. Levels of endogenous 
ceramide are rapidly stimulated, concommitant with a rapid decrease in 
sphingomyelin levels, in both 1NF-a. and IL-1 ~ treated cells (Schutze et al., 1992; 
Mathias et al., 1993. A possible mechanism for the action of ceramide as a second 
2 Interaction of IKBy with (c-rel)2 and p50/p65 is still controversial, and contrary reports exist (e.g.:-
Nolan et al., 1993). 
3 Reports of an inhibitory function for Bcl3 acting against p50 homodimers (e.g.:- Franzoso et al., 
1992) are probably an artefact due to the use of a deletion clone ofNFKBl which has a product longer 
than mature p50 . 
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messenger is suggested by the isolation of a ceramide activated kinase (Mathias et al., 
1991 ). Introduction of a cell permeable analogue of ceramide into Jurkat T-cells 
activates NF-KB in a dose-dependent manner (Schutze et al.,1992). NF-KB can also 
be activated by both ceramide and sphingomyelinase in cell free extracts of both 
Jurkat T-cells and a human monocyte line (U937) (Machleidt et al., 1994). This 
activation can be inhibited using a range of serine protease inhibitors. These same 
protease inhibitors have been shown to prevent IKB dissociation and degradation in 
response to a range of NF-KB activating stimuli (Pallombella et al., 1994). Two 
possible scenarios could account for this data. Either ceramide is, directly or 
indirectly, activating a serine type protease, which subsequently degrades IKB, or 
ceramide acts to cause the modification (possibly phosphorylation) ofIKB, which 
somehow marks it out for degradation. The latter model would fit in with the 
evidence for IKB phosphorylation being necessary for NF-KB activation, and with the 
observation that the range of protease inhibitors able to inhibit IKB degradation 
corresponds to those able to inhibit the proteasome (Machleidt et al., 1994). 
The intracellular tyrosine kinase raf has also been implicated in NF-KB 
activation by TNF-a and other activators. Finco and Baldwin have shown recently 
that a dominant negative form ofraf-1 (which has an inactivated kinase domain, and 
is thought to act by saturating the binding sites of one or more upstream activators) can 
block activation of NF-KB by TNF-a, serum and phorbol esters when overexpressed 
in Balb/c 3T3 cells (Finco and Baldwin, 1993). They also demonstrated that 
overexpression of activated forms of raf-1 and ras ( an upstream activator of raf-1) was 
sufficient for NF-KB activation in the same cell line. Two lines of evidence suggest 
that raf-1 may activate NF-KB by acting directly on IKB. Firstly, recombinant raf-1 
can phosphorylate recombinant, purified IKB in vitro, and secondly raf-1 and IKB 
have been shown to associate in vivo using the yeast two hybrid system (Li and 
Sedivy, 1993). No work appears to have been carried out so far on the relationship of 
ceramide and raf-1 in this pathway (e.g.:- does dominant negative rafblock ceramide 
activation of NF-KB). However, assuming the interaction of raf-1 and IKB are 
physiologically relevant, one might expect raf-1 to act downstream of, or in parallel 
with the ceramide pathway of activation (see figure 2) 
It has recently become apparent that proteolytic processing of p 105 is , at least 
in some contexts, a signal-dependent process, which can by stimulated by, for 
example, TNFa and PMA (Mellitis et al., 1993; Mercurio et al., 1993). Like the 
degradation ofIKBa this process involves phosphorylation prior to proteolytic 
degradation which again appears to involve the proteasome (Pallombella et al., 1994). 
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FIG. 2:- Model for activation of NF-KB by TNFa. / IL-1 
PM 
"?, ~?/ ~ 
Raf / 0th« targell, / \ Serine protease Including EGF-R 
~::. l ~ ►@ ► locBdegradation 
Abbreviations:-
ocB 
1ite 
SM = sphingomyelin; SMase = Sphingomyelinase; EGF-R = epidermal 
growth factor receptor 
PM= Plasma Membrane 
P( circled) = phosphate. 
1.1.3. Variation in DNA binding specificity between different rel dimers. 
The rel family were initially characterised as binding to a group of decameric 
sequences known as Kl3 sites which are variations on a palindromic site with the 
sequence 'GGGAA TTCCC' in which the first 4 nucleotides, and the terminal 'C' are 
always conserved. A range of Kl3 sites of this form from various promoters are 
summarised in figure 3 . Even within this limited range of sites there is difference in 
specificity between different rel dimers (see figure 4). However, it is increasingly 
becoming apparent that the range of sites bound by rel dimers is much larger than the 
these canonical Kl3 sites. A study by Kunsch and colleagues using a PCR selection 
assay to define the complete range of sites bound by homodimers ofp65, pSO, and 
Rel has highlighted a range of new sites not so far found in promoters (Kunsch et al., 
1992). This study also defined sites specific for each of the three homodimers which 
could be a useful tool for investigating the presence of particular homodimers, and 
have already proved useful for studying which residues confer specificity (see page 
12). The sites found to bind Rel homodimers included some of the sites most 
8 
divergent from the palindromic KB site (e.g.:- CTAAAAAACC), and recently c-rel 
has been shown to bind to an important site in an intron of the IFN-y gene which is 
also almost totally unlike a 'canonical' KB site (AA TTTTCC). 
1.1.4. Transactivation by rel family members 
In naturally occurring promoters the context of a site is frequently an important 
factor in whether transactivation occurs. For example, transactivation by NF-KB 
from an HIV-LTR driven reporter is dependent on the presence of Spl sites adjacent to 
the two KB sites (Perkins et al., 1992). Despite this it has become common to test rel 
dimers for the ability to transactivate from artificial promoters consisting of a number 
of adjacent copies of particular KB site next to a minimal promoter (e.g.:- the 
thymidine kinase promoter). This method is not, of c~urse, able to distinguish 
between dimers which can transactivate alone, and those requiring further interactions 
with factors present in vivo ( e.g.:- (p50)2 or (p52)2 requirement for Bcl3). Data from 
such experiments is summarised in figure 4. 
FIG. 3:- Types of KB site. 
KB site Sequence 
lg (K-light chain) and GGGACTTTCC 
HIVLTR 
IL-2 GGGATTTCAC 
IL-2R GGGAATCTCC 
11-6 GGGATTTTCC 
Urokinase GGGAAAGTAC 
H2 GGGATTCCCC 
IFN-~ GGGAAATTCC 
Palindrome (PD) GGGAATTCCC 
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FIG. 4:- Table of rel dimers and their activities 
Dimers Characterised IKB family interactions1 Binding sites2 Transactivation3 
p50/p65 IKBa, IKBp, IKBy, IKBy-1, IKB-y-2 lg/HIV, IFN-P, H2, IL-2, IL- IgG/HIV, IFN-P (requires HMG l(Y) , 
(NF-KB) (nuclear (Not Bcl3) 2R, IL-6, Urokinase H2 
p52/p65 IKBa lg/HIV, PD, H2, IL-2R lg/HIV (but not H2, IL-2R or PD) 
p50/relB IKBa lg/HIV, PD lg/HIV, PD 
p52/relB IKBa (Weakly binding) lg/HIV, PD 
p50/C-rel IKBa lg/HIV 
p52/C-rel IKBa IL-2R 
p65/C-rel IKBa Urokinase (Not lg/HIV) 
(p50)i IKB-y, IKB-y-1, IKB-y-2 (nuclear, inhibitory), lg/HIV, IL-2, IL-2R, IFN-P, H2, lg/HIV (but not IFN-P) 
Bcl3 (transactivating) (Not IKBa or P) H2, but not IFN-y intron. 
(p52), Bcl3 (transactivating) H2 (but not lg/HIV) 
(p65)i IKBa, IKBP, IKB-y (Not IKB-y-1 or -2 or Bcl3) lg/HIV, IFN-P, IL-2R IL-2R ( repressor for IL-6) 
(C-rel)i IKBa, IKBp, IKBy (Not IKBy-1 or -2) IL-2R , IL-6, IFN--y intron (but 
not lg/HIV, or IL-2) 
Adapted and updated from Liou & Baltimore, 1993, references for DNA binding specificity and transactivation can be found there. References 
for IKB specificty can be found in the text (see section 1.1). It is important to note that not all of potential interactions/ activities in these 
categories have been characterised. Where there is known to be no interaction this is also mentioned. 
Note RelB does not homodimerise, and heterodimerises only with p50 and p52 (Bours et al., 1994). 
1 Note, it is still not clear whether interaction with a particular rel subunit allows interaction with all dimers containing that subunit. I have therfore only included 
characterised interactions with particular dimers. 
2 All results are as tested by GMSA (see section 4.1 for details). The list only includes binding sites characterised in promoters, and does not take into account additional 
binding activities characterised by PCR selection. 
3 Transactivation as measured from artificial promoters consisting of multiple adjacent KB sites and a minimal promoter. 
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1.1.5. Physiological roles of rel family members. 
There has long been circumstantial evidence for a role for the rel family in the 
functioning and development of the vertebrate immune system. Many of the genes 
containing promoter elements characterised as being responsive to activation by rel 
family dimers, are involved in the immune acute phase and inflammatory responses 
(Liou and Baltimore, 1993). Where expression patterns of rel family members are 
restricted they also suggest a role in the immune system. The expression of c-rel, for 
example, is restricted to the hematopoietic organs in the mouse, with highest levels in 
B and T lymphoid cells (Grumont and Gerondakis, 1990). c-rel expression in the B 
cell lineage during maturation is a good illustration of the potential importance of 
combinatorial variation of rel dimers in differentiation. c-rel expression is 
stage-specific so that, in pre-B cells the main rel dimer is p50/p65, but in mature B 
cells it is p50/Rel (Grumont and Gerondakis, 1994). RelB expression also suggests a 
role in the immune system, being localised to the thymus and lymph nodes. rel A and 
NFKBJ, on the other hand, are thought to be ubiquitously expressed, so roles outside 
of the immune system are possible. 
Recently homozygous null alleles of a number of members of the rel family 
have been generated in mice by homologous recombination. It is important to note 
with such data that as there appears to be significant overlap in the activities of some 
rel dimers it is possible that in some situations other rel family members may be able 
to substitute for an eliminated rel protein. Investigation of this possibility will have to 
await the generation of double mutant mice. So far, none of the homozygous null 
phenotypes have included developmental defects. Embryos which are homozygous 
null for NFKB 1 develop normally, but have a variety of immune response defects as 
adults (Sha et al., 1995). In support of the redundancy hypothesis many genes 
characterised as possible targets for p50 containing dimers are expressed normally in 
these mice. RelB -/- mice also develop relatively normally apart from having a 
number ofhematopoietic defects, and a reduced population of dentritic cells in the 
thymus (Weih et al., 1995). These mice also have impaired cellular immunity and 
infiltration of a number of organs by inflammatory cells leading to inflammation. 
Embryos homozygous null for re/A again have no obvious developmental 
abnormalities. The major defect observed in mice which lack re/A is that the liver 
undergoes apoptosis at about 15 dpc, after apparently normal prior development (Beg 
et al., 1995). Finally, mice lacking c-rel also have immune defects, most or all of 
which may result from the inability of mature B and T cells from these mice to 
transduce mitogenic signals (Kontgen et al., 1995). 
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1.1.6. Mapping the domains of activity of rel family members. 
Extensive deletion and in vitro mutagenesis analysis of NFKBJ, relA and v-
rel have lead to the mapping of regions essential for DNA binding and dimerisation 
(see figure 25 for schematic representaions of these domains). The first attempts at 
domain mapping were crude deletions of NFKBJ, which lead to the identification of a 
region at the N-terminal end of the RHO, necesssary for DNA binding. For example, 
the deletion p50i:iSP which lacks residues 10-201 (along with the IKBy encoding 
domain) encodes a protein which lacks DNA binding activity, but is still able to 
dimerise with wild type rel family members (Kieran et al., 1990). The region which 
has been deleted in pS0i:iSP contains a 15 residue stretch which is highly conserved in 
all the known members of the rel family (see figure SA). Analysis of the functions of 
individual residues within this region has been carried out by in vitro mutagenesis 
(summarised in figure SB). As well as identifying residues essential for DNA 
binding, or necessary for binding with normal affinity, one residue has been shown to 
be an important determinant of sequence specificity (see figure SB). Mutagenesis of 
this residue in relA to its NFKB 1 equivalent causes a broadening of specificity to 
include targets ofNFKBl, whereas mutagenesis of the residue in NFKBl to its relA 
equivalent is sufficient to change its specificty to that of relA as tested using probes 
specific for each homodimer (Coleman et al., 1993). The recently published structure 
of (p50)2 bound to a consensus KB site (GGGGAA TCCC) supports a role for this 
region in determining DNA binding specificity. Residues 56-7l(see figure SA) form 
a 'recognition loop' that projects into the major groove of the bound DNA and interacts 
directly with bases in the site (Ghosh et al., 1995; Millier et al., 1995). 
Perhaps because the relevant domain(s) is/are not as well conserved or 
localised, mapping of regions and residues necessary for dimerisation has been less 
successful. One of the first clues to the position of residues essential for dimerisation 
was the isolation of a naturally occuring alternative splice form of re IA known as p65i:i 
, which lacks amino acids 222 to 231 (Narayanan et al., 1992). This protein is 
unable to dimerise, stabilise IKB, bind DNA or transactivate (the loss of the latter two 
functions are likely to be a secondary consequence of loss of dimerisation activity). 
Interestingly, despite the loss of all these activities, this deletion has transforming 
activity, although the mechanism of this activity remains obscure. The equivalent 
region of p50 has also been shown to be essential for dimerisation (Bressler et al., 
1993). However, residues outside this region also have a role in dimerisation. 
Mutagenesis of a highly conserved cysteine residue (C216 in rel A), and of residues 
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FIG. 5:- (a) Comparison of the highly conserved regions of rel family 
DNA binding domains 
Dorsal (58-72) K F L R F R y E C E GR s AG 
hI-rel (131-145) R G M p F R y E C E GR s AG 
mRelB (115-129) R G M R F R y E C E GR s AG 
hNFKBl (54-68) R G F R F R YV C E G p s HG 
hNFKB2 (45-59) R G F R F R y G C E G p s HG 
v-Rel (27-41) R G T R F R y K C E G R s AG 
me-Rel (19-33) R GM R F R y K CE G R S AG 
hRelA (30-44) R GM R F R y K C E G R s AG 
XrelA (30-44) R G M R F R y K C E G R SAG 
xrel.2 (33-47) R G M R y R y K C E G R CAG 
* * 
- - - - - # # - # # # - - - # 
Completely conserved residues are marked with a'#'. Residues which differ between 
Xrel.2 and all other rel family members are marked with a'*'. No published data 
currently exists on the effects of mutagenesis of these residues. Gene name prefixes: 
'm' denotes mouse and 'h' denotes human 
(b) Summary of specificity and affinity changes due to 
mutagenesis of single amino acids in this region. 
(Note:- Specificity differences can be tested using specific probes isolated by Kunsch 
and colleagues (see page 12)):-
GENE SUBSTITUTION EFFECT ON SPECIFICITY /AFFINITY 
NFKBl H67R p50 specificity to p65 specificity 
RelA A43H p50 and p65 specificity 
RelA R41P pS0 and p65 specificity 
RelA M32F Decreased affinity, same specificity 
RelA K37V Decreased affinity, same specificty 
v-rel C35S Binding affinity increased4 
v-rel R27W Binding abolished 
v-rel R30Q Binding abolished 
v-rel R32N Binding abolished 
(from Kumar et al., 1992 and Coleman et al., 1993) 
4 This residue appears to be involved in red ox control of v-rel activity, as unlike the wild-type the 
binding affinity of the C35S mutant ofv-rel is not increased in reducing conditions (Kumar et al., 
1992). 
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' ,) 
in a conserved consensus PK.A binding site at 271-274 are able to abolish the ability 
of p65 to homodimerise, but not to heterodimerise with p50 (Ganchi et al., 1993). 
1.1.7. Rel family members inXenopus. 
The aim of this section is to outline the results of work on XrelA prior to the 
start of this project. More recent results are detailed, where appropriate, in later 
chapters. 
XrelA; Clonin2, properties and expression, 
AXenopus member of the rel family, now known as XrelA, was isolated by 
Jill Richardson (Richardson, 1991 ; Richardson et al., 1994 ), during a screen for 
Xenopus rel genes using a fragment of the v-rel RHD to screen an oocyte library. 
cDNAs encoding two slightly different RNAs were isolated by this method, called 
XrelA.1 and .2., and found to be identical (except at two residues) to the clone Xrel.1, 
independently reported by Kao and Hopwood (Kao and Hopwood, 1991 ). XrelA.2 
was used throughout this study and will henceforth be referred to as XrelA. XrelA is 
most similar at the amino acid level to the relA subunit of NF-KB (see figure 1B) 
having a similarity of77.5% to relA in the RHD (allowing for conservative changes). 
XrelA and relA are identical over most of the region of the RHD which has been 
shown to be necessary for DNA-binding activity (see section 1.1.6), and is absolutely 
identical in the part of this region characterised as controlling specificity (see figure 5). 
It seems likely, therefore, that the DNA-binding specificity ofXrelA, and relA will 
be very similar. As can be seen from figure 6, XrelA is also very similar to relA over 
the regions identified as essential for homo- and heterodimerisation. XrelA also 
contains the conserved nuclear localisation signal (KRKR; residues 300-304) found in 
all other rel family members. The C-terminal domain of XrelA has a much lower 
degree of similarity with relA (only 27 %). By analogy with relA this region would 
be expected to have a transactivating function. The C-terminal domain of relA has 
been classed as an acidic-type activation domain. Recent work has characterised short 
sequences in this domain known as acidic activation modules, which have been shown 
to be capable of acting independently as transactivators in HeLa cells when fused to 
the DNA binding domain of yeast transcription factor Gal-4 (Blair et al., 1994). 
Similar putatively conserved sequences can be found in the C-terminal domain of 
XrelA, as shown in figure 7. 
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FIG. 6:- Comparison of rel family dimerisation domains 
me-rel (205) FLLCDKVQKD DIEVRFVLND ..... WEARG 
· Xrel .2 (218) FLLCDKVQKD DIEVRFFTDN ..... WEAKG 
mrela (213) FLLCDKVQKE DIEVYFTGPG ...... WEARG 
Xrela (213) FLLCDKVQKE DIEVIFGLGN ..... WEARG 
hNFKBl (270) YLLCDKVQKD DIQIRFYEEE ENGGVWEGFG 
******** ** * ** * 
me-rel (259) VKMQLRRPSD 
Xrel.2 (273) VKMQLRRPSD 
mrela (268) VSMQLRRPSD 
xrela (266) VQMQLRRPSD 
hNFKBl (329) VFVQLRRKSD 
* **** ** 
Sequence alignments taken directly from complete alignments using Pileup. 
All residues whose function has been investigated by deletions or by in vitro 
mutagenesis (detailed in table below) are shown in bold.Gene name prefixes:-
m = mouse, h = human. 
GENE Substitution/deletion Effect Reference 
re/A 222-231 (naturally Abolishes all Narayanan et al., 1992 
occuring deletion, dimerisation 
relM) 
hNFKBJ 269-278 (equivalent Abolishes all Bressler et al., 1993 
deletion to relA~) dimerisation 
mrela C216S Abolishes Ganchi et al., 1993 
homodimerisation, 
but not 
heterodimerisation. 
mrela S276A (part of Abolishes Ganchi et al., 1993 
conserved PKA homodimerisation, 
consensus site but not 
(RRPS) heterodimerisation. 
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That XrelA has transactivation activity has been confirmed by experiments 
demonstrating that XrelA can stimulate transcription from an HIV-L TR driven CAT 
reporter construct (pLC2R; Herbomel et al., 1984), when over-expressed in embryos 
(Richardson et al., 1994). However, transactivation is not seen in this assay with 
very high levels of XrelA expression (2 ng/embryo ). Interestingly, at such high 
levels of expression transactivation from a reporter driven by the thymidine kinase 
promoter (Edlund et al., 1985), which does not contain a KB site, is decreased. This 
could be explained by XrelA causing a general inhibition of activated transcription, 
known as squelching. Squelching is thought to occur when an overexpressed 
transcription factor sequesters a protein or protein(s), via interaction with its 
transactivation domain, which are required generally for activated, but not basal, 
transcription. It has been shown recently that acidic activation modules from the relA 
transactivation domain have squelching activity when fused to the DNA binding 
region of Gal4 and overexpressed in HeLa cells, as tested by inhibition of 
transactivation by the acidic class transactivation domain ofVP16 (Blair et al., 1994). 
As with other examples of squelching, basal transcription was unaffected, as shown 
by the failure of overexpressed relA to inhibit transactivation by a GAL4-Tat fusion. 
To test for a general decrease in transcription due to squelching in embryos 
expressing high levels ofXrelA, the incorporation of tritiated uridine into poly (A)+ 
RNA as a proportion of incorporation into total RNA was measured (Richardson et al., 
1995). No significant reduction in this ratio was seen in embryos over-expressing 
XrelA compared to controls. However, as this method is fairly crude it may not be 
useful in detecting general decreases in mRNA transcription rates which are 
nevertheless significant, especially when one considers that basal transcription is 
unaffected by squelching effects. 
The spatial and temporal expression pattern of XrelA has been analysed by 
Northern blotting. XrelA is expressed at low levels maternally, but levels increase 
sharply after MBT, rising to highest levels in the late blastula / early gastrula, then 
tailing off by neurula stages, although transcripts can still be detected at stage 35 
(Richardson et al., 1994). No obvious dorsal-ventral distribution of transcripts was 
observed in the early embryo. 
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FIG. 7:- Alignments of putative conserved acidic activation modules 
535-545 (muRelA) 
muRelA s I AD MD F s A L L 
huRelA s I A D M D F s A L L 
XRelA s L F E L D F s s L L 
* * * * * * 
and more tentatively:-
442-453 (muRelA) 
muRelA L Q F - - - D D E D LG ALL 
huRelA L Q F - - D AD E D LG AL L 
XRelA p s F p G DAN L D L VE ML 
* * * * 
Alignments taken directly from full sequence alignments (Richardson, 1991) using 
Clustal analysis (programs 1,2 and 3; Higgins and Sharp, 1988) 
Note that the central 'conserved' phenylalanine residues in each case have been shown 
to be essential for the function of these modules (Blair et al., 1994). 
Phenotypes due to injection of RNA encodinr: XrelA. and RNA encodinr: a 
transactivation deficient deletion of XrelA 
A two-pronged approach has been used to investigate the developmental role of 
XrelA. The phenotypic effects of over-expressing XrelA have been investigated in 
some detail (Richardson et al., 1995). This approach has proved successful in 
revealing developmental activities of a number of genes expressed early in Xe no pus 
development. The homeobox gene goosecoid (gsc) for example, has the ability to 
induce secondary axis formation when injected as RNA into ventral blastomeres (Cho 
et al., 1992; also see section 7.1.3.). However, it should be noted that one potential 
complication of this approach in the case of XrelA is that overexpression would lead to 
the expression ofhomodimers, which may or may not be the predominant species of 
dimer present in the embryo. 
17 
High level overexpression of Xre/A in embryos {>2 ng) resulted in arrest of 
embryonic development at stage 10 (early gastrula),just after formation of the dorsal 
blastopore lip. As this phenotype is seen mainly at or above the same levels of 
expression ofXrelA as 'squelching' of transcription driven by the thymidine kinase 
promoter, it seems likely to be a consequence of squelching. In fact it is similar to 
the phenotype caused by treatment of embryos with the transcriptional inhibitor a.-
amanitin, which also blocks gastrulation, although in this case prior to the formation 
of the dorsal blastopore lip (Newport and Kirschner, 1982). The squelching 
hypothesis is also supported by an analysis of early marker expression using RNase 
protection assays (Richardson et al., 1995). The results of these experiments show a 
decrease in the levels of transcripts of all markers tested (Xbra, goosecoid, 
pintallavis, Xwnt-8, Xsna and noggin) in embryos injected with high levels ofXrelA 
(>2 ng/embryo) when compared to the levels of RNA of the maternal and zygotic 
housekeeping gene ornithine decarboxylase (Richardson et al., 1995). 
Embryos injected with lower levels ofXrelA complete gastrulation and often 
develop with a disruption of the mid-dorsal axis. Somite segmentation and 
organisation is affected and the nervous system is small and poorly organised, in 
contrast, notochord seems to develop normally. In addition, thickening of the 
epidermis into multi-layered patches is often seen in these embryos. The least affected 
embryos exhibit a mid axis 'kink' associated with local disruption of axial tissue. The 
difficulty with interpreting this phenotypic data, compared say to the phenotype 
resulting from ventral injection of gsc RNA, is that it cannot be fitted easily into 
currently accepted models of Xenopus early development (see section 1.3). 
The other approach which has been used to investigate the developmental 
function of XrelA is the use of dominant inhibitory deletions5 of XrelA to study the 
phenotypic effects of eliminating the activity of XrelA in the embryo. The only such 
deletion clone whose activity and phenotypic effects have been characterised is one 
lacking the C-terminal transactivation domain. This deletion clone, known as XrelA.:i 
222 (the C-terminal 222 amino acids are deleted), can inhibit both background and 
XrelA stimulated levels of transcription from pLC2R (Richardson et al., 1994; Fig. 
29). This probably occurs by the saturation of promoter sites by homodimers of 
XrelA.:i222. It is also possible that XrelA.:i222 could act by forming transactivation 
deficient heterodimers with XrelA, although this is difficult to prove. Dominant 
S There is a general discussion on the design of dominant inhibitory deletions ofrel family members in 
chapter 5 (sections 5.1 and 5.2). 
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negative transcription factors which act by saturating promoter sites have the 
disadvantage that, when expressed at highly non-physiological concentrations they 
may interact with promoter elements which are not normal targets of the factor to be 
inhibited. This is not a problem for which controls may be easily designed. 
Embryos injected with RNA encoding XrelA~22 exhibit a markedly different 
phenotype to those over-expressing wild-type XrelA. They appear to gastrulate 
'over-vigorously', at least posteriorly, so that the resulting blastopore ends up as a pit. 
At later stages this develops into a large cloaca, sometimes encompassing the whole 
of the posterior end of the trunk, which tends to be shortened. In more extreme 
embryos tail extension is inhibited, and somewhat less frequently, head defects are 
seen. In extreme cases the head is completely lost. Histological examination of these 
embryos revealed that they had relatively normal mid-trunk regions, but were 
increasingly disorganised towards the posterior, particularly with respect to 
segmentation of the somites. 
Xrel, 2: A member of the rel family with similarities to c-rel 
Recently, a secondXenopus rel homologue has been identified with significant 
homology to c-rel (David Tannahill, pers. comm.). Like XrelA, it is expressed both 
maternally and zygotically and so is a potential heterodimerisation partner of XrelA. 
Close comparison of the sequence ofXrel.2 with other rel family members in 
the region of the rel homology domain (RHD) shown to be necessary for DNA-binding 
activity, and implicated in controlling DNA-binding specificity (see section 1.1.6) 
suggests that the similarity ofXrel.2 and c-rel could be misleading with respect to 
DNA binding-specificty. Xrel.2 has substitutions (albeit relatively conservative ones) 
at two residues in this region which are completely conserved in all other rel family 
members (see figure SA, page 13). The substituted phenylalanine (which becomes a 
tyrosine residue in Xrel.2) lies between two conserved arginines which in p50 form 
bidentate hydrogen bonds with guanines 3 and 4 in the consensus site (Ghosh et al., 
1995). The other substituted residue, a cysteine instead of the serine residue found in 
other rel family members, is adjacent to a residue essential for conferring specificity 
differences between relA and NFKBl (see Fig. 5 AandB, page 13). All of this points 
to the possibility ofXrel.2 having novel DNA binding specificity properties. 
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1.2. O-V Patterning in Drosophila - An example of pattern 
specification by a rel family member. 
The aim of this section is to outline the role of the Drosophila rel family 
member dorsal in dorsal - ventral (D-V) patterning of the Drosophila embryo as an 
illustration of the potential of rel family members for pattern specification. The first 
section deals with the mechanisms by which a gradient of nuclear concentration of 
dorsal from ventral to lateral is specified during the syncytial blastoderm stage. This 
is reviewed in much more detail elsewhere (e.g.:- Chasan and Anderson, 1993). The 
second section deals with the mechanisms by which target gene expression is regulated 
by the nuclear concentration of dorsal protein leading ultimately to the specification of 
D-V pattern. 
1.2.1. Control of dorsal localisation 
During Drosophila oogenesis one germ cell divides four times to produce 16 
cells, which remain connected by cytoplasmic bridges. One of these cells becomes 
the oocyte, while the rest become nurse cells which export large amounts of protein 
and RNA into the oocyte. Surrounding most of the oocyte are somatic cells known as 
ovarian follicle cells. These cells are responsible for secreting the vitelline membrane 
and the chorion ( eggshell). The chorion becomes visibly polarised both antero-
posteriorly and dorso-ventrally during oogenesis. Fertilisation is followed by rapid 
synchronous nuclear division which occurs without cellular cleavage. After nine 
divisions most of the nuclei migrate to the periphery. This is called the syncytial 
blastoderm stage, and it is not until a further four divisions have taken place that 
cellular cleavage occurs. 
Genetic analysis has identified 18 maternally expressed genes required to 
define D-V pattern in the Drosophila embryo (see figure 8). Six of these genes are 
required for both embryo and chorion patterning (the future polarity of the embryo can 
be predicted by the D-V asymmetry of the chorion). The remaining 12 genes are 
required for patterning of the embryo after fertilisation. Embryos from flies which are 
homozygous for null alleles of eleven of these genes (known as the dorsal group) 
produce completely dorsalised embryos, whereas null alleles of the remaining gene 
(cactus) give a completely ventralised phenotype. Isolation of partial loss of function, 
weakly dorsalising mutants of the dorsal group originally lead to the proposal that 
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FIG. 8:- Table of maternal effect genes controlling D-V patterning. 
Loss of 
Gene function Protein encoded 
phenotype 
Eggshell fs(l)KJO dorsalising bHLH protein 
and cappuccino dorsalising ? 
embryonic spire dorsalising ? 
patterning torpedo ventralising EGF-R homologue 
gurken ventralising ? 
cornichon ventralising ? 
Embryonic pipe ? 
patterning nude/ ? 
windbeutel ? 
gastrulation 
defective Dorsal group ( serine protease ?) 
snake genes serine protease 
easter serine protease 
spiitzle secreted protein 
Toll transmembrane protein 
pel/e Ra£'Mos type tyrosine kinase 
tube (no known homologues) 
dorsal Rel family member 
cactus ventralising IKB family member 
Adapted from Chasan and Anderson, 1993. 
D-V patterning relied on a gradient of a ventralising signal, the absence of which 
leads, by default, to dorsalisation. The weakly dorsalising (lateralising) mutants of 
the dorsal group could then be interpreted as depleting this ventralising signal. The 
proteins encoded by these genes are now known to be involved in a chain of events 
which carries a signal from the follicle cells surrounding the embryo to peripheral 
nuclei during cleavage of the syncytial blastoderm. This ultimately leads to the 
formation of a gradient of nuclear localisation of dorsal protein from ventral (high) to 
lateral (none) across the embryo, between cleavage cycles 10 and 14. 
It is possible to genetically dissect the order in which a group of genes act in a 
linear pathways, such as signal transduction pathways, by using double mutant 
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analysis. This makes use of the fact that embryos carrying two mutant genes involved 
in such a pathway should display the phenotype of the further downstream of the two 
genes. The phenotype due to mutation in the downstream of the two genes is referred 
to as being epistatic to the phenotype due to the other mutation. This technique is 
obviously only applicable where the mutations in question involve loss of function, 
or are dominant alleles, and give different phenotypes. Epistasis analysis has therefore 
allowed the positioning of maternal D-V patterning genes with respect to cactus, 
torpedo and gurken (ventralising as null alleles) and Toll, easter (ventralising as 
dominant alleles) and spatzle (lateralising as a dominant allele) (see figure 9). 
FIG. 9:- Order of genes in D-V pathway by genetic dissection. 
fs(1)k10 
cappuccino 
spire 
dorsal 
~ 
gurken 
torpedo 
cornichon 
pel/e 
/tube 
cactus 
Updated from Chasan and Anderson, 1993. 
nudel 
windbeutel 
gastrulation defective 
snake 
easter 
~ 
spatzle 
Toll / 
/ 
Note:- It is unclear from the epistasis experiments whether tube and/or pe/le acts 
directly on dorsal, cactus or both. 
This model correlates well with data on the localisation of gene products. 
Pipe, windbeutel and nudel are all required in the follicle cells (Govind and Steward, 
1991), where they are postulated to encode proteins responsible for laying down the 
initial asymmetric patterning signal. Snake, easter and spatzle are all present in the 
perevitelline space and in fact, all three of these mutant phenotypes can be rescued by 
injection of perivitelline fluid from a WT host into the perivitelline space of a mutant 
donor. Toll is present in the plasma membrane, and tube, pelle and cactus are 
present in the embryo itself. 
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snake and easter both encode trypsin-like serine proteases which are secreted 
as inactive zymogens requiring protease cleavage for activation (Delotto and Spierer, 
1986; Chasan and Anderson, 1989). The cloning and characterisation of these genes 
led to the suggestion that they might participate in a self amplifying zymogen cascade, 
similar to that involved in blood clotting or complement activation (Chasen et al., 
1992). This hypothesis fits with the observation that the D-V orientation of mutant 
embryos rescued by injection of wild-type perivitelline fluid corresponds to that of the 
chorion rather than depending on the position of injection. This form of rescue 
experiment provided the basis for a form of epistasis experiment for snake and easter. 
These experiments involved injection into embryos of RNA encoding the catalytic 
regions of snake and easter fused to a signal sequence to direct secretion into the 
periviteline space. In wild-type embryos these RNA's produce a dominant lateralised 
or ventralised phenotype which is epistatic with respect to null alleles of nude!, pipe, 
winbeutel and gastrulation defective (Smith and Delotto, 1994; Chasan et al., 1992). 
These experiments also place easter downstream of snake, but upstream of spatzle 
and Toll. Recently, a dominant gain of function allele of spatzle has been isolated 
which produces a completely lateralised phenotype which is epistatic to easter . 
. Unlike snake and easter, increasing the amount of wild type protein in the periviteline 
space by RNA injection into embryos does affect the phenotype. 
These experiments support a model in which the easter gene product acts 
downstream of snake to activate spatzle. In this model easter and snake encode 
elements in a zymogen cascade, in which snake is activated by an initial asymmetric 
cue acting through, or in parallel with, the product of gastrulation defective. 
Toll itself encodes a transmembrane protein which shows weak homology to 
the Interleukin 1 receptor in its intracellular domain. In vitro mutagenesis of residues 
conserved in the intracellular domain of the IL-1 receptors of humans, chickens, and 
mice has identified a number a functionally essential residues. The functional 
significance of two equivalent residues present in Toll is indicated by the finding that 
they are substituted in two recessive dorsalising mutants of Toll. As genetic and 
biochemical evidence suggest that spiitzle acts immediately upstream of Toll it seems 
likely that spatzle encodes the Toll ligand. 
Transduction of the signal from Toll which leads to nuclear localisation of 
dorsal is still not well understood. Tube has no known homologues, but is known to 
be localised evenly to the plasma membrane in syncytial blastoderm embryos (Galindo 
et al., 1995) and pelle is predicted by sequence similarity be a raf/mos type ser/thr 
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kinase (Shelton and Wasserman, 1993). Recently pelle and tube have been shown to 
associate physically independently of any activating signal, using the yeast two hybrid 
system (Galindo et al., 1995). This interaction appears to be essential, as two loss of 
function tube mutants do not interact with pelle in this assay. Intriguingly, a 
dominant gain offunctionpelle can be created by fusing the kinase domain ofpe/le to 
a non-functional mutant of the transmembrane receptor torso, suggesting that 
activation of pelle simply requires localisation to the plasma membrane. This is 
analogous to the activation ofraf by ras, where ras is thought to be involved in 
recruiting rafto the plasma membrane where it can be activated by phosphorylation 
(Marais et al., 1995). This dominant gain offunctionpe/le has been used in epistasis 
experiments to show that pelle functions downstream of tube. One possible 
interpretation of this data that a signal from Toll somehow facilitates sequestration of 
pelle at the plasma membrane by tube where it can fulfil its signalling role. This 
could involve a signal dependent interaction of tube and Toll but yeast two-hybrid 
experiments show no signal independent interaction of the two. 
Cactus is homologous to a mammalian gene IKB which encodes the inhibitory 
component of NF-kB (Kidd, 1992). Like llcB, cactus protein is cytoplasmic where it 
is bound in a complex with dorsal homodimers (!soda and Nusslien-Volhard, 1994). 
Loss of cactus from this complex correlates with nuclear localisation Like IKB, 
cactus is rapidly degraded in response to signalling. Signal dependent degradation 
occurs by some direct mechanism as it does not require the presence of dorsal (Belvin 
et al., 1995). Both dorsal and cactus are phosphorylated in vivo. However, in 
contrast with the mechanism of activation of NF-KB it is dorsal, rather than cactus 
phosphorylation which correlates with nuclear localisation (Whalen and Steward, 
1994). Intriguingly, even null alleles of cactus do not completely abolish differential 
nuclear localisation of dorsal (Chasan and Anderson, 1993), indicating the existence 
of some cactus-independent mechanism of control, e.g.:- dependence of dorsal 
nuclear import on phosphorylation state. 
1.2.2. Pattern specification by dorsal 
Dorsal protein binds with differing affinities to a range of different promoter 
sites, with the consensus GGG(Aff)5CCC. When bound it can act as either a 
repressor or activator of transcription depending on the site and its context (Jiang and 
Levine, 1993). This allows the gradient of dorsal nuclear localisation to set up 
domains of expression of various target genes across the D-V axis, which then go on 
to define which regions become (from ventral to dorsal) mesoderm, neuroectoderm, 
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FIG. 10:- Diagram illustrating model of Toll activation leading to 
activation of dorsal. 
Follicle cells 
~ 
zymogen cascade 
anake 
{ 
~ Perlvitelline 
easter Space 
--... lplltzle -------... 
Plasma membrane 
pelle 
8-✓ ' . 
Cactua degradation _ ? ? 
~ / ~~ 
Cytoplasm 
Nucleus 
dorsal epidermis or amnioserosa. Perhaps the simplest example of the importance of 
site affinity in pattern specification by the dorsal protein gradient is seen in the control 
of twist expression. Twist encodes a helix-loop-helix (HLH) type transcription factor 
which is expressed in a steep dorsal-dependent gradient from ventral (high) to lateral 
(low). The pattern of expression of twist is due to a small region of the twist 
promoter known as a ventral activator region 01 AR). This region was defined by its 
ability to drive early ventral transcription of a heterologous promoter (HSP-70) (Pan et 
al., 1991). The VAR contains a number of essential low affinity dorsal binding sites. 
Variation of the number and affinity of dorsal sites in the VAR changes the pattern 
and the gradient of expression seen in reporter assays. 
It should be noted, however, that there is no simple mapping between the 
domains of expression or repression of dorsal target genes and the affinity of the 
dorsal binding sites thought to be responsible for controlling expression. For 
instance, zerknullt (zen) and decapentaplegic (dpp), which are both repressed 
ventrally by dorsal, have nearly identical domains of expression, but whereas 
repression of zen appears to be due to a small number of high affinity dorsal binding 
sites, repression of dpp is thought to be due to a larger number of weak dorsal 
binding sites (Huang et al., 1993). What does seem to be important in controlling the 
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domain of expression of dorsal target genes is the context of the sites driving 
transcription. The sites necessary for ventral repression of zen, dpp, and tolloid (t/1) 
are all present in ventral repression elements (VRE's). These are negative enhancers 
(or silencers), definable by their ability to overcome the activity ofheterologous 
promoters independent of orientation and context, and by their ability to act over large 
distances (Huang et al., 1993; Jiang et al., 1993a; Kirov et al., 1994). Cross 
species comparison of the zen VRE has identified conserved T-rich regions adjacent to 
the dorsal binding sites which have been shown by mutagenesis to be essential for 
VRE action, although the nature of the factors which bind these sites is still unknown. 
In fact mutagenesis of these T-rich sequences can be used to convert the zen VRE into 
an enhancer, illustrating that the choice of repression or activation is context and not 
site sequence dependent (Kirov et al., 1993; Jiang et al., 1993a). The existence of a 
similar repressor element adjacent to a KB site in the IFN-y enhancer suggests that this 
repressor may be conserved in mammals (Nourbakhsh et al., 1993). A maternal 
factor which can bind this T-rich sequence and is capable of converting dorsal into a 
repressor when bound to the zen VRE, as well as NF-KB bound to the IFN-y 
enhancer, has recently been isolated in a functional screen in yeast (Lehming et al., 
1994). This factor, dorsal switch protein 1 (DSpl), hashomologytoamammalian 
gene HMG I(Y) and may be involved in the potentiation oftransactivation by NF-KB 
from the IL-2R promoter (John et al., 1995). 
Ultimately sharp domains of expression of dorsal target genes are specified 
by the interaction of dorsal with both transcriptional activators and repressors, some 
of which are dorsal targets genes themselves. One good example of this is the control 
of expression of the repressor protein snail in the mesoderm. Expression of snail in 
the mesoderm is required for the restriction of neurectodermal genes, such as 
rhomboid (rho), to the lateral regions, so a sharp lateral boundary of snail expression 
is required for precise definition of the mesoderm/neuroectoderm boundary. Snail is 
initially expressed weakly in only the ventral-most nuclei. The domain of snail 
expression then gradually moves laterally during the next cleavage cycle (nuclear 
division, not cellular cleavage), but still with a poorly defined lateral boundary. This 
is then quickly refined to give strong uniform expression throughout the mesoderm 
with a sharp lateral boundary. In tw;-/tw;- mutant embryos this mature pattern fails 
to form (Kosman et al. , 1991 ). Analysis of the snail promoter has shown it to 
contain both dorsal and twist binding sites and it has been suggested that it is the sum 
of both the dorsal and twist gradients acting on this promoter that produces the strong 
and sharply defined late expression pattern of snail (Ip et al., 1992a). 
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Expression of dorsal target genes in the lateral regions of the embryo 
(prospective neuroectoderm) where the nuclear concentration of dorsal protein is low 
requires both dorsal and HLH proteins. A good example of this is the control of 
expression ofrhomboid (rho). rho expression is driven by an enhancer called the 
neuroectoderm enhancer (NEE), which contains a consensus snail binding site 
essential for ventral repression (Ip et al., 1992b), four dorsal binding sites and at least 
five consensus E-boxes (bHLH binding sites). In reporter studies, the loss of four of 
these E-boxes abolishes all expression apart from a low level of ventral expression in 
the syncytial blastoderm. In a sna-/sna- background expression is restored ventrally 
but not laterally, i.e.:- the E-boxes are required for lateral expression (Ip et al., 
1992b ). Exactly which HLH proteins are required is not currently known, however 
genetic studies show that embryos doubly or triply heterozygous for both dorsal and a 
number of bHLH protein encoding genes show severely abnormal neurectoderm 
development (Gonzalez-Crespo et al., 1993). Also, dorsal protein has recently been 
shown to physically interact with various HLH proteins in vitro, including the 
products of the twist and scute genes, which also bind co-operatively with dorsal to 
DNA containing adjacent dorsal binding sites and E-boxes (Gonzalez-Crespo et al., 
1993). Intriguingly the interactions between rel family, HLH family members and 
snail related proteins may be conserved in mammals. Evidence for this comes from 
the fact that the 1C immunoglobulin light chain enhancer (K enhancer), which normally 
controls a temporal pattern of 1C light chain expression during B-cell maturation, can 
be used to drive expression of a reporter gene in Drosophila to give an expression 
pattern almost identical to that of rhomboid (Gonzalez-Crespo and Levine, 1994). 
The 1C enhancer does not show any overall homology with the rhomboid NEE, but 
like the NEE it does contain consensus snail binding sites and E-boxes adjacent to KB 
sites. 
1.2.3. Summary 
This account illustrates the potential of rel family members for specifying 
positional information in embryos. It is important to note, however, that D-V 
patterning of a Drosophila embryo at the syncytial blastoderm stage, is not in any 
obvious way an event directly comparable to the establishment and patterning of the 
D-V axis inXenopus. In the former the germ layers are specified by the D-V 
patterning event itself, whereas in the latter patterning events are thought to take place 
in the prospective mesoderm ( on receiving inductive signals from the vegetal region of 
the embryo). It could be argued that the situation in insects, where patterning of the 
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early axes takes place in a syncytial blastoderm, provides a situation where 
morphogen gradients can be easily produced and utilised for patterning. This is a 
rather different situation to that found in vertebrate embryos where most patterning 
events take place in a cleaved embryo where it is less easy to envisage morphogen 
gradients forming across large parts of the embryo by free diffusion of a ligand. 
However, as discussed later (see page 46), a series of elegant experiments carried out 
by John Gurdon's group do in fact provide evidence that a peptide ligand can form 
gradients in a Xe no pus embryo by diffusion. 
On the molecular level comparisons between the two systems are much 
stronger. A number of developmentally important signalling pathways found in 
Drosophila are now known to exist in vertebrates, e.g.:- hedgehog and wingless 
signalling pathways and, as discussed, the Toll - dorsal pathway does seem to be, in 
some ways comparable with the IL-IR- NF-kB pathway. 
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1.3. Models of mesoderm induction and patterning in Xenopus. 
The aim of this section is to provide sufficient background for the discussion of 
phenotypes, and models of their origins, in later chapters. The section consists of an 
account of currently accepted models of pattern specification during the early stages 
of Xenopus development, and their experimental bases. The first part deals with 
classical models of this process, after a brief descriptive account of early 
development. The second part deals with models for the molecular nature of these 
processes. All stages referred to are as defined by Nieuwkoop and Faber (Nieuwkoop 
and Faber, 1967). 
1.3.1. A brief descriptive account of early Xenopus development. 
The unfertilised Xenopus egg is a single large cell with externally visible 
assymetry. One half of the egg, the animal hemisphere, is darkly pigmented due to a 
layer of pigment granules under the surface while the other half, the vegetal 
hemisphere, is a yellowish white, due to the high concentration of yolk granules it 
contains. The egg appears to be rotationally symmetrical about the animal-vegetal 
axis, and as discussed later (see page 31), this seems also to be true with respect to 
developmental potential. Internally the egg is divided into visually distinct cortical 
and inner cytoplasmic layers. After fertilisation the cortex rotates approximately 30° 
with respect to the inner cytoplasm, leading to the formation equatorially of a lightly 
pigmented arc on one side of the embryo, corresponding to pigmented animal 
cytoplasm underlying unpigmented vegetal cortex (in some amphibia, e.g.:- Rana, 
this is known as the grey crescent). As discussed later ( see page 31 ), this arc marks 
the future dorsal side of the embryo. The direction of cortical rotation is determined 
by the site of sperm entry so that the arc of reduced pigmentation forms on the 
opposite side to the sperm entry point. Shortly following this event cleavage begins. 
During cleavage a cavity opens up in the animal hemisphere called the blastocoel 
( embryos from stage 7-9 are referred to as blastulae ). 
There is quite a high degree of topographic projection from the fertilised egg 
onwards. This combined with the fact that the first few cleavage planes usually 
follow a predictable pattern6 has allowed the construction of probabilistic' fate8 maps 
6 It is important to note that no particular pattern of cleavage is necessary for normal development. 
7 The maps are probabilistic because of slight variations in the positioning of cleavage planes, and 
because of the extent of cell mixing during later stages. 
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by the labelling of individual blastomeres during early cleavage (e.g.:- Dale and Slack, 
1987a). Briefly, such studies, along with later stage fate maps, have shown that the 
ectoderm arises from the animal hemisphere, with future epidermis arising mainly 
from the ventral half and future neural plate from the dorsal half. Mesoderm arises 
from a torus of material around the equator, but not from the surface layer, the dorsal 
part of which has an endodermal fate. The equatorial region can be further 
subdivided with mesodermal tissues arising from positions along the dorsal-ventral 
(D-V) axis roughly corresponding to their final D-V arrangement (following 
gastrulation), with head mesoderm also arising dorsally. The remaining endoderm 
arises from the vegetal hemisphere (summary from Slack, 1991). 
During stage 9 the inner cells of the animal hemisphere undergo radial 
intercalation so that the animal hemisphere thins from 3-4 cells down to just two cell 
layers, leading to an expansion of the animal cap vegetally, and a convergence of 
animal cells in the marginal zone (the equator of the blastula). This process is known 
as epiboly. Gastrulation begins at stage 10 with the formation of a darkly pigmented 
arc called the dorsal blastopore lip, on the future dorsal side on the edge of the vegetal 
hemisphere. This lip then extends ventrally to form a complete circle (the 
blastopore). As gastrulation proceeds epiboly continues, leading to the closure of the 
blastopore, which ends up in a ventral, posterior position. During gastrulation the 
future mesoderm involutes and migrates over the blastocoel roof leading to the 
collapse of the blastocoel, and the formation of a second cavity, the archenteron, 
which will become the gut lumen. Involution is driven by a co-ordinated pattern of 
radial intercalation of prospective mesoderm (Shih and Keller, 1992a). Extension of 
the mesoderm occurs to the greatest extent on the dorsal side, with the leading edge 
reaching well past the animal pole, and is driven by convergence of dorso-laterally 
involuting mesodermal cells towards the dorsal midline by medio-lateral intercalation 
(Shih and Keller, 1992a). This process continues after gastrulation in the dorsal 
mesoderm and other tissues (Discussed in Keller, 1992) leading to lengthening of the 
embryo. The future head mesoderm behaves slightly differently. It is derived from 
the leading edge of the involuting mesoderm and becomes morphologically distinct 
early in gastrulation due to the fact that, instead of undergoing convergence and 
extension, it actively migrates over the blastocoel roof (Winklbauer and Nagel, 
1991). The next stage of development is known as neurulation. During neurulation 
the neural plate (future central nervous system) forms from ectoderm overlying the 
8 Note that Cate refers to 'the future experience of a region of the embryo ... , [ and] does not imply 
anything about the commitment of the region in question' (Slack 1991 ). 
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dorsal mesoderm, and rolls up to form the neural tube, overlain by epidermis arising 
from ectoderm adjacent to the neural plate. 
1.3.2. Classical Models 
Early development can be viewed as a process of symmetry breaking. The 
first such event in Xenopus development is cortical rotation which breaks the rotational 
symmetry around the animal-vegetal axis so that the resulting arc of reduced equatorial 
pigmentation attains a dorsal fate. The causal connection between the cortical rotation 
and future establishment of fate has been confirmed by experiments using inhibitors of 
microtubule polymerisation, such as U. V. irradiation shortly after fertilisation , to 
inhibit cortical rotation (Malacinski et al., 1975). At their most extreme these 
treatments lead to the formation of rotationally symmetrical 'ventralised' embryos. 
The mechanism of action of the U.V. treatment used in these experiments is confirmed 
by phenotypic rescue experiments where treated embryos are immersed in a solution of 
Ficoll (a polysaccharide which osmotically removes water from under the vitelline 
membrane preventing free rotation), and then tipped, allowing the cortical rotation to 
occur under the influence of gravity (Scharf and Gehart, 1980). 
In order to understand how cortical rotation might lead to the establishment of 
dorsal-ventral patterning it is important to understand the context into which such a 
patterning event must fit. One of the most important, and well accepted concepts of 
amphibian development is that, in order for mesoderm to form, inducing signals must 
pass from vegetal to equatorial cells. This phenomenon was initially discovered in 
urodeles with experiments which were later repeated by the same groups using 
Xenopus. Specification experiments performed by Nakamura and Takasaki using 
Triturus showed that explants from the equatorial region of the mid-blastula formed 
mesoderm in neutral culture, whereas explants from the same regions of 32-64 cell 
embryos became ciliated ectodermal cells (Nakamura and Takasaki, 1970). Taken 
together with work by Nieuwkoop and colleagues showing that blastula animal cap 
explants, which form 'atypical epidermis' when cultured alone, could be induced to 
form mesoderm when combined with vegetal explants (Nieuwkoop, 1969a), this lead 
to the hypothesis that mesoderm inducing signals from the vegetal hemisphere were 
essential for the induction of mesoderm equatorially. The original experiments 
demonstrating the existence of these signals involved combining blastula 'animal cap' 
explants with vegetal pole tissue of the same stage and scoring the mesoderm induced. 
In fact, heterochronic combinations of animal and vegetal explants have shown that 
31 
mesoderm induction is initiated during cleavage (Jones and Woodland, 1987). These 
experiments put the beginning of animal cap competence between stage 6 and 6.5 (64 
cell stage) ending at around stage 10.59• Secretion of the inductive signal may begin 
even earlier and is over by stage 11. The fact that mesoderm induction is already 
occurring in cleavage stage embryos means that, at least at these stages, mesoderm 
induction occurs independently of transcription, as zygotic transcription does not 
begin until the Mid-Blastula Transition (MBT) at about stage 8.5 (Newport and 
Kirschner, 1982). 
Early models of the nature of the asymmetry established by cortical rotation 
were based on the results of investigations into the nature of the mesoderm induced in 
animal caps when combined with different regions of the vegetal hemisphere. Such 
experiments show that dorsal-ventral polarity is present in the vegetal hemisphere and 
is communicated to the prospective mesoderm by induction (Nieuwkoop, 1969(b)). 
This conclusion is backed up by the results ofblastomere ablation and transplantation 
experiments. At the eight cell stage ablation of either of the two dorso-vegetal cells 
produces ventralised embryos (Kageura and Yanama, 1984). At the 32-cell stage 
dorsal blastomeres from both the vegetal-most tier and those from the overlying tier 
can rescue U.V. ventralised embryos when transplanted into their corresponding 
positions (Gimlich, 1986). As the vegetal-most dorsal blastomeres are fated not to 
become mesoderm, but to contribute to the endoderm, it has been suggested that these 
cells contain at least part of a vegetal dorsal signalling centre. Interestingly, at the 
eight cell stage substitution of either of the two ventro-vegetal blastomeres for a dorso-
vegetal one leads to the formation of double axis embryos (Kageura and Y anama, 
1986). The converse experiment, however, produces no phenotype. This result has 
been taken to imply that the signal emitted by the dorsal-vegetal signalling centre is 
dominant over the ventral inducing signal. This signalling region is now generally 
referred to as the Nieuwkoop centre. 
This, however, is not the complete extent of dorsal/ventral patterning in the 
blastula. It has been known for some time that notochord formation can be induced 
by vegetal hemispheres in conjugates containing isolated dorsal but not ventral animal 
cap halves. This bias is also seen with respect to induction of animal cap halves by 
mesoderm inducers activin (when used externally) and bFGF (when injected as 
mRNA (see p.39)); (Sokol and Melton, 1991; Kimelman and Maas, 1992). In both 
9Note - Studies of induction with activin put the end of competence as later (S 11.5), this may be 
because the Jones and Woodland study scored only dorsal and intermediate mesoderm. 
32 
cases the differential response of dorsal and ventral animal cap halves is not seen in 
animal caps from U.V. irradiated embryos. This demonstrates a causal connection 
between the 'competence pre-pattern' exhibited by the animal hemisphere and the 
cortical rotation. Interestingly, dissagregation of animal caps from U.V. ventralised 
embryos can restore competence to respond to high activin concentrations by 
producing dorsal mesoderm as long as the caps are re-aggregated before control stage 
10 (Green et al., 1994; also see page 45). Thus the competence prepattern appears to 
arise from the presence of a diffusible ventralising agent on the ventral side. The 
developmental significance of this pre-pattern currently remains obscure. 
The molecular nature of the Nieuwkoop centre signal is hinted at by the 
teratogenic effects of lithium on cleavage stage embryos. Such treatment produces, 
as a most extreme limit form, rotationally symmetrical antero-dorsalised embryos. 
One of the major biochemical effects of lithium is to inhibit the enzyme inositol-1-
phosphatase, which is essential for the re-synthesis of the pool of target lipid 
phosphatidylinositol-4,5-bisphosphate (PIP2) in the phosphoinositide signalling 
pathway. As the pool of PIP2 in the plasma membrane available for signalling is 
limited this leads to an inhibition of the phosphoinositide signalling pathway 
(Berridge, 1989) . That the teratogenic effects of lithium are due to this biochemical 
effect is confirmed by the fact that lithium has been shown to inhibit an increase in 
endogenous levels of the second messenger inositol-1,4,5-trisphosphate (lnsP3) 
occurring at the 32-64 cell stage (Maslanski et al., 1992) and that the lithium 
phenotype can be rescued by injection of inositol (Busa and Gimlich, 1989). 
The simplest interpretation of this data is that the lithium phenotype results 
from the inhibition of a signalling pathway, suggesting that an active ventral signal is 
required for induction of ventral mesoderm, and that dorsal mesoderm is formed as a 
default in its absence. That the limit form of the phenotype is not just dorsalised, but 
dorso-anteriorised could be taken to imply that the instructive nature of the 
Nieuwkoop centre is more complex than merely specifying dorsal mesoderm. This 
need not be the case as the fate maps indicate that while head mesoderm arises solely 
from the dorsal-most mesoderm of the blastula, the dorsal trunk mesoderm has a large 
contribution from laterally involuting cells due to medio-lateral intercalation. 
Presumably these cells achieve a more anterior fate in embryos where the entire 
marginal zone has been re-specified as organiser by lithium treatment. It is difficult 
to understand, however, how the same argument could be applied to explain the 
range of phenotypes, from headless to radially ventralised, resulting from U. V. 
treatment. Another implication of the phenotype is that, as the limit form is 
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rotationally symmetric, the competence pre-pattern of the animal cap appears to be 
either unnecessary for dorsal tissue formation, or dependent (directly or indirectly) on 
the signal inhibited by lithium. 
Of course, talking simply in terms of dorsal and ventral fates is an 
oversimplification. Some patterning mechanism must be responsible for specifying 
intermediate fates. Interestingly, at the blastula stage the fate map differs 
significantly from the specification map10 with respect to intermediate tissues. For 
example, 60% of somite is fated to come from the ventral marginal zone (Dale and 
Slack, 1987a), but when blastulae are divided in half, the ventral halves form only 
ventral mesoderm, and little or no muscle (Dale and Slack, 1987b ). These 
experiments imply the presence of a 'dorsalising' signal emanating from the dorsal half 
of the embryo. Experiments using explant combinations have shown that this signal 
comes from tissue arising from an arc of approximately 60° in the dorsal most region 
of the marginal zone, and that dorsalisation itself takes place mainly during 
gastrulation. This idea fits well with one of the most famous experiments in 
amphibian embryology-the organiser graft (Spemann and Mangold, 1924). This 
experiment, originally done with newt embryos but easily repeatable in Xenopus 
(Smith and Slack, 1983), involves grafting the dorsal blastopore lip of a stage 10 
embryo onto the ventral marginal zone of a donor embryo. This results in the 
formation of a double embryo, with the grafted lip contributing mainly to the 
notochord and prechordal plate of a secondary axis. Most importantly however, the 
graft 'organises' ( dorsalises) the surrounding prospective ventral mesoderm to form the 
rest of the mesoderm of the secondary axis (i.e.:- intermediate mesoderm such as 
somites and lateral plate etc.). As the dorsal blastopore lip region and the earlier 
dorsalising centre of the blastula dorsal marginal zone are contiguous structures it 
seems sensible to consider them as different developmental stages of the same 
phenomenon (the organiser). 
The events of mesoderm induction and dorsalisation are summarised by the 
three signal model (see figure 11) proposed by Slack and colleagues (Smith and Slack, 
1983). In this model the mesoderm inducing signals emitted by the vegetal 
hemisphere consist of one found both dorsally and ventrally (signal 1), and a 
dominant second signal activated by cortical rotation (signal 2, also called the 
Nieuwkoop centre signal) which is present only dorsally. This asymmetry then 
1 ospecification here is used to mean 'commitment of a commitment of a tissue region which is 
manifested on culture in a neutral medium but may still be reversible' (Slack, 1991) 
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induces the formation of a 'dorsalising centre' in the dorsal marginal zone which 
secretes the third signal. One way of reconciling this model with the implications of 
the lithium phenotype is simply to propose that one of the effects of signal 1 is to 
stimulate IP3 levels, and that the sole purpose of signal 2 is as an antagonist of 
phosphoinositide signalling. This satisfies the criterion that signal 2 should be 
dominant, with lithium acting to mimic its effect. The three signal model, while 
providing a framework for future work, is probably an oversimplification. It is 
particularly important to bear in mind that each of the three signals could actually be a 
combination of different inducers and/or different concentrations of the same inducing 
agent, and that the same inducing agents may have different developmental effects at 
different stages of development. It is also important to bear in mind that the actual 
time windows for particular inductive events may be much tighter than those 
suggested by classical experiments with limited resolution. 
Kimelman and colleagues, synthesising data from a variety of sources, have 
proposed a more detailed model of organiser action than that outlined in the three 
signal model (Kimelman et al., 1992). A comparison of the fate map at 32 cells with 
the specification map at 128 cells shows a significant difference with respect to the 
region which will contribute to notochord. The fate map shows animal cells from 
close to the marginal zone forming notochord, but the specification map shows that 
this state of specification has not been achieved by the 128 cell stage (Dale and Slack, 
1987(a) and (b)). In fact, notochord specification seems to be due to an inductive 
signal secreted by the lower DMZ. The evidence for this comes from some elegant 
experiments combining normal and U.V. ventralised stage 9 embryos cut between the 
upper and lower DMZ which show that lower DMZ from a normal embryo can induce 
ventralised upper DMZ to form notochord (Stewart and Gerhart, 1991). The lack of 
secondary notochord induction in Spemann organiser grafting experiments shows that 
the ability of DMZ to induce notochord formation (or the competence to respond to 
those signals) has disappeared by stage 10 even though the ability to dorsalise ventral 
mesoderm ( or the competence to respond) is obviously not lost. Collectively this has 
lead Kimelman and colleagues to propose that the role of the blastula organiser (in the 
lower DMZ) is to induce notochord (in the upper DMZ), and that the prospective 
notochord then acts as a source of the late organiser signal, dorsalising the ventral and 
lateral mesoderm as it converges on the dorsal mid-line during gastrulation (see page 
30). The lower DMZ becomes the prospective head mesoderm (head organiser ?) 
during gastrulation. 
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FIG. 11:- The Three Signal Model. 
0 oogenesis A V 
\ 
A 
VY 
early gastrula \ blastula fertilized egg 
later gastrula early neurula 
The three areas A (animal), VV (ventro-vegetal) and DV (dorso-vegetal) are set up in 
the egg as a result of oogenesis and the postfertilisation cortical rotation movements. 
In the blastula stages, the DV region emits a signal which induces the organiser (0) 
and the VV region emits a signal which induces default, or ventral type, mesoderm 
(M3). During gastrulation, the organiser emits a third, graded, signal, termed 
dorsalisation, which regionalises the mesoderm into zones forming somite (Ml), 
lateral plate (M2) and blood islands (M3). Finally. neural induction by the archenteron 
roof is shown. This occurs progressively during gastrulation (Figure from Slack, 
1991). 
Organiser grafted embryos frequently form, not just a second trunk, but a 
complete double embryo including a head. This obviously suggests some element of 
antero-posterior pre-patterning exists (implicitly or explicitly) in the dorsal blastopore 
lip (DBL) at stage 10. The extent to which such patterning can occur is limited by the 
extent of cell mixing which occurs during gastrulation. As the DBL in Xenopus is 
small and the prospective mesoderm lies below the surface, detailed fate mapping is 
technically very difficult. Equivalent experiments carried out in the urodele Cynops 
show a projection of approximately head-trunk-tail resolution (Okada and Hama, 
1945). However, when the state of specification of these regions was investigated by 
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culturing the appropriate regions wrapped in ectoderm, the regions fated to become 
head and trunk both formed dorsal axial mesoderm, and the prospective tail formed 
only epidermis (Hama et al., 1985). Thus, the 'pre-patterning' of this region is 
implicit, presumably requiring the correct tissue movements in its normal 
embryological context to form the right structures. One example of how this may 
occur, comes from work by Ray Keller on the organising properties of the epithelium 
of the DBL inXenopus. As already mentioned, inXenopus the surface 'epithelial' 
layer of the dorsal marginal zone (DMZ) has an endodermal fate, and does not mix 
with the deep prospective mesoderm. However, organiser grafts can be successfully 
carried out using this tissue, leading to the formation of a secondary trunk, but no 
head structures (Shih and Keller, 1992b ). In fact the direction of convergent 
extension of mesoderm induced by epithelial DMZ grafts is dependent on the 
orientation of the graft. This suggests a role for this layer in organising directed 
convergent extension, Interestingly, during normal development, the epithelial layer 
loses contact with the prospective head mesoderm (which does not undergo 
convergent extension) early in gastrulation (stage 10.5). The timing of this event 
correlates quite precisely with the onset of differential head/trunk marker expression 
(see page 38) and soon afterwards (stage 11) head mesoderm becomes 
morphologically distinct from prospective axial mesoderm (see page 30). 
Anterior-posterior (A-P) patterning in the other two germ layers is thought to 
arise from signalling from the mesoderm during and after gastrulation, although 
comparatively little is known about this process in endoderm (reviewed in Slack, 
1991). The ability ofmesoderm to induce and pattern neural tissue from the animal 
hemisphere (reviewed in more detail in Slack and Tannahill, 1992) was first indicated 
by the fact that secondary axes arising from organiser grafts have a secondary nervous 
system with correct A-P patterning 11 • This patterning occurs by a combination of at 
least two types of signal. Explant combinations have been used to show that 
mesoderm can induce the formation of neural tissue with positional specification 
slightly anterior to its own (reviewed in Slack and Tannahill, 1992). This is known 
as vertical or appositional induction. It is also possible that a series of vertical signals 
received during gastrulation as the dorsal mesoderm moves underneath the prospective 
neural plate are important for patterning (Sive et al., 1989) It has also become clear 
recently that some neural induction and patterning can occur via inducing signals 
travelling through the plane of the ectoderm from the organiser during gastrulation 
(Doniach et al., 1992; Ruiz-i-Altaba, 1992). This process is known as planar 
l l This arises from ventral animal cap whose nonnal fate is epidennal. 
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induction. It seems likely that the final A-P positional character of the neural plate is 
a result of a combination of vertical and planar inductive signals, possibly along with 
further signalling within the neural plate itself. 
It is interesting to note that the expression patterns one might predict for neural 
inducers and organiser signals are essentially similar 
1.3.3. The molecular nature of mesoderm induction and patterning 
For the sake of simplicity in this section I shall deal almost exclusively with 
the molecular nature and activity of candidates for endogenous inducing factors, 
leaving discussion of transduction of such signals, and specification activities of 
transcription factors to the relevant sections of the results and discussion chapters. 
Non secreted gene products will only be discussed as markers of specification. 
Encouragingly, the expression patterns of almost all of the mesodermal markers 
expressed in the late blastula cloned so far conform to what might be predicted by the 
three signal model. Markers can be divided into three groups based on their blastula 
expression patterns. They are either pan-mesodermal, such as Xbra and snail, 
organiser specific such as Goosecoid (gsc), Xlim, pintallavis and noggin, or 
ventrally expressed ( everything but the organiser) such as Xwnt-8 and Xpo. Xnot 
expression is initially ubiquitous (stage 9), but gradually becomes restricted, first to 
the mesoderm and then to the organiser region. By stage 10.5 it is localised within the 
organiser to non-involuted cells not adjacent to the lip (Yon Dassow et al, 1993). It 
appears to be a very early marker of prospective trunk, but not prospective head 
regions of the organiser, and as such suggests that specification of head and trunk 
mesoderm has begun by stage 10.5. 
Inducin~ a~ents 
There are currently three experimentally testable requirements which must be 
fulfilled by a factor in order to qualify as a potential mesoderm inducer. The first of 
these is mesoderm inducing activity as tested in an animal cap assay. Such 
experiments can take the form either of direct treatment of animal cap explants with 
soluble protein, or of auto-induction of caps excised from embryos injected with a 
specific transcript. These experiments also provide evidence of the type of inducing 
activity possessed by the factor, although competence pre-patterning of the cap 
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complicates the interpretation of such data. In addition to experiments of this form, 
overexpression experiments in whole embryos can frequently give clues to the 
potential in vivo role(s) of an inducing agent. The second requirement is that the 
potential mesoderm inducer be expressed, in an active form, in the right place at the 
right time as suggested by the classical models, e.g.:- the three signal model. It 
should be noted however that expression patterns do occasionally suggest activities 
not previously predicted. Finally, the third experimental requirement, which 
provides evidence that a factor may be necessary rather than merely sufficient for an 
inductive event, is that inhibition of signalling by the factor in whole embryos 
produces a phenotype consistent with the factor's predicted role. Such evidence comes 
from the expression of dominant inhibitory mutants of receptors or ligands12. The 
problem with this form of experiment is that the specificity of oligomerisation of 
receptors used in these experiments, with related receptors or other signalling 
components, is not currently well understood. 
All mesoderm inducers currently characterised are members of the FGF or 
TGFP super-families of peptide growth factors (PGF's) and can be grouped into four 
classes with distinct activities. Incubation of animal cap explants with members of the 
FGF family only induces formation of ventral type mesoderm in animal caps (Slack, 
1987). However, in auto-induction assays with bFGF animal caps form both dorsal 
and ventral mesoderm, presumably because of longer and/or earlier exposure of the 
induced cells (Kimelman and Maas, 1992). TGF P2 and activin, both members of the 
TGF-P superfamily, can induce a range of mesodermal types from ventral at low 
concentrations, through dorsal axial mesoderm at intermediate concentrations to head 
mesoderm at the highest concentrations (Green and Smith, 1990; Green et al., 1990). 
The complex nature of this dose response and its possible significance will be 
discussed later. The cloning of a maternally expressed Xenopus member of the TGFP 
superfamily named V g-1 around the same time as the inducing activity of activin was 
discovered raised hopes that an endogenous mesoderm inducer had been found (Weeks 
and Melton, 1987). Initially, however, no inducing activity, by injected mRNA or 
by purified protein, could be detected. Further investigation showed that the 
exogenous protein was not being processed in vivo into a (predicted) active form 13. 
This problem was eventually overcome by two separate groups using the same 
12for a discussion of the design and action of dominant negative PGF-R's see chapter 6 
13 All TGFP family members are thought to require dimeristaion and proteolytic cleavage to generate 
the active form. 
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approach of fusing the predicted active region of V g-1 to the pre-proregion of a more 
readily cleaved member of the TGFl3 superfamily. The results obtained by these two 
groups appear, however, to be conflicting. A Vg-1/BMP-2 fusion generated by 
Thomsen and Melton containing the BMP-2 proteolytic cleavage site can induce the 
whole range of mesodermal tissues in auto-induction assays (Thomsen and Melton, 
1993). Another fusion, made by Dale and colleagues, using the cleaved region of 
BMP-4, but this time retaining the V g-1 cleavage site, has only ventral and lateral 
mesoderm-inducing activity (Dale et al., 1993). Whether this difference simply 
reflects a difference in the maximum amount of cleaved product that can be generated, 
or some more fundamental difference such as dimerisation specificity is not yet clear. 
It is important to note that the activity of the Vg-1/BMP-2 fusion in axial rescue assays 
(see below) clearly makes processed V g-1 activity distinct from that of activin. 
Finally, BMP4 and BMP2, also members of the TGFJ3 superfamily can induce 
extreme ventral mesoderm in auto-induction assays (Dale et al., 1992), and as protein 
secreted by transfected COS cells (Koster, 1990). Somewhat suprisingly for a 
putative ventral mesoderm inducer, it has been shown that BMP-2/-4 induction of 
ventral mesoderm is dominant over activin (Jones et al., 1992). 
Animal cap assays only give an idea of the type of mesoderm which can be 
induced in isolation by a particular factor. An idea of how these factors might act in 
vivo can be gleaned from the results of whole embryo expression studies For 
example, factors which can completely rescue axial development in U.V. ventralised 
embryos when 'unilaterally' injected, or can induce a complete second axis by ventral 
injection, are candidates for the Nieuwkoop centre signal, and/or for a complete 
organiser signal. The only characterised mesoderm inducer which falls into this 
category is Vg-1 (in the form of Thomsen and Melton's Vg-1/BMP-2 fusion). In the 
same assay activin only rescues trunk development (Steinbeisser et al., 1993), 
suggesting, if the three signal model holds, that it could be a component of the 
organiser signal, but is not a Nieuwkoop centre signal candidate. Injection of mRNA 
encoding BMP-2 or -4 seems to have the opposite effect to activin in that dorsal 
injection of normal embryos leads to ventralisation (Dale et al., 1992; Jones et al., 
1992). Interestingly embryos ventralised in this fashion differ from embryos 
ventralised by U.V. treatment in that they form what looks like a normal blastopore. 
This has been taken to imply that BMP-4 acts late to ventralise mesoderm, possibly 
during gastrulation (Dale et al., 1992). A dominant ventral mesoderm inducing 
activity such as this is seems to conflict directly with the classical data. It is difficult 
to understand how organsiser grafts can induce a second axis in the presence of a late 
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acting dominant ventralising signal. A possible resolution of this apparent paradox is 
discussed later (see page 48). 
Mapping the distribution of active PGF's is not a simple matter. Although 
the distribution of transcripts can be assayed easily by in situ hybridisation or RNase 
protection assay, mapping the distribution of secreted PGF's has proved more 
difficult. The situation is complicated in the case ofTGF-~ family members by their 
requirement for post-secretion processing (involving a specific protease) in order to be 
active. Unfortunately no data so far exists on the distribution of active forms ofTGF-
~ family members, or of proteases capable of cleaving them. An additional 
complication with FGF family members is that the effective affinity of ligand for 
receptor can be positively or negatively regulated by the local concentration of 
different proteoglycans (Mason, 1994). 
A number of forms of FGF are found in the early Xenopus embryo. aFGF 
(FGF-1) and bFGF (FGF-2) were early candidates for endogenous mesoderm 
inducers, as they are both expressed maternally (Slack and Issacs, 1989). The 
distribution of secreted bFGF and aFGF can not be easily mapped, however 
intracellular aFGF and bFGF are not localised. As neither of these molecules 
contains a signal sequence their secretion in vivo was initially thought to be doubtful. 
More recently, evidence has accumulated that the lack of a signal sequence need not 
prevent secretion under all circumstances (reviewed in Mason, 1994). Consequently, 
some form of controlled secretion of bFGF and/or aFGF cannot be ruled out. The fact 
that injected bFGF mRNA can induce mesoderm formation in animal cap explants 
(Kimelman and Maas, 1992) shows that secretion is at least possible, but this effect is 
only seen at highly non-physiological expression levels (Thompsen and Slack, 1992). 
Another hopeful candidate for an endogenous FGF family mesoderm inducer, 
complete with signal sequence, is Xenopus embryonic FGF (XeFGF), which is most 
closely related to mammalian FGF-4 and FGF-6 (Issacs et al., 1992). XeFGF mRNA 
is expressed at low levels maternally and at much higher levels zygotically, peaking 
during gastrulation. In situ hybridisations have shown that the zygotic expression is 
initially localised to the dorsal blastopore lip. This expression then extends completely 
around the forming blastopore, before becoming concentrated dorsally in both 
mesoderm and ectodenn in the posterior of the forming axis during the gastrula and 
neurula stages. At the tailbud stage, expression becomes limited to the tailbud. 
XeFGF has been shown to be part of an autoregulatory loop with the mesodennal 
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marker Xbra14, so that overexpression of either in animal caps will induce expression 
of the other (Isaacs et al., 1994). This suggests a role for XeFGF in maintenance of 
mesodermal fate during gastrulation. This is backed up by marginal zone 
dissagregation experiments showing that XeFGF can substitute for an endogenous 
factor lost in dissagregated culture which is necessary for the maintenance of Xbra 
expression in these cells during gastrulation, and that it has this activity after the 
ability of FGF to induce mesoderm formation in animal caps is lost. 
The strongest evidence for an in vivo role for FGF in mesoderm induction 
comes from the phenotypic effects of overexpression of a dominant negative FGF 
receptor known as XFD. FGF receptors belong to the tyrosine kinase family of 
transmembrane receptors, and like other members of that family undergo ligand 
dependent dimerisation leading to auto-phosphorylation (reviewed in Mason, 1994). 
Phosphorylation occurs on multiple tyrosine residues, turning them into binding sites 
for SH2 domain containing proteins such as Phospholipase C-y (PLC-y) and the ras 
recruiting factor Grb-2, which are then phosphorylated by the receptor. XFD is a 
truncated form oftheXenopus FGFR-1 (also called flg-1), which lacks the 
intracellular tryosine kinase domain. It can completely abolish the response of 
Xenopus oocytes expressing exogenous wild type receptor to FGF treatment, as 
assayed by the ability of FGF to cause an increase the intracellular calcium 
concentration (Amaya et al., 1991). 
The penetrance of the XFD phenotype is variable (possibly due to limited 
diffusion of RNA targeted for translation on the rough endoplasmic reticulum (rER)). 
The most extreme embryos have extreme trunk deficiencies, showing little or no 
development of somites or notochord but develop completely normal heads (Amaya 
et al., 1991). Ventrally, they usually form hearts, but these are generally abnormal, 
and blood is found ectopically or not at all. Gastrulation in these embryos is 
abnormal, with incomplete lateral and ventral invagination and involution, resulting 
in failure of the blastopore to close and its positioning dorsally. It is often difficult 
with such phenotypes to separate cause from effect when trying to dissect effects on 
mesodermal specification from effects on gastrulation. However, analysis of the 
mildly affected embryos has shown that, even when gastrulation proceeds apparently 
normally, muscle and notochord formation is impaired (Amaya et al., 1993). 
Moreover, this effect appears to be direct, as lineage marking experiments involving 
co-injection of lacZ m.RNA show a precise correlation between muscle defects and 
14See chapter 7 for discussion ofXbra properties & expression. 
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XFD expression. Analysis of early marker expression has shown that, consistent 
with a role for XeFGF in controlling its expression, Xbra expression is inhibited by 
XFD. The fact that expression of the immediate early lateral and ventral mesodermal 
marker Xpo is also inhibited also suggests an essential role for some form of FGF in 
the specification of ventral mesodermal fate. Not suprisingly maybe, expression of 
goosecoid, an early dorsal lip marker which becomes a marker of prospective head 
mesoderm during gastrulation, is unaffected. 
The situation with regard to the precise nature of endogenous activin like 
signalling molecules is more ambiguous. Activins are active as cleaved homo or 
heterodimers of activin PA and PB chains ((PA)i is referred to as activin A, (PB)i as 
activin B and (PA/PB) as activin AB). Zygotic expression of activin PB begins in the 
blastula, whereas activin PA expression commences towards the end of gastrulation 
(stage13.) Although no activin transcripts are present maternally there is evidence for 
the presence of a maternal activin protein from activity purification experiments 
(Asashima et al., 1991 ). The dimeric nature of activins makes them ideal targets for 
dominant negative interference clones. Although no experiments with such inhibitors 
have been carried out to date in Xenopus, an elegant set of activin dominant negative 
experiments have been carried using the teleost Oryzias latipes (Japanese Medaka), 
which distinguish between the contributions of maternal and zygotic activin (Wittbrodt 
and Rosa, 1994). Two dominant negative constructs were used. One of these, an 
uncleavable activin variant could inhibit mesoderm induction by co-expressed activin, 
presumably by forming an inactive dimer, but not by exogenous activin. 
Overexpression of this variant produced no phenotype. However, overexpression of 
the other activin dominant negative, which was thought to act as an antagonist of the 
activin receptor, produced non gastrulating embryos completely lacking mesoderm. 
The conclusion then is that, at least in the Medaka, neither maternal nor zygotic 
activin transcripts are necessary for mesoderm induction, but maternal activin protein, 
and/or something which acts through the same receptor(s) is. 
Activins can also be specifically inhibited using follistatin, which is known to 
inhibit activins B and AB by binding to the activin p chain, and can inhibit some, but 
not all activities of activin A (e.g.:- Mather et al., 1993). Overexpression of 
follistatin in embryos at levels which Schulte-Merker and colleagues calculate should 
be capable of inhibiting predicted endogenous levels of activin activity produces 
completely normal embryos (Schulte-Merker et al., 1994). Therefore, they conclude, 
activins AB and B are not essential for mesoderm induction. However, it is 
interesting to note that at high levels (2ng down to 500pg) follistatin mRNA is 'toxic', 
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causing lethality at late gastrula, although gastrulation itself appears to proceed 
normally. Consistent with the theory that activin '3B expression is unnecessary for 
mesoderm induction or patterning, mice in which the activin PB gene has been 
disrupted form mesoderm normally (Vassalli et al., 1994). 
V g-1 is a much clearer candidate for a maternal endogenous mesoderm 
inducer. During oogenesis maternal Vg-1 transcripts become localised in a tight band 
close to the plasma membrane in the vegetal hemisphere, extending right up to the 
equator (Weeks and Melton, 1987; Kloc and Etkin, 1995). After fertilisation the 
RNA is released and diffuses to form a fuzzy vegetal band before being irreversibly 
localised by cleavage. This obviously puts V g-1 in the right place at the right time to 
be either signal 1 of the three signal model, or if processing is dorsally localised, a 
component of the Nieuwkoop centre signal. However, it is important to note that 
processed V g-1 has not been detected in vivo to date. 
The results of experiments using /:l.1 XAR 1, a dominant inhibitory form of the 
Xenopus activin type II receptor XARl, are a good illustrations of the problems of the 
dominant negative approach. As with the dominant negative FGFR the penetrance of 
the phenotype is highly variable, however, the most extreme examples form no 
mesoderm whatsoever, and show no signs of gastrulation (Hemmati-Brivanlou and 
Melton, 1992). This was initially taken as evidence that activin, or at least 
something acting through the same receptor, is essential for all mesoderm induction. 
However, it is now known that /:l.lXARl can inhbit induction ofmesoderm in animal 
caps by bVg-1 and BMP-4, as well as by activin (Schulte-Merker et al., 1994; 
Wilson and Hemmati-Brivanlou, 1995). As BMP-4 is thought to be late acting, the 
effect may be an indirect one on competence. This result is difficult to reconcile with 
the fact that the AlXARl phenotype can be rescued by the co-expression of wild-type 
XARl, which suggests that the targets of AlXARl are at least functionally equivalent 
to XARl. Interpretation of these results will obviously remain a problem until the 
interactions and activities ofTGF'3 receptors found in the early Xenopus embryos are 
better characterised. Because of the ambiguity surrounding the nature of the signal(s) 
blocked by AlXARl candidates will be referred to as 'activin-like' for the rest of this 
discussion. 
One of the more striking implications of the limit form of the /:l.lXARl 
phenotype is that the signal(s) which it blocks are necessary for the induction of 
mesoderm by FGF to occur in vivo. Mesoderm induction by FGF in animal caps is 
not inhibited by expression of AlXARl so this is not due to an effect on competence. 
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This would seem to leave effects on the control of translation or secretion (not to my 
knowledge investigated) which could take place pre-MBT, or more simply, control of 
expression, XeFGF being a candidate, which of course must be post MBT. In fact 
the relationship between the roles of the 'activin-like' signal and FGF in mesoderm 
induction is complicated. XFD can block the induction of a number of markers by 
activin in animal caps, suggesting an essential role for a secondary FGF signal (e.g.:-
XeFGF) in this process (Labonne and Whitman, 1994; Cornell and Kimelman, 
1994). Recent evidence suggests that the relationship between FGF and activin 
signals may be even more tangled. XFD can also block the induction of immediate 
early genes such as Xbra by activin (in the presence of cycloheximide ), suggesting a 
requirement for a prior or concomitant FGF signal (Labonne et al, 1995). This may 
at first seem difficult to reconcile with the fact that the ~lXARl phenotype suggests 
that activin is required for mesoderm induction by FGF. The resolution of this 
problem may lie in the observation that animal caps contain sub-inducing levels of 
activated MAPK which is inactive in animal caps expressing XFD. It therefore seems 
likely that the prior or concomitant FGF signal in caps is a sub-inducing, permissive 
signal, rather than the instructive inducing signal which is a component of the second 
signal. 
From investigations of the complex dose response to activin it is clear that 
activin is a very versatile mesodermal patterning agent. The most fruitful method 
used to investigate the dose response to activin has been to use dissaggregated animal 
cap cells which are washed and re-aggregated following treatment. The resulting 
tissue can then be cultured until a control stage convenient for measuring the 
expression levels of relevant markers. All mesodermal markers assayed at control 
stage 10.5, after treatment of dispersed cells for an hour and re-aggregation prior to 
S 10, show a broad dose response with expression quickly reaching a plateau as the 
activin concentration is raised. If however, the same markers are assayed at control 
stage 17 tight windows of expression are seen ( Green et al., 1994 ). For example, 
Xwnt-8 is expressed only in response to low concentrations of activin, Xbra only in 
response to low to intermediate concentrations, and Gsc only in response to high 
concentrations. This profile corresponds well to the results of the original animal cap 
induction experiments with activin which showed that head structures were induced at 
the highest concentrations, dorsal axial ones at intermediate concentrations and 
ventral mesoderm at the lowest. The later, refined expression pattern could result 
either from intercellular interactions after stage 10.5 or by some cell autonomous 
mechanism. In fact, experiments in which the cells are kept in a dissaggregated state 
show that cell-cell interaction is essential even for the maintenance of expression of 
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most markers. FGF in some form is an obvious candidate for at least a component of 
this secondary signal. 
An intriguing set of experiments involving re-aggregation of mixed 
populations of animal cap cells treated with different doses of activin suggests that 
secondary interactions following re-aggregation allow cells to 'poll' for their fate 
(Wilson and Melton, 1994). For example, mixtures of high dose treated cells with 
low dose treated cells form dorsal axial mesoderm expressing Xbra. If these cell 
populations had been kept separate the high dose treated cells would have expressed 
the head mesodermal marker Gsc and the cells receiving a low dose the ventral marker 
Xwnt-8. This could potentially solve the problem of how cells might accurately 
respond to an in vivo gradient of activin, but in itself, it does not constitute evidence 
for the existence of such a gradient. 
A set of rather elegant experiments by John Gurdon and colleagues has 
provided evidence that activin is capable of forming a gradient by some form of 
(active?) diffusion from a source across non-expressing tissue. They carried out a 
series of experiments involving the combination of lineage labelled animal caps with 
vegetal explants from embryos over-expressing activin (Gurdon et al., 1994). When 
the resulting conjugates were stained for expression of the pan-mesodermal marker 
Xbra, which is induced by medium but not high concentrations of activin, a band of 
expression was seen up to 6-cell diameters from the source tissue, with no expression 
seen in the intervening tissue. Gsc on the other hand, which is induced only by 
higher concentrations of activin, produces a band of expression including 
immediately adjacent cells, but which does not extend as far as the outer border of 
Xbra expression. These results are consistent with the formation of a gradient of 
activin by diffusion from the over-expressing tissue. The fact that this tissue can be 
successfully replaced by an activin soaked agarose bead shows that no extra signal is 
needed from the inducing tissue. It also seems that the result does not stem from the 
action of some 'relay mechanism' in which activin induces its own expression ( or that 
of some other 'activin-like activity'), as the same result is obtained if the two explants 
in the conjugate are separated by a 'neutral' tissue (Xenopus gut) which has been pre-
treated with cyclohexamide to inhibit translation. 
Another way in which activin ( or some activin-like molecule) could act as a 
patterning agent is suggested by the data on how animal cap competence changes with 
stage. Animal cap cells can only be induced to form notochord by high doses of 
activin prior to control stage 10. Between control stages 1 O and 11 the same dose 
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induces animal caps to form muscle, and between control stages 11 and 11.5 only 
lateral and ventral mesoderm can be induced. After stage 11.5 competence is lost 
completely (Kimelman et al., 1992). This change in competence is suggestively 
close to the actual sequence of inductive events attributed to the organiser at different 
stages of early development (see page 35). This has lead Kimelman and colleagues 
to propose that organiser action could be explained in terms of the secretion of activin, 
or an 'activin-like activity' at a constant level, with patterning occurring via the 
change in competence of the tissues coming into contact with the signal during 
development (Kimelman et al., 1992). 
BMP-4 seems to fulfil all the current experimental criteria for being an 
endogenous mesoderm inducer. It is expressed at low levels maternally and 
subsequently at much higher levels after MBT. As might be expected of a putative 
dominant inducer of ventral mesoderm zygotic expression is localised to the ventral 
marginal zone by S10 (Fainsod et al., 1994). Injection of a dominant negative form 
of aXenopus BMP-2/4 binding receptor into U.V. ventralised cleavage stage embryos 
rescues axis formation to a limited degree (Graff et al., 1994). Significantly, the 
rescued axes do not contain notochord, consistent with BMP-4 being necessary for 
ventral mesoderm formation, but being active from stage 10 onwards, i.e.:- after 
notochord specification usually takes place. The recent report of the phenotype of 
BMP-4 null mice suggests an even broader role in mesoderm induction than may be 
the case for Xenopus (Winnier et al., 1995). 
One rather novel model has been proposed for BMP-2/4 action in the late 
blastula/early gastrula based on the observation that dominant negative BMP-2/4 
receptor expressed in the animal cap alone (as judged by lineage marking by co-
injection with lacZ mRNA) can dorsalise ventral marginal zone (Maeno et al., 1994). 
This result, along with classical experiments showing that association of gastrula 
stage animal cap with prospective ventral mesoderm is required for proper ventral 
mesoderm differentiation (Maeno et al., 1992; Tiedemann, 1993 (using Ambystoma 
mexicanum) suggests that endogenous BMP-4, expressed in the animal cap is 
required for normal ventral mesoderm differentiation. 
The presence of BMP4 in the animal cap at sub-inducing levels may also have 
other effects. Graff and colleagues note that overexpression of a dominant negative 
BMP-2/4 receptor causes dorso-anteriorisation of the response of animal caps to 
activin so that, for example Xwnt-8 expression is decreased and Gsc expression 
increased (Graff et al., 1994). This could provide a solution to the problem of animal 
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cap 'competence pre-patterning', with sub-inducing levels of ventrally localised/active 
BMP-4 (which is known to be dominant over activin) being the diffusible ventral 
patterning agent whose presence was predicted by Green and colleagues (Green et al., 
1994; also see page 33). This could be simply tested by repeating the above 
experiment using dissected animal cap halves. This of course, still leaves the nature 
of the causal connection between cortical rotation and competence pre-pattern 
unsolved. 
There still seems to be somewhat of a paradox here with respect to how 
organiser grafts or DMZ grafted to VMZ are able to dorsalise tissue expressing a 
dominant ventralising factor. Remember, BMP-4 can ventralise whole embryos 
when injected dorsally, implying dominance over the whole range of organiser 
signals. The answer may lie in the fact that overexpression experiments swamp any 
mechanisms which may regulate the injected factor at the transcriptional level. 
Consistent with this hypothesis BMP4 is expressed in all of the marginal zone except 
the organiser at stage 11-11.5, but by stage 13-14 has become restricted to the ends of 
the lateral plate and the ventral third of the slit blastopore (Fainsod et al., 1994). 
However no evidence of transcriptional control ofBMP-4 by dorsalising factors has so 
far been published. 
BMP4 also has a second inducing activity, apparent at much lower 
concentrations. This is the ability to induce epidermis. Although animal cap 
explants form atypical epidermis as a default state when cultured in neutral medium, 
animal cap ~ have a default neural state when subjected to prolonged dispersal in 
neutral medium (Slack, 1991). Animal cap explants taken from embryos expressing 
the dominant negative activin receptor ~lXARl are also neuralised. This was 
initially taken as evidence for a role for activin in supressing neural fate. However as 
~lXARl, directly or indirectly, also inhibits mesoderm induction by BMP-4 in 
animal caps, and animal caps express BMP-4 at sub-inducing levels, this would also 
seem a likely target. In confirmation of this hypothesis it has recently been confirmed 
that BMP-4 can induce epidermal fate (i.e.:- supress auto-neuralisation) in dissociated 
animal cap cells at concentrations 1000 fold lower than those required to induce 
mesoderm formation in whole animal caps (Wilson and Hemmati-Brivanlou, 1995) 
Pattern modifyini: ai:ents 
As well as signalling molecules capable of directly inducing mesoderm a 
number molecules are known to be capable of modifying mesodermal patterning once 
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induction has occurred. One such modifying activity is exhibited by a number of 
members of the wnt family of signalling molecules. The family of genes to which 
these molecules belong includes the Drosophila gene wingless (wg), the mammalian 
proto-oncogene Wnt-1, and a whole array of recently cloned Xenopus members. 
Interest in the possible role of wnt family members in mesodermal patterning 
originates from experiments showing that ventral injection of mRNA encoding Wnt-1 
or Xenopus wnt family member Xwnt-8 into marginal or vegetal blastomeres at the 8-
16 cell stage produces embryos with a double axis (McMahon and Moon, 1989). 
Xwnt-8 RNA injection can also be used to rescue embryos ventralised by exposure to 
UV prior to the first cleavage (Sokol et al., 1991). As the injected cells do not 
necessarily contribute to the secondary or rescued axis, Xwnt-8 appears to be causing 
injected cells to act as a Nieuwkoop centre, with Xwnt-8 either acting directly to 
induce a Spemann organiser in adjacent cells or inducing the injected cells to secrete 
such a signal. This activity appears to be at odds with a gene normally expressed only 
zygotically, and even then in a pattern mutually exclusive with the organiser 1s (Smith 
and Harland, 1991 ). This apparent paradox could be resolved by supposing the 
existence of a maternal wnt or 'wnt like factor' present in the organiser or Nieuwkoop 
centre at early stages, which is mimicked by exogenous dorsal expression of Xwnt-8. 
A recently isolated maternally expressed member of the wnt family (Xwnt-11) seems 
to fit the criteria for being the endogenous wnt-like Nieuwkoop centre signal (Ku and 
Melton, 1993). Xwnt-11 transcripts are vegetally localised in the egg, but instead of 
the broad pattern of localisation seen with V g-1, transcripts are sequestered in a small 
region at the vegetal pole prior to fertilisation (Kloc and Etkin, 1995). Currently 
nothing has been published on whether this distribution, or that of its protein product 
changes with cortical rotation. Endogenous Xwnt-8 seems to have the opposite role to 
the Nieuwkoop centre signal after MBT when it appears to act as a ventralising signal. 
Evidence for this comes from experiments using an expression vector to mis-express 
Xwnt-8 in the organiser after MBT, which leads to the formation ofventralised 
embryos. Xwnt-8 can also ventralise the response of animal caps to the dorsal 
mesoderm inducer activin when expressed after MBT (Christian and Moon, 1993). 
Although the biochemical nature of wnt signalling is still unknown there are 
suggestive parallels between the actions of Xwnt-8 and lithium. Both are dorsalising 
agents which can induce ectopic Nieuwkoop centre formation by ventral-vegetal 
injection during cleavage. However after MBT they both become ventralising agents. 
Both Xwnt-8 and lithium can also act to dorsalise the response of animal caps to FGF 
IS See section 7.1.2. for more detailed discussion of the expression pattern. 
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(Christian et al., 1992; Slack et al., 1988) and to low levels of activin (Sokol and 
Melton, 1992; Cooke et al., 1989). As might be predicted these effects require 
preMBT treatment. These parallels have been used to suggest that Xwnt-8 may act to 
suppress inositol phosphate metabolism (Slack, 1994), although this currently 
remains untested. 
Although there has been no direct dominant negative test of the necessity of a 
wnt signal as a component of the Nieuwkoop centre signal, expression of a predicted 
dominant negative allele of XGSK, a homologue of the Drosophila gene zeste white 
3/shaggy which is an antagonist of wingless signalling, gives a dorsalised phenotype 
(Dominguez et al., 1995) 
Another recently characterised mesodermal patterning agent, known as 
noggin, was cloned from a dorsally enriched library made from lithium dorsalised 
embryos by a functional screen for transcripts with the ability to rescue U.V. 
ventralised embryos (Smith and Harland, 1992). This secreted factor was 
subsequently shown, like Xwnt-8, to be a potential Nieuwkoop centre mimic/inducer, 
by its ability to induce a complete secondary axis, including heads, when injected 
vegetally into ventralised embryos. Maternal expression of noggin is lower than 
levels required to rescue ventralised embryos, and transcripts are uniformly localised 
during cleavage stages. Consequently it seems unlikely to act endogenously as a 
Nieuwkoop centre signal. Noggin can also rescue ventralised embryos when 
expressed after MBT and, when added as soluble protein, can dorsalise ventral 
marginal zone explants (Smith et al., 1993). Unlike activin it retains this latter 
activity well into the gastrula stage. Not only does noggin have the correct pattering 
activity to act as the predicted third signal (see fig. 11, page 36) it also has the correct 
zygotic expression pattern. Expression in the late blastula is localised to the 
organiser. During gastrulation expression is initially concentrated in the involuting 
mesoderm and ends up in the presumptive notochord. This obviously makes noggin a 
prime candidate to be at least a component of the third signal. It is important to note, 
however, that unlike RNA injection during cleavage, post MBT expression of noggin 
does not completely rescue ventralised embryos. The induced axes always lack 
anterior head structures. This may indicate that other components are necessary for 
complete organiser activity. Alternatively, more complete organiser activity may be 
dependent on tighter localisation of expression than is afforded by microinjection 
experiments. 
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Noggin has a second important activity. As well as being a potential organiser 
signal it also has the ability to induce cement gland and anterior neural tissue when 
added to animal cap explants in the form of soluble protein (Lamb et al., 1993). 
Finally, another novel putative secreted factor known as chordin, which is 
localised to the organiser and subsequently throughout the dorsal mesoderm during 
gastrulation and then in the prospective notochord and prechordal plate in the neurula, 
has recently been shown to have both organiser and (anterior) neural inducing activity 
(Sasai et al., 1994; Sasai et al., 1995). Chordin is capable of inducing secondary 
axes, complete from the hindbrain back, and of dorsalising both VMZ's and FGF 
induced caps. The only known gene with any homology to chordin is the 
Drosophila gene short gastrulation (sog) (Francois and Bier, 1995) 
1,3,3.1, Summary 
In summary, and taking the dominant negative receptor data at face value, the 
molecular evidence seems to back up the three signal model albeit with some 
additions. Processed V g-1 is a candidate for both signals 1 and 2 (Nieuwkoop centre 
signal). Maternal activin A, present as protein imported from the follicle cells during 
oogenesis, is also a candidate for signal 1. The other major candidate for the 
Nieuwkoop centre signal is Xwnt-11, with XGSK-1 wild-type and dominant negative 
phenotypes suggesting that some wnt protein is also necessary for Nieuwkoop centre 
signalling. The precise nature of the third signal is altogether more confused. 
Certainly the molecular data supports the idea of separate trunk and head organisers, 
at least once gastrulation has begun. Noggin is almost certainly a component of the 
trunk organiser signal, having the right activity and expression pattern, but as it 
cannot induce anterior head structures when expressed after MBT, it does not seem a 
likely candidate for the head organiser signal. Rather oddly, considering its broad 
expression pattern, it is a candidate component of the anterior neural inducing signal. 
Chordin is probably another trunk organiser signal component, as well as being an 
anterior neural inducer. 
What then of activin, which fits the requirements of a trunk organiser both in 
terms of dose response, and the changing competence of the tissues 'dorsalised' by the 
third signal? As activins themselves seem to have been ruled out, the only 
alternatives seem to be leftover V g-1 (present equatorially in the egg) or some 
unidentified activin-like molecule. Factors related to nodal, a mouse TGF~ family 
member essential for gastrulation, which has also recently been shown to have 
/ 
51 
'organiser activity' by its ability to cause axial duplication in zebrafish embryos, may 
be possible candidates. 
In addition to these three signal model signals, maintenance of both dorsal and 
ventral mesodermal fate also seems to require signalling. Some form ofFGF (or 
something using its receptor16) seems to be required for the maintenance of all 
mesodermal fates apart from prechordal plate (head). This role can be further 
subdivided. Some maternal form ofFGF is likely to be required, at sub-inducing 
levels, to act as a competence factor for activin induction of most, but not all, 
mesodermal markers. Zygotic FGF, probably in the form ofXeFGF, is required later 
in the developmental for the maintenance of posterior/dorsal mesodermal fate. 
Maintenance of a ventro-lateral fate may involve Xwnt-8, and require 
BMP2 and/or 4 dwing gastrulation. It also possible that BMP-2 and/or -4 are 
responsible for competence pre-patterning of the animal cap, and for maintenance of 
epidermal fate in naive ectoderm. 
1.3.4. Postscript - Does D-V patterning of the blastula mesoderm require 
mesoderm induction after all ? 
An intriguing recent paper by Lemaire and Gurdon, questions whether all 
dorso-ventral patterning of Xenopus mesoderm requires mesoderm induction after all 
(Lemaire and Gurdon, 1994). They stained dorsal and ventral sides of embryos with 
different vital dyes and then cultured the resulting embryos in calcium and magnesium 
free medium in order to disrupt cell-cell communication. At stage 6 (32 cell stage) 
vitelline membranes were removed, the differently labelled cells were manually 
separated and cultured in a dissociated state until the late blastula when the RNA was 
harvested. Marker assays for Xwnt-8 and Gsc, surprisingly showed the same pattern 
of expression as seen in non-dissociated embryos of the same stage, although Xbra 
expression was shown to be inhibited. Gurdon and Lemaire take this to suggest that 
cytoplasmic determinants are already in place in the equator of the fertilised egg (post-
cortical rotation) to direct the correct dorsal-ventral expression of some mesodermal 
markers in the blastula marginal zone. This could, presumably be due to some kind 
of auto-induction, but not by conventional mesoderm inducers which all induce Xbra 
expression. 
16Toere is intriguing recent evidence for adhesion molecules signalling via FGF receptors (reviewed by 
Mason, 1994) 
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FIG. 12:- Model for the role of FGF activin-like, and wnt-like signalling 
in the pre-MBT Xenopus embryo. 
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In this model, interactions between FGF and activin-type signalling are proposed to 
divide the embryo into 3 tissue layers. Vgl mRNA is localised to the vegetal 
hemisphere of the embryo, so its product is most likely to be more concentrated 
vegetally, with lower levels present in the equatorial zone. FGF signalling is excluded 
from the vegetal cells and consequently V g 1 signalling in the vegetal hemisphere 
results in endoderm formation and not mesoderrn induction. The Vgl and FGF 
signals overlap in the marginal zone, so mesoderm is induced. In the animal caps, 
Vgl is absent, and FGF levels are sub-mesoderm inducing, therefore this region 
becomes ectoderm. Definition of the dorsal ventral axis arises from a dorsally 
localised signal, which could be maternal X wnt-11 or noggin, or a very high local 
level of Vgl. (Model and figure from Cornell et al., 1995). 
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1.4. Aims and objectives. 
The broad aim of the work described in this thesis was to investigate the 
role(s), if any, ofXrelA and other rel family members in the early development of 
Xenopus. More specifically, my aims were as follows:-
(A) To develop a specific assay for active XrelA which could be used to characterise 
its temporal and spatial distribution during early development. 
(B) To characterise the distribution ofXrelA protein. I was particularly eager to 
investigate the possibilty of differential nuclear localisation of XrelA protein in the 
embryo, which, by analogy with dorsal, could be an indicator of the the distribution 
of active XrelA. 
(C) To develop new methods of inhibiting the activity of endogenous XrelA, and other 
rel family members using a dominant negative approach, the efficacy of which would 
be testable using the assay mentioned in {A). 
(D) To characterise the phenotypic effects of the inhibition of the activity ofXrelA and 
other rel family members present in embryos, by histology and the analysis of marker 
expression. 
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2, Materials and Methods, 
2.1. Oocytes, eggs and embryos from Xenopus laevis. 
2.1.1. Stock solutions for oocyte and embryo culture and fixation. 
Barth X medium (BX):- 88 mM NaCl; 1.0 mM KCl; 2.5 mM NaHCO3; 15.0 
mM Tris.Cl pH 7.6; 0.3 mM CaNO3; 0.41 mM CaCl2; 0.82 mM MgSO4. 
MEMFA (Prepared fresh when needed):- 0.lM MOPS pH 7.4; 2 mM EGTA; 1 mM 
MgSO4; 3.7% formaldehyde (filtered). 
2.1.2. Oocyte collection and culture. 
Oocytes were manually dissected from ovaries freshly dissected from adult 
female Xenopus, and cultured in BX. 
2.1.3. Micro-injection of oocytes. 
Dissected oocytes were transferred onto a piece of moist filter paper on a 
microscope slide and injected with approximately 30-40 nl ofmRNA (prepared as in 
section 2.2.16.). Microinjection was carried out under a dissecting microscope using a 
fine, drawn out glass capillary mounted on a micromanipulator. The needle was 
linked via a thin gauge pipe to a syringe driven by a vernier, and the system partially 
filled with oil. 
2.1.4. Collection, fertilisation and culture of embryos. 
FemaleX /aevis were induced to ovulate by injection of 100 U of follicle 
stimulating hormone (FSH) 48 hrs to 1 week before laying, and then injection of 600 
U of human chorionic gonadotrophin (HCG) 16 hours before laying. Eggs were laid 
into BX where they remained prior to fertilisation. Eggs were fertilised in vitro by 
brushing with a testis dissected from a maleX laevis (stored on ice in BX), in a small 
volume of BX. After approximately 2 minutes the eggs were flooded with distilled 
water. Fertilised eggs (as judged by rotation within the vitelline membrane occurring 
after approximately 20 minutes) were dejellied in 2% cysteine (w/v) pH 8.0. Embryos 
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were then washed and subsequently cultured in 1/10 BX. Embryos were staged 
according to Nieuwkoop and Faber (1956). 
2.1.5. Micro-injection of embryos. 
Embryos were generally injected with mRNA at the two cell stage either 
bilaterally or unilaterally (as specified) using the apparatus described in 2.1.3.. Prior 
to injection embryos were transferred to BX containing 5% Ficoll (w/v). After 
injection, embryos were maintained in Ficoll until stage 6 to reduce leakage. After 
this stage injected embryos were cultured in 1/10 BX (to avoid exogastrulation). 
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2.2. Molecular Biology. 
2.2.1. Stock solutions for molecular biology, 
TE:- 10 mM Tris.Cl pH 7.5; 1 mM EDTA pH 8.0. 
TE.I:- 10 mM Tris.Cl pH 7.5; 0.1 mM EDTA pH 8.0. 
10 x TBE (pH 8.0):- 108 g/1 Tris base; 55 g/l Boric acid; 9.5 g/1 EDTA. 
20 x SSC:- 3 M NaCl; 0.3M Na Citrate pH 7.0. 
10 x C Buffer:- 0.5 M Tris.Cl (pH 7.6); 0.1 M MgCl2; 50 mM Dithiothreitol (DTT); 
1 mM spennidine HCI; 1 mM EDT A. 
2.2.2. Bacteriological media. 
Luria-Bertani medium (LB):- 10 g/1 NaCl; 10 g/1 bactotryptone; 5 g/1 yeast extract. 
LB/agar plates:- LB + 15 g/1 agar. 
Note:- Ampicillin (Amp) was added as required to a final concentration of 100 µg/ml. 
NZYCM medium:- 10 g/1 NZ amine; 5 g/l NaCl; 5 g/l yeast extract; l 'g/1 casamino 
acids; 2 g/1 MgSO4.7H2O (pH 7.0). 
2.2.3. E.coli strains used:-
(see Sambrook et al. (1989) for details) 
DHSa \.,,-
BL21(DE3)- alsti see Studier and Moffat, 1986. 
MC1061 
JM101 
2.2.4. Transformation of E.coli with plasmid DNA. 
For Host Strains MC1061 and BL21(DE3);-
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E.coli were grown overnight in LB (BL2l(DE3) cells were grown in NYZCM) until 
an optical density of0.5 was obtained at 600nm (OD600 ~ 0.5). They were then spun 
down at 2500 RPM for 5 minutes (4°C), and resuspended in ice cold 0.1 M MgC12 
(half original volume). They were then spun as before and resuspended in ice cold 0.1 
M CaCh (half original volume) and spun down again before finally resuspending in 
I/20th volume of ice cold 0.1 M CaC12, and incubation on ice for 90 minutes. 100 µl 
aliquots were combined with an appropriate quantity of plasmid DNA/ ligation 
reaction and incubated on ice for a further 30 minutes. Aliquots were then heat 
shocked for 2 minutes at 42°C and incubated for a further 10-15 minutes on ice, 
before plating 10 µ1 onto one LB / Ampicillin / Agar plate and the remainder onto 
another. Plates were inverted and incubated overnight at 3 7°C. 
for Host Strain JM101:-
E.coli (JM101) were grown until OD600 ~o.4, spun down (2500 RPM; 5 minutes; 4° 
C), resuspended in 1/2 volume of 50 mM CaC}i, and incubated on ice for 20 minutes. 
Cells were then re-pelleted (2500 RPM; 5 minutes; 4°C), resuspended in I/10th 
volume of 50 mM CaCli, and incubated on ice for a further 10 minutes. Appropriate 
quantities of plasmid DNA/ diluted ligation reaction were added to 200 µl aliquots of 
cells before incubation on ice for a further 40 minutes, heat shocking and plating as 
for MC1061. 
for Host Strain DHSa:-
Toe majority of transformations were carried out using frozen stocks of competent 
DH5a E.coli, prepared in the following manner (see Hanahan, 1983). 
50 µl of overnight culture were used to seed 25 ml of LB and grown to OD550=0.3-
0.4. This was then diluted into two 250 ml flasks of LB and grown to OD550 = 
0.4-0.5. The flasks were then cooled for 15 minutes on ice and then the cultures spun 
down in sterile pre-cooled pots (2500 RPM; 10 minutes; 4°C). Pellets were then 
resuspended in 100 ml ice cold TFB I (0.1 M RbCl; 50 mM MnC}i_4H2O; 33 mM 
KAc (pH5.8); 10 mM CaCJi.2H2O; 20% glycerol (w/v)), and then re-spun (2500 
RPM; 10 minutes; 4°C). Pellets were then resuspended in 10 ml (each) TFB II (10 
mM MOPS (pH 7.0); 10 mM RbCl; 75 mM CaC}i_2H20; 20% glycerol (w/v), 
separated into 1 ml aliquots and flash frozen in dry ice / methanol. Aliquots were then 
stored at -70°C until needed. 
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Aliquots were allowed to thaw on ice when required. 100µ1 aliquots were used in 
transfonnations in the same manner as competent MC1061 cells (see above). 
2.2.5. Glycerol stocks. 
Glycerol stocks of transformed bacteria were made by adding 0.5 ml of sterile 50% 
glycerol to 0.5 ml of overnight culture, vortexing vigorously to mix, and flash 
freezing on dry ice / methanol. Stocks were then stored at -70°C. Stabs were plated 
from these stocks as required. 
2.2.6. Large scale plasmid isolation. 
'Ice Prep' Method 
100 ml of overnight culture of the appropriate transformed E.coli (in LB + 
Ampicillin 100 µg / ml) was centrifuged (3000 RPM, 10 minutes), and resuspended 
in lysis buffer (SO mM glucose; 25 mM Tris pH8.0; 10 mM EDTA). The bacteria 
were then lysed by the addition of 8 ml of alkaline SOS (0.2 M NaOH; 1 % SOS), 
followed by gentle inversion (to avoid shearing of genomic DNA), and incubation on 
ice for 5 minutes. The lysate was neutralised by the addition of 6 ml 3M KAc pH 
4.8), followed by inversion to mix, and incubation on ice for a further 10 minutes. 
Toe resulting precipitate was removed by centrifugation at 8000 RPM for 15 minutes, 
and the remaining nucleic acids were precipitated by the addition of 17 ml of 
isopropanol, followed by 10 minutes incubation at -70°C. After centrifugation at 
8000 RPM for 20 minutes ( 4 °C), the air dried precipitate was resuspended in 2 ml of 
TE. I. This solution was then further purified by the addition of 2.5 ml of 4 M Li Cl 
and incubation on ice for 60 minutes. After removal of the precipitate by 
centrifugation at 8000 RPM for 10 minutes ( 4 °C), the nucleic acids were again 
precipitated by the addition of 10 ml of ethanol followed by incubation on ice for 10 
minutes and centrifugation at 8000 RPM for 15 minutes. RNA was removed by 
resuspending the pellet in 400 µl ofTE.l containing 25 µg/ml RNase A, followed by 
incubation at 3 7°C for 10 minutes. After the addition of 20µ110% SOS and heating 
to 70°C for 10 minutes the solution was extracted once with phenol, once with phenol 
/chloroform/ isoamyl alcohol (100:96:4) (P:C:I), and once with chloroform. Plasmid 
DNA was precipitated ~Y the addition of 1/10th volume of 3M NaAc (pH 6.8) and 2.5 
volumes of ethanol and incubation at -20°C for 30 minutes. The resulting pellet was 
washed with ice cold 70% ethanol, dried in air, and resuspended in TE. The yield 
was determined spectrophotometrically (OD260nm) 
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CsCI ~dients (plasmids for injection into embzyos) 
Although the Ice Prep method yielded plasmid pure enough for most purposes, it was 
not suitable for preparation of reporter constructs for direct injection into Xenopus 
embryos, due to toxicity. DNA for running on the gradients was prepared using the 
first three steps of the ice prep method. Following precipitation with isopropanol, 
pellets were dried in a vacuum desiccator and resuspended in 20 ml of TE (pH 8.0). 
20 g of CsCl was then added and dissolved by vortexing, along with 600 µl ethidium 
bromide (EtBr) (10 mg I ml) for visualisation of nucleic acids under ultra violet (UV) 
irradiation. Solutions were then loaded into sealable ultracentifuge tubes, covered 
with a layer of heavy white paraffm, and balanced to within 10 mg before sealing. 
These tubes were then ultracentrifuged under a vacuum at 45 000 RPM for 18hrs and 
allowed to decelerate without breaking. DNA was then visualised under UV and the 
lower band (supercoiled plasmid) removed using a hypodermic needle and syringe, 
avoiding any precipitate on the side of the tube. EtBr was removed by extraction into 
butanol ( 4 times with 1 volume), and Cs Cl removed by overnight dialysis against TE 
(pH 8.0) at 4°C (2 changes 1 L, 1hr each, then 1 L overnight). Finally preps were 
extracted with phenol, P:C:I, and chloroform before precipitation with NaAc and 
ethanol (as in previous method). Plasmids injected in circularised form were 
precipitated in the same manner twice more before being washed twice with ice cold 
70% ethanol, and resuspension in millipure water. Plasmids requiring linearisation 
prior to injection were digested as appropriate after the first precipitation, and then 
cleaned again by extraction with P:C:I, chloroform, and then precipitated as for 
circular plasmid. 
2.2.7. Small scale isolation of plasmids ('mini-preps'). 
Small scale plasmid isolation was carried out using essentially the same initial 
steps as in the ice prep. but scaled down. l ml of overnight culture was spun down 
(13 000 RPM; 1 minute; room temperature CRn) and resuspended in 100 µl lysis 
buffer, lysed by the addition of 200 µl alkaline SDS (mixing by gentle inversion), and 
incubation on ice for 5 minutes, and neutralised with 150µ13M K.Ac pH 4.8, with a 
further incubation on ice of 10 minutes. After centrifugation at 13 000 RPM for 5 
minutes the supernatant was extracted with 1 volume of P:C:I and then with 1 volume 
of chloroform, before precipitation of nucleic acids by the addition of 2.5 volumes (~I 
ml) of ethanol and incubation at -20°C for 30 minutes. After centrifugation at 13K 
RPM for 20 minutes pellets were resuspended in 30 µI TE containing RNase A (25 µg 
/ml) 
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2.2.8. Agarose gel electrophoresis of DNA and RNA. 
Agarose gels of the appropriate percentage were made with 0.5 x TBE 
containing 0.5 µg/ml EtBr were run in 0.5 x TBE (+ 0.5 µg/ml EtBr) at lO0V. For 
RNA gels tanks were pre-treated with 6% H202 for 1 hr prior to use and all glassware 
used for the preparation of buffers and the gel was pre-baked. DNA was first mixed 
6: 1 with 6 x agarose gel loading buffer (3 x TBE; 0.5% bromophenol blue; 0.5% 
xylene cyanol; 10% glycerol) before loading onto gels. 
2.2.9. Elution of DNA from agarose gel slice. 
Appropriate bands were visualised using UV trans-illumination and excised 
from agarose gels using a razor blade with the minimum UV exposure possible, to 
minimise nicking. All purification of DNA from agarose gel slices was carried out 
using a Geneclean II kit (Bio 101). 
2.2.10. Restriction digests. 
All restriction digests were carried out in commercially supplied buffers at 
manufacturers recommended conditions with a minimum dilution of enzyme stock of 
1/10. 
2.2.11. Depbospborylation of linearised vector ligatable ends. 
Dephosphorylation reactions were carried out using calf intestinal alkaline phosphatase 
(Gibco-BRL) in C-buffer (see section 2.2.1.) 
2.2.12. Ligations. 
All ligations were carried out with T4 DNA ligase (Gibco-BRL) in the commercially 
supplied buffer, usually for 4 hours at 18°C (for sticky ended ligations), or from 8 hrs 
to overnight at 4°C for blunted ended ligations. Ligation mixes were always diluted 1 
in 5 into sterile distilled water prior to transformation, in order to dilute out the 
polyethylene glycol (PEG) in the ligation buffer. 
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2.2.13. Preparation of oligonucleotide stocks. 
All oligonucleotide ( oligo) stocks were prepared by taking 100 µ1 from a lyophilised 
master stock resuspended in 500 µ1 TE and extracting with phenol and chloroform. 
Oligos were then precipitated by adding 9 volumes ofbutan-1-ol and vortexing 
rapidly. After centrifugation (20 minutes; 13 000 RPM), pellets were washed with 
ice cold 70% ethanol and allowed to dry briefly in air before resuspending in 100 µl 
sterile TE. 
2.2.14. Polymerase Chain Reaction (PCR). 
All PCR primer pairs were designed using PRIMER DESIGNER (Scientific 
and Educational Software) to optimise (equalise) melting temperatures and avoid the 
risk of primer dimer and secondary structure formation which might prevent proper 
priming. PCR reactions were generally carried out using the following conditions:-
For a 100 µI reaction (reactions were frequently scaled down to 50 or 20 µ1):-
10 µl lOx Taq buffer 
x µl 50 mM Mg Ch (MgCJi concentration was usually titrated from 1 to 2.5 mM, and 
the lowest successful concentration used for preparative PCR reactions to reduce error 
incorporation (Innis et al., 1990)). 
y µI nucleotide mix (Usually to give a final concentration of 100 µM, although lower 
concentrations were sometimes used to improve fidelity in preparative PCR reactions 
(Innis et al., 1990)). 
z µl target DNA (If target concentration was known then generally 100 pg to 1 ng /100 
µl reaction was used, but higher concentrations were sometimes empirically found to 
be necessary). 
0.5 µl Taq DNA polymerase (5 U/µl) 
This was made up to 100 µl with millipure water, and overlaid with UV treated light 
paraffin (UV treatment destroys any contaminating nucleic acids, e.g.:- from pipette 
aerosols). 
PCRs using plasmid as target were preceded by a hot start (3 minutes at 95°C) prior to 
adding the enzyme to melt the target sufficiently. Where it was found to be necessary, 
plasmid targets were linearised. The conditions for the PCR reaction cycling were 
determined as follows:-
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Melting:- 15 seconds at 95°C. 
Annealing:- 30 seconds at 1-2°C below melting temperature predicted by PRIMER 
DESIGNER, or determined empirically if necessary. 
Extension:- 45 seconds, plus a further 30 seconds/kb product length for each extra kb 
over 2 kb, at 72°C. 
2.2.15. Colony screening by PCR. 
Colonies were picked with a sterile pipette tip into 1 ml of sterile distilled water, 
which was then vortexed thoroughly. A loop-full of the resulting suspension was then 
streaked onto a segment of an LB/ Amp agar plate, and the remainder boiled for 5 
minutes. 5 µl of dilute lysate was used per 50 µl diagnostic PCR. 
2.2.16. Transcription and capping of synthetic mRNA. 
Template preparation 
Templates were prepared from Ice Prep. DNA by digestion to completion with 
the appropriate restriction enzyme, followed by digestion for at 56°C for 30 minutes 
with proteinase K (100 µg/ml) in the presence ofSDS (0.5 %) and EDTA ( 5 mM). 
Following this preparations were further purified by extractions with phenol, P:C:I 
and chloroform, before precipitation with 1110th volume ofNaAc pH 6.8 and 2.5 
volumes of ethanol. Resulting pellets after 20 minutes centrifugation at 13 000 RPM 
were washed with ice cold 70% ethanol and resuspended in sterile TE made with 
millipure water. 
Note :- It is important not to gel purify templates, as nicking resulting from 
visualisation with UV can have an adverse effect on transcription efficiency. 
Transcription 
Transcriptions were carried out using a mMessage mMachine in vitro 
transcription kit (Ambion). This system uses a ratio of rGTP to CAP analogue of 4: 1, 
rather than the more conventionally used 10: 1. Although this leads to a reduction in 
the efficiency of capping of around 20%, it leads to an increase in yields of around 3-5 
fold. After 3-4 hrs template was removed by digestion with DNase I (2 U) for 15 
minutes at 3 7°C, and the RNA was cleaned and precipitated three times with ethanol 
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and ammonium acetate, washed twice with 70% ethanol and resuspended in millipure 
water for injection into oocytes or embryos. 
RNA yields were calculated by measuring 00260nm and batches of RNA were tested 
for equivalent levels of translation as in 2.2.17. Groups of transcriptions carried out 
using a common stock were generally found to give approximately equivalent 
tranlation levels as judged by this assay. 
2.2.17. In vivo translation assays. 
Groups of 10-12 oocytes were injected with the appropriate mRNA (as in 
2.1.3.) and incubated overnight in BX containing 5-10 µCi of 35S-methionine (1000 
Ci/mmol). Oocytes were subsequently homogenised as in section 2.3.1., and 
products were visualised by SDS-PAGE, as in section 2.3.4. 
2.2.18. Whole mount in situ hybridisation. 
(Method from Richard Harland, modified by Derek Gatherer) 
Probe synthesis 
Templates were prepared as for transcription of synthetic mRNA (see section 
2.2.16.). Transcriptions were carried out with the appropriate RNA polymerase (50 
U) to produce antisense RNA (see Appendix 2). Transcription / labelling reactions 
using Digoxygenin-11-UTP (DIG-UTP; Boehringer) contained the following:- 0.5-1 
µg template; 0.25 mM DIG-UTP; 0.5 mM UTP; 0.75 mM each ATP, CTP, and 
GTP; 10 U RNasin; 4 µ15 x transcription buffer (Gibco-BRL) - made up to 20 µI 
with millipure water. Probes were then treated with 2 U DNase I for 15 minutes at 37 
~C and then precipitated once with NaAc and ethanol, washed with ice cold 70% 
ethanol and resuspended in 50 µl millipure water. Probe concentrations were 
estimated spectrophotometrically (OD260) and stored at -70°C until needed. 
Embryo fixation 
Embryos of the appropriate stages were fixed overnight in freshly made 
MEMF A at 4 °C with the vitelline membranes removed (membranes were manually 
dissected shortly after placing the embryos in fixative). Embryos were stored at -20°C 
under 100% ethanol (after dehydration through increasing concentrations of ethanol). 
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Pre-hybridisation Washes 
Embryos were re-hydrated through a graded series of ethanol concentrations 
into PTw (PBS+ 0.1% Tween-20 (SIGMA)). They were then washed three times for 
5 minutes each in PTw, before the addition of PTw containing 1-5 µg/ ml proteinase 
K and incubation at room temperature for 5 minutes. Note:- for pre-neurula stages 
low concentrations of proteinase K were used, and the embryos were observed under a 
dissecting microscope for signs of damage during incubation. After proteinase 
digestion embryos were washed 3 times for 5 minutes with PTw and then re-fixed in 
MEMF A for 20 minutes ( embryos showing damage during digestion were fixed 
immediately). Embryos were then washed a further 4 times (5 minutes) with PTw to 
remove fix and then transferred to 1:1 PTw:Hyb mix (se below) for 5 minutes before 
transfer to full strength Hyb mix (50% Formamide (FLUKA); 5 x SSC; 100 µg/ml 
heparin (SIGMA); 1 mg/ml yeast torula RNA (SIGMA); 0.1 % Tween-20; 0.1 % 
Chaps (SIGMA); 2% Boerhinger blocking powder) at 60 °C for 5-6 hours. 
(Note:- Baked glass vials were used for this and subsequent stages.) 
Hybridisation 
Embryos were placed in fresh hyb. mix containing 1 µg/ml of probe at 53°C 
overnight. 
Post-hybridisation washes and RNase A diaestion. 
Hyb mix plus probe was replaced with fresh hyb mix preheated to 53 °C, and 
the embryos were further heated to 60°C. The embryos were then washed at 60°C 
with preheated washes as follows:-
Once with 50% Hyb: 50% 2xSSC, 0.3% CHAPS; 10 minutes 
Once with 25% Hyb: 75% 2xSSC, 0.3% CHAPS; 10 minutes 
Twice with 2xSSC, 0.3% CHAPS; 20 minutes each 
Embryos were then transferred to RNase digestion buffer (2 x SSC; 0.3% CHAPS; 20 
µg/ml RNase A) and incubated at 37°C for 30 minutes. Following this treatment the 
embryos were washed as follows:-
Twice with 2 x SSC, 0.3% CHAPS, at RT for 10 minutes 
Twice with 0.2 x SSC, 0.3% CHAPS at 60°C for 30 minutes 
Twice with PTw + 0.3% CHAPS at 60°C for 10 minutes 
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Antibody Incubation 
Embryos were transferred to antibody blocking solution (PTw; 0.1 % CHAPS; 
0.5% Boehringer blocking powder) and left to equilibrate for 5 minutes before 
replacing with fresh antibody blocking solution and incubating at 4 °C for 4 hrs. After 
blocking embryos were transferred to fresh antibody blocking solution containing a 
1/2000 dilution of alkaline phosphatase linked anti-digoxygenin antibody 
(Boerhinger), and incubated overnight at 4°C. 
Colour reaction 
Embryos were washed 4 times for 60 minutes each with PTw containing the 
phosphatase inhibitor Levamisol, 5 mM (SIGMA), and then transferred to 
chromogenic buffer (100 mM Tris.Cl pH 9.5; 50 mM MgCl2; 100 mM NaCl; 0.1 % 
Tween-20; 5 mM Levamisol) in a multi-well plate. After equilibration for 5 minutes 
this was replaced with fresh chromogenic buffer containing 4.5 µI/ml NBT (from 75 
mg/ml stock in 70% dimethylformamide (DMF)) and 3.5 µI/ml BCIP (from 50 mg/ml 
stock in 100% DMF). When desired signal to background ratio was reached 
(anywhere from 4 hrs to overnight) the reaction was quenched by washing for 5 
minutes with TE pH 8.0, fixing for 20 minutes in MEMF A and then dehydrating in 
ethanol for storage (at 4°C) prior to photography under a dissecting microscope. 
66 
2.3. Protein extraction, separation, purification and detection. 
2.3.1. Protein extraction from oocytes and embryos. 
Protein extracts for gel mobility shift assays (GMSA) were made by homogenisation 
of embryos or oocytes using a glass homogeniser into Buffer A (10 mM Hepes pH 8.0; 
50 mM NaCl; 0.5 M Sucrose; 1 mM EDTA; 0.5 mM spermidine; 0.15 mM 
spermine; 0.2% Triton X-100; 7 mM ~-mercaptoethanol; 15% glycerol) with the 
addition of protease inhibitors PMSF (1 mM), leupeptin (0.5 µg/ml), and aprotinin 
(0.5 µg/ml). After centrifugation to remove yolk, and other insoluble material (13 
000 RPM; 5 minutes; 4 °C), the extract was flash frozen on dry ice. 
Oocyte nuclear extracts for GMSA's were made by homogenisation of 
manually dissected nuclei into buffer B (20mM TrisCl pH 79; 1.5mM MgC12; 
500mM KCl; 5 mMNaF; 1 mMNa3V04; 20% glycerol) with the addition ofDTT 
(to 0.5 mM) and protease inhibitors ( as above) immediately prior to extraction, at 10 µ 
I/nucleus. These extracts were then concentrated using Centricon-10 tubes as in the 
manufacturers instructions which reduced the total volume by approximately five fold. 
Protein extracts for SDS PAGE electrophoresis (for Western blotting) were 
made by the same method with Barth X (+ protease inhibitors) being substituted for 
buffer A. After centrifugation the cleared lysate was mixed with 0.8 volumes SDS 
Page loading buffer (see section 2.3.4.) and 0.2 volumes lM DTT and boiled for 5 
minutes immediately prior to loading. 
2.3.2. Extraction of protein from E.coli. 
Bacterial cultures were pelleted by centrifugation (5 minutes 10000 RPM), and 
re-suspended in 50 µl of ice cold PBS containing a cocktail of protease inhibitors 
(PMSF (1 mM), leupeptin (0.5 µg/ml), and aprotinin (0.5 µg/ml) per ml of culture. 
For quick testing of expression suspensions were mixed with 0.8 volumes 2x 
SDS-PAGE loading buffer (125 mM Tris.Cl; 5% SDS; 0.2% bromophenol blue; 
25% gycerol) and 0.2 volumes of 1 M DTT. Genomic DNA was sheared by rapid 
pipeting through a 200µ1 tip and the mixture was boiled for 5 minutes before loading 
on an SDS-PAGE gel. 
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For preparation of fusion proteins for use as antigen, or affinity purification 
bacteria re-suspended in PBS were lysed by sonication. This step also serves to shear 
genomic DNA. Insoluble material was removed from the lysate by centrifugation (5 
minutes; 13000 RPM; 4°C). Cleared lysate produced in this fashion was used for 
affinity purification of GST fusion. Cleared lysate containing fusion protein for 
purification by electroelution was mixed with 0.8 volumes of 2 x SDS-P AGE loading 
buffer (see above) and 0.2 volumes of 1 M DTT and boiled for five minutes before 
running on a 3 mm thick SDS-PAGE gel 
2.3.3. Protein Assays. 
All protein assays were carried out using a Bio-Rad protein assay kit according 
to the manufacturers instructions. 
2.3.4. Discontinuous SDS polyacrylamide gels. 
Acrylamide mix at 30% (29:1 acrylamide: N, N'-methylenebisacrylamide) was 
used to make discontinuous gels for protein separation. The concentration of 
acryamide in the separating gel was varied according to the protein sizes to allow the 
best resolution of the proteins, using the following as a guide: 
Acrylamide (%) linear range (K.Da) 
15 12-43 
10 16-68 
7.5 36-94 
5 57-212 
From Sambrook et al., 1989. 
As an example: 10% separating gels were made using 10% acrylamide mix; 
375 mM Tris.Cl (pH 8.8); 0.1% SDS; 0.1% ammonium peroxodisulphate (APS) and 
0.04% TEMED {N,N,N',N'-tetramethylethylenediamine). The gels were poured 
leaving enough space for a 0.5-1 cm stacking gel and overlayed with a small amount 
ofbutan-1-ol until set. The butan-1-ol was rinsed off and a 5% stacking gel (5% 
acrylamide; 125 mM Tris.Cl (pH 6.8); 0.1 % SDS; 0.1 % APS; 0.1 % TEMED) 
poured before inserting a comb and allowing to set. Gels were run in Tris-glycine -
SDS running buffer (25mM Tris; 250mM glycine (pH 8.3); 0.1 % SDS) at 100 Volts 
through the stacking gel and subsequently at 200 volts. 
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2.3.5. Staining with coomassie blue. 
Proteins were visualised by staining the gels in 5 volumes of coomassie blue 
stain (2.5% coomassie blue; 45% methanol (v/v); 10% glacial acetic acid.) for 4 
hours at RT. Gels were then destained with 3-4 changes of destain (45% methanol; 
10% glacial acetic acid) for 4-8 hours. Gels were stored dried. 
2.3.6. Electroelution of protein from an SDS-PAGE gel slice. 
SDS-PAGE gels were run as in 2.3.4.and stained without fixing in an aqueous 
solution of coomassie blue (1 %). A slice corresponding to the desired size of band 
was then excised with a razor blade and placed in a sealed piece of dialysis tubing 
along with 10 volumes of electro-elution buffer (0.2 mM Tris acetate pH 7.4; 100 
mM OTT; 0.1 % SDS). This was then arranged across the bottom of an agarose gel 
tank filled with enough electro-elution running buffer (50 mM Tris acetate pH 7.4) to 
just cover the dialysis tubing and run at 1 OOV for 4 hrs, or until there was no visible 
coomassie staining left in the slice. 
2.3.7. Removal of SDS from electro-eluted protein. 
To the eluate was added SDS (to give a final concentration of 1 %) and K.Ac (to 
give a final concentraion of0.3 M). This mixture was then incubated on ice for 30 
minutes before being spun at 10 000 RPM for 30 minutes at 0°C. The resulting pellet 
was washed twice with ice cold acetone/ HCl (0.1 M) before being resupended in 1 
ml of ice cold 10% trichloro-acetic acid (TCA) and centrifuged again (10 000 RPM; 
30 minutes; 0°C). This time the pellet was washed twice with ice cold acetone, dried 
and resupended in 0.5 ml sterile PBS. 
2.3.8. Western blotting. 
SDS-P AGE gels were blotted onto nitrocellulose filters (Hybond C 
(Amersham)) using Gibco-BRL electroblotting apparatus according to the 
manufacturer's instructions, in a transfer buffer consisting of (39 mM glycine; 48 mM 
Tris base; 0.1 % SDS, 20% methanol (v/v). Transfer was tested by staining the filter 
with 0.2% Ponceau S (Sigma) in 3% TCA, which was then removed by washing in 
PBS. 
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Blocking and antibody incubation of western blots 
Blocking and subsequent antibody hybridisations were carried out in blotto 
(5% Marvel; 0.02% Na azide in PBS). Filters were pre-blocked for 1 hr at RT. 
Primary antibody hybridisation was usually carried out overnight at 4°C (with 
shaking), filters were then washed 4 times 5 minutes with shaking in PBS, before 
hybridising with the horseradish peroxidase (HRP) linked secondary antibody at RT, 
usually for a further 2 hrs. Filters were washed a further 4 times with PBS at RT prior 
to staining for (HRP) activity using diaminobenzidine (DAB). 
Detection of antibody linked HRP activity with DAB 
Filters were stained with a 0.6 mg/ ml solution of DAB in 50 mM Tris.Cl pH 
7.6 with 1 µI/ ml of30% H20 2 added immediately prior to use. Staining was allowed 
to proceed until the desired signal to background ratio was achieved, and the reaction 
quenched by washing thoroughly with PBS. In the case of particularly weak signals 
staining was enhanced by the addition of 1110th volume of0.3% CoC12 to the staining 
solution. 
2.3.9. Whole-mount immunohistochemistry. 
Fixation and storaie 
Embryos were fixed in fresh MEMF A for 2 hours at room temperature before 
dehydrating through an ethanol series and stored at -20°C in 100% ethanol. 
Immediately before use they were gradually rehydrated through an ethanol series made 
up with PBS (90%, 80%, 70%, 50%, 25%), and then allowed to equilibrate in PBS 
for 5 minutes. 
Bloclcini, washinfit, and hybridisation. 
Embryos were blocked for 1 hour in PBT (PBS + 2 mg.ml BSA (fraction V) + 0.1 % 
Triton X-100) + 10% goat serum, with shaking at room temperature. Primary 
antibody incubations were carried out in PBT + 10% goats serum containing the 
appropriate dilution of primary antiserum, overnight at 4 °C with shaking. Embryos 
were then washed 4 times with PBT at room temperature, with shaking. In some 
cases, to reduce background a further overnight wash was carried out at 4°C, with 
shaking. Secondary antibody incubations were carried out in PBT + 10% goat serum 
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containing the approproate dilution of secondary antibody. Embryos were then 
washed as for after primary incubation. 
Confocal microscopy 
Flourescent staining of embryos was visualised by optical sectioning using a confocal 
microscope. Images were obtained by video printing. 
2.3.10. Detection of ~-galactosidase activity in whole embryos. 
Embryos were washed in PBS, and fixed in X-gal fix (2% formaldehyde; 
0.2% glutaraldehyde; 0.02% Nonidet P40 (BDH); 0.01 % sodium deoxycholate in 
PBS) for 1 hour at RT. After washing 3 times with PBS (5 minutes each) embryos 
were transfered to X-gal stain (5 mM potassium ferricyanide; 5 mM potassium 
ferrocyanide; 0.1 % X-gal; 2 mM MgC12 in PBS), and gently nutate in the dark until 
staining was clearly visible (usually 3-4 hrs). Stained embryos were then re-fixed in 
MEMF A overnight, and stored in 100% ethanol. X-gal stained embryos to be used 
subsequently for in situ hybridisation were stored under ethanol at -20°C until needed. 
2.3.11. Chloramphenicol acetyl transferase (CAT) assays. 
Embryos were homogenised into ice cold Tris.Cl pH 7.5 (50 µI/embryo) and 
centrifuged for 5 minutes. The supernatant was stored at -70°C until needed. Extracts 
were assayed for soluble protein as in section 2.3.3. 
For each assay 50 µl of extract was added to 5 µ1 14C-chloramphenicol (25 µCi/ 
µ1; 98 µCi/mrnol) diluted to 45 µ1 with sterile distilled water. This mixture was then 
warmed to 37°C and the reaction started by the addition of 5 µ1 Acetyl Coenzyme A. 
After incubation at 3 7°C for 60 minutes the reaction was quenched by the addition of 
90 µ1 of ice cold 0.25 M Tris.Cl (pH 7.5) and extraction with 1 ml of ice cold ethyl 
acetate (with vigorous vortexing). After centrifugation at 13 000 RPM for 5 minutes 
the upper phase was removed and dried under a vacuum. Pellets were resuspended in 
20 µ1 ethyl acetate and spotted onto a thin layer chromatography plate (TLC 
aluminium sheets, silica gel 60 (MERK)). The plate was run in a pre-saturated tank 
containing 150 mis chloroform:methanol (19:1). 
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Toe assay product was visualised using a Molecular dynamics phosphorirnager 
and quantified using Image Quant software 
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2.4. Detection of DNA binding activity (Gel Mobility Shift Assays 
(GMSA)). 
(This method was a personal communication from Laura Sanz (Ctr Biol Molec, Csic, 
Univ Autonoma Madrid, Madrid 34, Spain.) 
2.4.1. Annealing oligonucleotides for probes/competition. 
Oligonucleotide stocks prepared as in section 2.2.13. were mixed in TE to give a final 
concentration of2 ng/µl. This mixture was then heated to 98°C in a water bath which 
was then allowed to cool to room temperature. Stocks were stored at -20°C. 
2.4.2. Labelling the probe. 
Probe labelling reactions consisted of I Ong of annealed oligonucleotide., 40 µCi 32P-y 
-ATP (5000 Ci/ mmol), 1.5 µI 10 x C-buffer, and 1 µI T4 polynucleotide kinase 
(PNK) made up to 15 µl with sterile distilled water (SOW). Reactions were incubated 
for 60 minutes at 37°C and then extracted with P:C:I and chloroform before 
precipitating with Na Ac and ethanol (as in Ice Prep method) with the addition of 1 µg 
tRNA as carrier. Pellets were washed once in ice cold 70% ethanol and resuspended 
in 100 µI TE. 
2.4.3. Binding reaction. 
Binding reactions consisted of 0-10 µl of protein extract, prepared as in section 
2.3.1., made up to 10 µI with buffer A (section 2.3.1.) if necessary, with 6 µ15 x 
binding buffer (20% glycerol; 5 mM MgCl2; 2.5 mM EDTA; 2.5 mM DTT; 250 
mM NaCl; 50 mM Tris.Cl pH7.5; poly (dl-dC-dI-dC) (SIGMA) 0.5 µg/µ1, or as 
titrated. Cold wild type or mutant competitor was added as required, and the reaction 
made up to 29 µI and incubated at RT for 5 minutes prior to adding 1 µI of probe 
(prepared as above) and incubating for a further 5-10 minutes at RT. 
2.4.4. Electrophoresis. 
' Samples were run on a non-denaturing 6% polyacrylamide gel 
(acrylamide: bisacrylamide 29:1) in 1/4 x TBE at 200 V for 2 hrs in a cold room (4° 
C). 
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2.5. Histological Examination of Paraffin Embedded Tissue. 
2.5.1. Fixation and embedding. 
Samples were fixed overnight in MEMF A and dehydrated with an ethanol 
series (25%, 50%, 70%). Long term storage of samples was in 70% ethanol at 4°C. 
Prior to embedding embryos were further dehydrated into absolute ethanol, again 
through a graded series (80%, 90%, absolute, absolute), and then cleared using 
Histoclear (National Diagnostics). They were then taken through a further change of 
Histoclear and one change of Histoclear/wax (Histoplast) (1: 1) at 60°C, followed by 3 
changes of wax (1 hour each, at 60°C). Embryos were then embedded in fresh wax in 
plastic molds. 
2.5.2. Sectioning. 
Trimmed blocks containing the embedded embryos were cut into 1 0µm 
sections on a Bright microtome using disposable blades (Raymond Lamb). Ribbons 
of sections were floated in a water bath at 45°C, and then dried overnight (60°C slide 
drier) onto slides. 
2.5.3. Staining and mounting. 
Sections were dewaxed by washing twice in Histoclear (15 minutes each), and 
then rehydrated through a graded ethanol series (100%, 95%, 80%, 70%, 50%, 
30%, 25%). Rehydrated sections were stained in Haematoxylin solution (SIGMA) 
for 4 minutes, rinsed in tap water for 5 minutes, and then counter-stained with 1 % 
Eosin (BDH) for 1 minute and rinsed in tap water for a further minute. In preparation 
for mounting sections were rehydrated through the ethanol series detailed above, and 
then taken through two changes of Histoclear before mounting under coverslips using 
Depex mountant (BDH). 
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3, Detecting XrelA protein, 
3.1. Introduction 
An antiserum which recognises XrelA would be useful for a number of 
reasons. By analogy with dorsal in Drosophila, and also with other rel family 
members, differential activation of an XrelA containing complex might be expected 
to exhibit itself as differential nuclear localisation of that complex. The detection of 
endogenous XrelA protein in whole or sectioned embryos by immunohistochemistry 
might therefore provide a means of mapping activation of the endogenous protein in 
embryos. Another potential use of the antiserum would be to identify DNA binding 
complexes containing XrelA detected in gel mobility shift assays (see page 83). 
During the course of this work the distribution of XrelA was mapped by 
another group, first by using anti v-rel antiserum, which was shown to cross react 
with XrelA in western blots, and then later with antiserum raised against XrelA itself 
(Bearer, 1994). After the publication of this work I decided to concentrate my efforts 
elsewhere, rather than attempt to repeat the results using my antiserum. However, as 
the antiserum raised was used in GMSA supershift assays (see page 83), I have 
detailed how it was raised in this chapter. 
Bearer found that in the fertilised egg the protein is concentrated mainly in the 
nuclear region. However, by stage 4 (8 cells) the protein is arranged in a distinct 
animal to vegetal gradient in the cytoplasm. This may be just an effect of dilution of 
the cytoplasm by yolk in the vegetal hemisphere; a general effect born out by the fact 
that soluble protein yields from the vegetal hemisphere are comparatively low 
compared to those from other regions (H.R. Woodland, personal communication). 
Nuclear localisation is not seen until around about stage 7½, when it occurs in the 
nuclei of animal cap and equatorial cells. Nuclear staining becomes more intense the 
closer nuclei are to the animal pole. No staining of nuclei in the vegetal hemisphere is 
seen at this or later stages, but rather staining appeared to be localised in these cells to 
(unidentified) perinuclear particles. Nuclear staining in the animal hemisphere is still 
apparent at stage 10, but decreases to undetectable levels during gastrulation. The 
possible implications of these data, which are obviously an important consideration 
for any models of the role ofXrelA in early development, are discussed later (see 
chapter 8.) 
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3.2. Results 
3.2.1. Purification of protein for raising antiserum. 
In order to raise a polyclonal antiserum against XrelA it was important to be 
able to produce milligram quantities of relatively pure XrelA protein for use as an 
antigen. One way of doing this is to use a bacterial expression vector designed for 
producing affinity purifiable fusion proteins. One such group of vectors, known as 
pGEX vectors, allow the production of proteins fused to glutathione-S-transferase 
(GST), which can be inducibly expressed in bacteria (Smith and Johnson, 1988). 
The fusion protein, if soluble, can then be purified from a cleared lysate of the 
expressing bacteria using glutathione bound to agarose beads. The affinity purified 
protein can be eluted from the beads using soluble glutathione, and finally cleaved to 
separate the protein from the fused GST using a protease, a cleavage site for which 
has been incorporated at the fusion point. This approach, if successful, can be very 
powerful but problems can occur if the fusion product is insoluble or toxic. 
With the aim of producing an XrelA/GST fusion protein expression construct, 
the open reading frame ofXrelA was cloned into the fusion expression vector 
pGEX-2T (see Appendix 1 ). This vector allowed easy cloning of an in frame fusion. 
This was done by subcloning from the transcription construct 6b (Richardson, 1991; 
see Appendix 1 ), by digesting with BamHI and BglII, and cloning the resulting 
fragment into pGEX-2T digested with BglII. Clones containing insert in the desired 
orientation (from here referred to as pGEX-2TXr), as tested by diagnostic restriction 
digests, were transformed into E.coli JM101. Cultures of these cells were tested for 
the expression of fusion protein at various time points after induction with IPTG 
(cultures were induced when the density reached OD600= 0.8) by the rapid testing 
method decribed in section 2.3.2 .. Unfortunately, and for whatever reason, levels of 
fusion protein in extracts from pGEX-2TXr-transformed E.Coli induced with IPTG, 
were undetectably low (see figure 13), even after subsequent affinity purification with 
glutathione-agarose beads (data not shown). This was also true of extracts made soon 
after induction ( data not shown), suggesting the fusion product was either highly 
unstable or toxic. This made the purification of enough protein for raising the 
antiserum impractical. 
As an alternative to the pGEX system, it was decided to use an already 
existing inducible fusion protein construct in the form of a pET fusion construct made 
by Jill Richardson (Richardson, 1991). This construct, known as pET-3a526, 
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consists of the complete open reading frame (ORF) ofXrelA sub-cloned (in frame) 
into the fusion site ofpET-3a (see Appendix 1 for map). pET-3 vectors are a series of 
high level expression vectors which allow the production of proteins fused to the first 
10 amino acids ofT7 gene 10, under the control of a T7 RNA polymerase promoter. 
Expression can be controlled when the construct is transformed into the E.coli lysogen 
strain BL21 (DE3), which has an integrated phage lambda derivative containing the 
T7 RNA polymerase gene under the control of the lacZ promoter, making it inducible 
by IPTG (Studier and Moffatt, 1986). Because basal (uninduced) transcription from 
the T7 promoter in this system is negligible by comparison with systems which use 
direct control of expression by the lacZ promoter, it allows the production of toxic 
gene products as long as the culture has enough time to grow prior to induction. The 
main problem with using such a system is of course that it does not allow easy 
subsequent purification. The best approach seemed to be to gel purify the fusion 
protein and the isolate it by electroelution. As native and fixed protein were the 
intended targets of the antiserum, it was decided to further purify the eluate to remove 
SDS. The method chosen (see section 2.3.7.) involves a trichloroacetic acid (TCA) 
preciptation step, which is not necessarily disadvantageous as preciptated protein is 
often highly antigenic (Harlow and Lane, 1988). 
Protein was extracted from E.coli BL21(DE3) transformed with pET-3a526 
and induced for 3 hours with 0.1 mM IPTG, as described in section 2.3.2. Extracts 
were run on a 3 mm thick SDS-PAGE gel as decribed in section 2.3.4., which was 
then lightly stained with Coomassie blue (1 % in distilled water). The induced band 
was then excised and electroeluted as described in section 2.3.6., and the eluate treated 
to remove SOS as described in section 2.3.7., and resuspended in sterile PBS for 
injection. Yields were assayed using Bio-Rad Protein assay kit as described in section 
2.3.3. Preparations were stored in aliquots at-70°C until required. Induced fusion 
protein and the final purified product can be seen on the SOS-page gel shown in figure 
14. 
3.2.2. Raising and testing the antiserum. 
For the primary injections, the protein extract described in the previous section 
was mixed with an equal volume of Freund's adjuvent and injected intramuscularly 
into two rabbits (~30 µg / rabbit). Rabbits were then boosted every two weeks by 
intravenous injection of the protein extract without adjuvent (~15 µg / rabbit). Small 
test bleeds of around 5-10 mis were taken from injected rabbits prior to each boost and 
serum was prepared by decanting from clotted blood and stored in aliquots at -20°C. 
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FIG. 13:- pGEX-2TXR does not express detectable levels of XreWGST 
fusion protein. 
Cultures of E.coli JM101 transformed with pGEX-2T and the XreWGST 
fusion construct pGEX-2TXR were grown to 0D600= 0.8 and then induced to 
express GST I GST-XrelA fusion protein by the addition ofIPTG to give a 
concentration in the culture of 0.1 mM. After a 1 hour incubation protein 
extracts were prepared, and run on an SOS-Page gel. The resulting gel, 
stained with Coomassie blue, is shown opposite. From sequence data the 
predicted size of the fusion protein is 82 kd, however as XrelA protein runs 
anomalously high for its size the fusion product may run somewhat higher on 
the gel than predicted. 
FIG. 14:- Purification of pET3a-XrelA fusion protein for use as an 
antigen. 
SDS PAGE gel showing induction of pET-3a526 fusion protein expression 
with IPTG (1 and 2), and purification of fusion protein by electroelution 
(eluate shown in lane 3), and the final preparation after treatment to remove 
SDS. 
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pGEX-2TXR does not express 
detectable levels of fusion protein. 
Construct:-
IPTG:-
Mr 
75 
68 
50 
45 
25 
pGEX-2T pGEX-2TXR 
- + + 
- Predicted size of 
fusion protein 
(82 Kd) 
- Induced GST 
Purification of pET-3a526 fusion 
protein for use as antigen. 
1 2 3 4 
_ - fusion protein 
4 
Extracts:-
1. Uninduced culture; 2. Induced culture; 
3. After electroelution; 4. Final preparation. 
The serum was then tested by Western blotting, as described in section 2.3.8., using 
extracts from oocytes injected with XrelA mRNA. After 10 boosts the serum from 
one rabbit was capable of detecting a band of the same size as XrelA in Western blots 
of extracts from uninjected oocytes (see figure 15). This rabbit was then terminated 
by terminal bleeding from a cardiac puncture in order to collect the maximum volume 
of serum. From this point serum is refered to as B 175. 
3.2.3. Testing the antiserum by immunohistology. 
The ability of B 175 to detect XrelA protein in embryonic tissue was tested by 
whole mount staining, as decribed in section 2.3.9., to embryos injected with XrelA 
mRNA and to uninjected embryos from a range of stages. Overexpressed XrelA 
protein was easily detected by these methods and was shown to be predominantly 
localised to nuclei (see figure 16). Unfortunately, no localisation of endogenous 
XrelA could be detected. As staining with pre-immune serum gave a similar level of 
background it seems likely that high background due to the a non-rel specific binding 
activity present in B 17 5 which originated in the pre-immune serum ( see figure 15), 
was responsible for obscuring any signal from localised ofXrelA protein. 
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FIG. 15:- Western blots showing detection of exogenous and 
putative endogenous XrelA protein in oocytes and embryos. 
Protein extracts made as described in section 2.3.1. were run on a mini SOS-
PAGE gel at approximately 1/3 oocyte equivalent per lane. Western blots were 
carried out as described in section 2.3.8. using a 1/500 dilution of 
antiserum/pre-immune serum, and a 1/2000 dilution ofHRP-Goat anti-rabbit 
as a secondary antiserum. 
15A and 15B show identical filters probed with (B) pre-immune serum and (A) 
B175 (final bleed antiserum). 
Note the presence of the lower background band, which is also present in the 
pre-immune serum. XrelA itself runs at about 66 kd. Faint bands of this size 
can be seen in oocyte and stage 11 lanes, with a stronger band of that size in 
the stage 42 lane. 
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Western Blot showing putative 
detection of endogenous XrelA protein. 
A B 
Extract:- XrelA O S11 S42 XrelA O S11 S42 
XrelA-
Background -
band 
Extracts:-
XrelA :- Extract from oocytes expressing XrelA. 
O :- Uninjected oocyte extract. 
S 11 :- Extract from stage 11 embryos. 
S42 :- Extract from stage 42 embryos. 
/ 
45 
FIG.16:- B175 shows nuclear localisation of exogenous XrelA in 
embryos, but no endogenous XrelA can be detected over background 
levels. 
A. An optical section (by confocal microscopy) through the animal cap of a 
stage 9 embryo which was injected with 500 pg ofXrelA mRNA at the two cell 
stage, after whole mount incubation with B 175 (anti-XrelA) (1/150) and an 
FITC-conjugated goat anti rabbit lgG secondary antibody (1/200). 
Nuclear localisation of the exogenous protein is clearly visible. 
B. An optical section through the animal cap of a control embryo, stained as 
described in (A.). 
Note:- No differential nuclear staining (fluorescence) is visible in these 
embryos. In fact the level of staining is indistinguishable from that seen after 
staining of control embryos in which B 175 was substituted for an identical 
concentration of pre-immune serum ( data not shown). 
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3.3. Conclusions and further work. 
As discussed above, the inability of B 17 5 to detect localisation of endogenous 
XrelA protein by immunohistology is probably due to the presence of a background, 
non-rel specific activity, which is also present in the pre-immune serum. This· 
problem might feasably be overcome by affinity purifying the antiserum, which 
would, of course, require a pure source of protein. Given the problems encountered 
with expression of stable GST-XrelA fusion protein, and the fact that by this point the 
localisation pattern had already been characterised, I decided to concentrate my efforts 
elsewhere. Future attempts to produce pure protein for this or other purposes could 
make use of shorter affinity purifiable fusions, such as those produced by pQIA 
vectors (Diagen)17• 
17 These vectors allow the production of fusions with a tag of six histidine residues which can be 
purified by Nickel chelate chromatography. Like the pET fusion vectors expression is induced via T7 
RNA polymerase so preventing expression prior to induction. 
82 
4, Detecting endogenous JCB binding activity: Gel Mobility Shift 
Assays, 
4.1. Introduction 
The development of an assay for active XrelA and its subsequent use to 
establish the spatial and temporal distribution of active protein in the embryo is of 
obvious significance for establishing the role ofXrelA in embryogenesis. It is also 
crucial as a tool for testing the effectiveness of methods for inhibiting the activity of 
both exogenous and endogenous XrelA, and of any other rel family members which 
may be present in the embryo (see chapter 5.). 
Gel mobility shift assays (GMSA's) are widely used to detect specific DNA 
binding activities in cell and embryo extracts. In these assays a radioactively labelled 
double stranded DNA probe is incubated with a protein extract, and run on a non-
denaturing polyacrylamide gel. If the probe binds to proteins or multi-protein 
complexes present in the extract, its electrophoretic mobility is shifted. Specificity 
can be confirmed by the use of competition assays using an excess either of unlabelled 
probe, to compete out specific binding, or of a mutant competitor in which specificity 
defining residues have been altered, in order to compete out binding of undesired 
specificity. It is also possible to test for the presence of particular proteins in 
specifically binding complexes by using antibodies to further shift electrophoretic 
mobility, a phenomenon known as supershifting. As the conditions required for 
DNA binding have to be found empirically, the detection of individual binding 
activities often requires significant optimisation. 
As discussed in the introduction (section I.I.I) the paradigm for the activation 
of rel family members involves the signal dependent release of a rel dimer, which is 
held in the cytoplasm by an inhibitory protein of the IKB family. Binding of this 
inhibitor protein not only prevents nuclear localisation of the rel dimer, it also inhibits 
binding to DNA. Assuming that this is the case for the endogenous XrelA containing 
complex(es), it should be possible to use GMSA's to map the temporal and spatial 
distribution of activated XrelA containing complexes during development. XrelA 
containing complexes should be distinguishable from other KB binding complexes by 
supershifting with B 175 antiserum. It is important to note that the rel family is not 
the only group of transcription factors capable of binding specifically to KB sites 
83 
( discussed on page 98), so any complexes which do not supershift do not necessarily 
represent other rel family dimers. 
A previous, unsuccessful attempt to detect endogenous 1Cl3 binding activity 
attributable to an XrelA containing complex in Xe no pus embryos (Richardson, 1991) 
had used three different probes. One of these probes was based on a Dorsal binding 
site from the zen promoter, another on a 1C13 site in the Interleukin-2 receptor 
promoter, and a third on an idealised pallindromic site (see figure 17). It is now 
known that not all rel dimers will bind to these sites (see introduction: page 10 and 
figure 4). For this reason it was decided to repeat these experiments with a different 
probe using a variety of conditions in an attempt to increase sensitivity, and also to 
use a mutant competitor to confirm specificity. In case the period during which the 
endogenous complex is active during development is brief, it was also decided to test 
a comprehensive stage series of extracts. 
The choice of probe for a GMSA to detect active endogenous XrelA is 
complicated by the fact that the form which XrelA containing dimers might take in the 
embryo is unknown. As discussed in the introduction (section 1.1.3.), rel 
heterodimers have been found to bind to a wide range of promoter elements (see figure 
4 ). The use of PCR selection assays has further increased the number of sequences 
known to bind to rel family dimers, as well as finding some sequences that are 
specific for particular rel dimers. As the 1Cl3 site found in both the HIV-L TR and the K 
B light chain promoter binds to the widest range of vertebrate rel complexes so far 
tested this site was an obvious choice for attempting to repeat this work. Another 
reason for using this site comes from the fact that it was used as a probe in the only 
study in which an NF-KB-like activity has been detected inXenopus, although this 
activity was detected in oocytes rather than in embryos (Dominguez et al., 1992). 
During this study of the mechanisms of oocyte maturation, it was found that nuclear 
extracts from oocytes treated with insulin to induce maturation contained a specific KB 
binding activity. This activity was found to be inhibitable by anti-pS0 antisera and by 
IKBa which is known to require the presence of a c-rel, relB, or p65 subunit in order 
to bind to a rel dimer (see introduction section I.I.I.). An apparently identical 
activity was also detected in deoxycholate (DOC) treated cytoplasmic extracts from 
untreated oocytes. As DOC is capable of dissociating IKBa from NF-KB (Dominguez 
et al., 1992), this suggests that the rel complex detected is retained in the cytoplasm of 
unstimulated oocytes by interaction with an Il<l3 like molecule. 
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FIG. 17:- Probes used in GMSA's:-
(A) As used in Richardson et al., 1991 
PALLINDROMIC : -
IL-2R Kb Site:-
Dorsal (ZEN):-
(B) As used in this study 
SINGLE SITE WT:-
(SKBW) 
SINGLE SITE MUT :-
(SKBM) 
DOUBLE SITE WT:-
(NFKBW) 
DOUBLE SITE MUT:-
(NFKBM) 
CAACGGCAGGGGAATTCCCCTCTCCTT 
CAACGGCAGGGGAATCTCCCTCTCCTT 
GTTTTGGGAAATCCAGAAG 
CAACGGCAGGGGACTTTCCCTCTCCTT 
CAACGGCAGCTCACTTTCCCTCTCCTT 
*** 
ACAAGGGACTTTCCGCTGGGGACTTTCCAGGA 
ACAACTCACTTTCCGCTGCTCACTTTCCAGGA 
*** *** 
WT= Wild Type; MUT = Mutant; All binding sites and mutated binding sites are 
shown in italics. 
Toe complete sequence of the wild type double site probe is identical to a region of the 
IBV-L TR. In the other probes, however, sequences flanking the binding sites were 
chosen randomly. Note that, of the residues substituted in the mutant competitors 
(marked with a '*' ), guanosine residues at positions 1 and 3 have been shown to be 
essential for p50 homodimer binding (Kunsch et al., 1992). 
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It was important to try to replicate these experiments for a number of reasons. 
Firstly, as a preliminary to assaying for the same, or similar activity present in 
embryos, but also to test whether the complex in question contained XrelA, which 
should be easily tested by supershifting with B 17 5. 
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4.2. Results 
Protein extracts were made from oocytes or embryos as described in section 
2.3.1. and stored at-70°C. Gel Mobility Shift Assays were carried out using the same 
method used by the Dominguez group (Laura Sanz, personal communication) as 
described in section 2.4., using oligonucleotide probes labelled as described in section 
2.4.2. Unless otherwise stated, the equivalent of one oocyte of protein extract 
(approximately 20 µg of soluble protein) was used per incubation. Optimisation 
experiments were carried out where necessary, varying the NaCl concentration in the 
binding buffer, and the p(dl-dC) (non-specific competitor) concentration. Unless 
otherwise stated, all assays were carried out in the presence of 100-fold excess of 
mutant competitor. 
4.2.1. A constitutively active, nuclear localised specific KB binding 
activity can be detected in oocytes. 
Oocytes were treated with lµM insulin (in 0.1 % BSA in BX) at 19°C and after 
about 4 hours half the oocytes were harvested. The remaining oocytes were left 
overnight in insulin and then scored for germinal vesicle breakdown ( a marker of 
maturation visible as a white spot in the animal hemisphere). Nuclei were isolated 
from the harvested oocytes by manual dissection, and their extracts concentrated using 
Centricon 30 tubes (see section 2.3.1.), and the concentration of soluble protein 
determined as in section 2.3.3. Extracts from the enucleated oocytes were prepared as 
for whole oocytes. GMSA's were carried out, using the NFKBW probe (as used by 
Dominguez and colleagues), to compare the binding activities present in treated and 
untreated nuclear extracts (10 µg/binding reaction) and to test for DOC unmaskable 
binding activities in the cytoplasm of untreated oocytes. It is important to note that 
the use of a double KB site probe complicates the data, as two bands, representing 
single and double site occupancy, are seen for each binding activity. 
As can be seen from figures 18 and 19, no new binding activities were 
detected in nuclear extracts from insulin treated oocytes compared to controls. This 
was despite the fact that the concentrations of insulin used were able to induce 
maturation of24/28 oocytes after 24 hours compared to 1/30 controls. Titration of the 
concentration of the non-specific competitor, in the form of poly (dl-dC), failed to 
unmask any hidden activity. Similarly, no KB binding activity was unmasked in 
cytoplasmic extracts in the presence of DOC. However, a doublet of bands was 
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consistently seen in nuclear extracts and in whole oocyte extracts. This doublet could 
be competed out with wild-type competitor, leaving a single band, much fainter than 
either of the original two. The doublet could represent one or two specifically binding 
complexes. 
In conclusion, oocytes were found to contain one ( or possibly two) 
constitutively active rl3 specific DNA binding complexes, which are localised to the 
nucleus. Unlike Dominguez and colleagues I found no evidence for the existence of a 
further rl3 binding complex in oocytes activated by insulin treatment. 
4.2.2. Bl 75 is capable of supershifting exogenous XrelA homodimers, but 
not endogenous KB binding complexes found in oocytes. 
In order to test whether the antiserum B 175 could supershift the endogenous 
binding activities found in oocytes, GMSA's were carried out using oocyte extracts 
which were pre-incubated with or without Bl 75, prior to the addition of 
oligonucleotide probe (NFKBW). As a positive control, the same procedure was 
carried out with extracts from oocytes injected with XrelA RNA, and as a control for 
binding activities which might be present in the antiserum, a further assay was carried 
using antiserum but without any extract. The results of this experiment can be seen in 
figure 20. A doublet corresponding to the endogenous binding activities can be seen 
in all lanes apart from the negative control. No new bands result from the addition of 
antiserum to uninjected oocyte extract. Two bands can be seen in the XrelA injection 
lane, representing single and double site bound probe. In the presence of antiserum 
these bands are reduced in intensity, and two new slow migrating bands can be seen, 
presumably representing supershifted double and single site bound probe These 
bands are not seen in the control lanes. 
The supershifting of exogenous XrelA homodimers bound to probe shows that 
B 175 antiserum can be successfully used to identify XrelA containing rl3 binding 
complexes, under the conditions used. As the endogenous binding complex is not 
supershifted it seems safe to assume that this complex does not contain endogenous 
XrelA protein. 
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FIG. 18:- GMSA to detect insulin activated rlJ binding complex. 
To show that the concentration of insulin used was capable of inducing oocyte 
maturation, oocytes were treated with 1 µM insulin (SIGMA) for 24 hours at 
l 9°C and then scored for germinal vesicle breakdo\\n (GVBD) which is visible 
as a white spot in the animal hemisphere. From the treated group 24/28 had 
clearly undergone GVBD, compared to 1/30 untreated oocytes. Cytoplasmic 
and nuclear extracts were made from oocytes incubated +/- insulin for 4 hours. 
These extracts were then used in GMSA with NFKBW probe to assay for any 
activation of rll binding activity in nuclei by insulin, and for the presence of JC 
B binding activities in the cytoplasmic extracts unmaskable by sodium 
deoxycholate (DOC) treatment. 
No binding activities can be seen in untreated extracts, and none were 
unmasked by DOC treatment at any of the concentrations used. No new bands 
can be seen in the insulin treated oocyte nuclear extract lane compared to the 
untreated oocyte nuclear extract lane, although a doublet which be seen in the 
whole oocyte lane is also seen in both of these. 
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GMSA to detect insulin 
activated kB binding complex 
Extract:-
Insulin:-
EXTRACTS:-
Cyt. Nuc W 
- + 
Cyt. = Cytoplasmic extract DOC = sodium 
uc.= uclear extract deoxycholate 
W = Whole Oocyte extract 
FIG. 19:- Oocytes contain a constitutive KB binding activity. 
Oocytes were treated for 24 hours at l 9°C with 1 µM insulin in 
BX containing 0.1 % BSA (Fraction V, Sigma). After this time 22/25 
treated oocytes showed clearly visible evidence of germinal vesicle 
breakdown (GVBD), whereas out of 25 untreated controls none 
underwent GVBD. Extracts of oocytes treated in the same way for 8 
hours were made to test for the presence of insulin-activated KB binding 
activities. The specificity of binding activities present in these extracts 
was confirmed by adding a 200-fold excess of cold probe to half the 
binding reactions. The concentration of non-specific competitor (pdI-
dC) was also titrated in the hope that this might reveal any binding 
activities masked by non-specific binding. 
This experiment confirms that the constitutively active binding activity 
is KB specific, but as in the previous experiment, no insulin-activated 
KB binding complexes can be seen. 
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Oocytes contain a constitutively active 
KB binding activity. 
[pdl-dC]/µg/ml:- 0.25 
Competitior:- M W 
Insulin:- + - + -
0.5 
M W 
+ - + -
1.0 
M W 
+ - + -
Probe :- Double KB site (NFKBW) 
Competitors:- M=Mutant, W=Wild-type 
both used at 100 fold excess over probe. 
FIG. 20:- Bl 75 is capable of supershifting exogenous XrelA 
homodimers, but not endogenous 1eB binding complex found in 
oocytes. 
Extracts were made from uninjected oocytes, or oocytes injected with RNA 
encoding XrelA and incubated overnight. These were then used in GMSA's 
with double site probe (NFKBW; see figure 17) +/- preincubation with B 175 
antiserum (1 µI/incubation). As a further control for binding activities 
originating in the antiserum, binding reactions with antiserum in the absence 
of extract were also carried out. 
Because a double site probe was used in this experiment bands can be seen 
representing XrelA homodimers bound to a single site and to both sites. The 
addition of Bl 75 antiserum leads to a decrease in intensity of these two bands 
and the appearance of two new, slower migrating bands, which are not present 
in the control lane. These bands are likely to be due to supershifting of the 
single and double site bound probe. No supershifting of the endogenous 
binding activities can be seen. 
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Supershifting of XrelA by bl 75 antiserum. 
Antiserum + + + 
Extract UI XrelA Ul XrelA -
supershifted bands = 
double site bound _ 
endogenous binding activities -
single site bound -
Extract :-
XrelA - Extract from oocytes injeced with 2 ng XrelA mRNA 
UI- Extra ct from uninjected oocytes 
Probe:- Double kB site (NFKBW) 
4.2.3. Three specific KB binding activities are present in embryos. 
To study the temporal distribution of KB binding activities in embryos, protein 
was extracted from a comprehensive stage series of embryos, and assayed for soluble 
protein. These extracts were then used in GMSA's using SKBW probe and an extract 
concentration of 20 µg of soluble protein per binding reaction. The results of this 
experiment are shown in figures 21 and 22. Of the seven distinct binding activities 
detected only three are completely competed out by the addition of a 100-fold excess 
of wild type competitor (cold probe), indicating that they represent binding activities 
specific for the HIV-L TR type KB site. These three binding activities are referred to 
from here onwards as KBl, KB2 and KB3 (see figure 21). A fourth binding activity 
(the top band in each lane), was reduced but not eliminated by wild-type competition. 
None of these, however, has a temporal pattern of activation that corresponds to what 
would be predicted from the data on nuclear localisation of XrelA protein, i.e. 
activation during blastula stages followed by loss of activity around stage 10 (Bearer, 
1994). The levels of activity of KB2 and KB3 appear to vary with stage. KB2 activity 
increases steadily up to the mid/late neurula before levelling off. KB3 activity, 
although present in unfertilised eggs, appears to increase slightly in level in the late 
blastula and then tails off in the neurula stages. This latter result has, however, 
proved difficult to repeat, as there is often significant variation between experiments, 
in the levels detected compared to other bands, presumably because of a lack of 
stability of the complex. Consequently the variation in binding with stage seen here 
may be artifactual. 
In order to test for the presence of any KB binding complexes whose activity 
might be masked by binding to an IKB family member, extracts from all stages were 
pre-incubated with and without DOC (0.8 rnM) before the addition of probe. No new 
binding activities were uncovered, and none of the existing activities was noticeably 
enhanced by this treatment (see figure 23). One of the main aims of this work was of 
course to try to detect an endogenous KB binding complex containing XrelA protein. 
To test whether any of the KB binding complexes detected contained XrelA protein, 
extracts were pre-incubated with and without the antiserum B 175 (1 µI per extract) 
prior to the addition of probe. As can be seen in figure no supershifting of any of 
these bands was observed. 
92 
FIG. 21:- GMSA showing 1eB binding complei:H present in 
embryos from fertilisation to stage 16. 
This figure shows GMSA carried out using a protein extracts from 
various stages (as indicated) from fertilisation to stage 16. Extracts 
were assayed for soluble protein, and binding reactions were carried 
out using 20 µg of soluble protein per reaction. 
Note there are (at least) three bands which are competed out by the 
addition of wild-type competitor, but not by mutant competitor, 
indicating that these bands represent KB-specific binding complexes. 
These are referred to as KB 1, KB2 and KB3 with KB 1 being the slowest 
migrating and KB2 the fastest Of these activities KB2 and KB3 vary 
with stage. KB2 is first seen in the early gastrula, after which levels 
gradually rise up to the mid-neurula. Active KB3 is present at all 
stages, but levels seem to decrease somewhat after gastrulation. 
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GMSA showing KB binding complexes 
present in embryos. 
Competitor Mutant 
Stage UF 9 10.5 12 14 16 
UF = U nfertilised 
Probe :- SKBW 
Wild Type 
UF 9 10.5 12 14 16 
KBI , 2 & 3 are specific binding activities 
FIG. 22:- GMSA showing 1eB binding activities present in embryos 
between stages 21 and 37. 
This figure shows GMSA carried out using a protein extracts from various 
stages (as indicated) from stage 21 to stage 37. Extracts were assayed for 
soluble protein, and binding reactions were carried out using 20 µg of soluble 
protein per reaction. 
The same three KB specific binding complexes can be seen in these extracts as 
in extracts from earlier stages (see figure 21). No differences in binding levels 
of these complexes can be seen over these stages. 
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Stage series showing specific KB binding 
activities present between stages 21 and 37 
Competitor:- Mutant Wild-Type 
Stage:- 21 23 25 33 37 21 23 25 33 37 
JCB l 
JC8 2 
JC83 
Probe:- SKBW 
KB 1, 2 & 3 are specific binding activities 
FIG. 23:- GMSA showing that no binding activities are unmasked in 
embryo extracts by DOC and that endogenous rl3 binding activities 
do not supershift with Bl 75. 
Extracts from stages as indicated were pre-incubated prior to addition of the 
probe with or without DOC (0.8 %) and with or without antiserum B 175 (1 
µI/binding reaction) as indicated. No binding activities are apparent in the 
extracts treated with DOC in addition to those already characterised. None of 
the specific KB binding activities previously characterised (see figure 21 for 
comparison) are supershifted by B 175 antiserum indicating that none involves 
XrelA. 
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GMSA showing that no binding activities are 
unmasked in embryo extracts by DOC and that 
endogenous KB binding activities 
do not supershift with B175. 
Competitor:-
Antiserum (b 175):-
DOC (0.8%):-
Stage:-
M 
------
+ + + + + 
UF 9 10.5 12 14 
. . 
:,· ·: '' • -~} ;< ~,· ·-.~ .,··. 
' ·• r •· ' : :;- .---~ ' . 
·... t f 
.. 
Probe:- SKBW 
UF=Unfertilised 
WT 
- - - - - -
+ + + + + 
UF 9 10.5 12 14 
DOC= Deoxycholate 
M = Mutant competitor 
WT= Wild-Type competitor 
M 
~
- + 
12 12 
KB 1, 2 & 3 are specific binding activities 
4.2.4. Interaction of Xrel.2 with XrelA. 
The only likely heterodimerisation partner for XrelA known to be present in 
the embryo is a novelXenopus member of the rel family known as Xrel.2 (see 
introduction, page 19). As discussed later (section 4.3.) one possible explanation for 
the lack of detection of endogenous XrelA using GMSA's is that XrelA is present as a 
dimer with Xrel.2 and that this heterodimer is unable to bind to HIV-L TR type K13 
sites. 
A transcription vector (pSP64T) containing the Xrel.2 gene, along with 
sequence information, was obtained as a gift from David Tannahill towards the end of 
this work, so possible experiments were limited by time. Protein extracts from 
oocytes expressing Xrel.2 alone and in combination with XrelA were tested for their 
ability to bind IBV type KB sites in a GMSA. As part of the same experiment, the 
possibility that the mutant competitor used might inhibit specific binding of these 
complexes was also tested In order to clarify which bands, if any, represent 
heterodimers, supershifts were carried out on the same extracts, using Bl 75. The 
results of these experiments are shown in figure 24. 
Although the results of this experiment are slightly ambiguous, it appears that 
heterodimers ofXrelA and Xrel.2 are probably not being detected. Distinct binding 
activities can be seen for XrelA and Xrel.2 (slower migrating). However, it is 
difficult to see whether there is an intermediate band, representing the heterodimer, in 
the extract from co-expressing oocytes (lane 3). In the presence of antiserum, a band 
representing supershifted XrelA can be clearly seen, but there is no obvious band 
representing supershifted heterodimer. 
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FIG. 24:- Xrel.2 / XrelA heterodimeruation and supenhifts. 
Extracts were made from oocytes injected with XrelA or Xrel.2, or a 
combination of the two and assayed for their ability to bind to the probe 
SKBW by GMSA, and for supershifting by Bl 75. 
Distinct binding activities can be seen for XrelA and Xrel.2 (slower 
migrating), but smearing means that it is not clear whether a 
heterodimer band is present. In order to clarify the situation 
supershifting of these binding activities was investigated. The fact that 
no band representing supershifted heterodimer can be seen suggests that 
it may have a different binding specificity. 
97 
GMSA showing DNA binding and 
heterodimerisation of Xrel.2 
Antiserum (bl75):- • • • 
Competitor:- MUTA T 
Exract:- 1 2 3 
Xrel.2 -
XrelA -
• • • 
. - . 
C 2 3 
,. 
1 lng XrelA 
2 lng Xrel.2 
+ + + + + 
MUTA T 
C - 1 2 3 
3 1 ng XrelA + 1 ng Xrel.2 
- XrelA 
supershift 
4.3. Conclusions, discussion and future work. 
4.3.1. Possible reasons for failure to detect an endogenous XrelA 
containing complex. 
A number of explanations could be proposed for the failure to detect an 
endogenous relA containing KI3 binding activity. Exogenously expressed XrelA 
homodimers tend to appear as a smudge rather than a distinct band on the gel making 
detection even of low levels of exogenous homodimer difficult (see figure 27). If 
most of the XrelA protein is present as homodimers it is possible that the assay used is 
not sensitive enough. It is also possible that XrelA is present in a novel heterodimer, 
with novel DNA binding specificity. 
The only rel family member known to be present in the embryos besides XrelA 
isXrel.2. OverallXrel.2 has most similarity to c-rel (65% inclusing conservative 
substitutions), although this similarity is significantly less than the similarity of XrelA 
and relA. The one relA containing heterodimer which does not bind to an HIV-LTR 
type 1<l3 site is relA/Rel, which binds instead to a urokinase promoter type KI3 site 
(Hansen et al., 1992). Probes with this site may be a good bet for future attempts to 
detect an active endogenous XrelA containing complex. However, as discussed in 
the introduction (see page 19), Xrel.2 has some novel substituions in a highly 
conserved region of the rel homology domain (RHD) implicated in the control of 
DNA-binding specificity, which opens up the possibilty that Xrel2. may have a novel 
range of specificity. 
Finally, another possible explanation for the lack of detection of a binding 
complex is suggested by work on the effects ofNF-l<l3 interaction with C/EBP 
proteins (see page 151). NF-l<l3 interacts physically with a number of transcription 
factors belonging to the C/EBP family. This interaction leads to a potentiation of 
binding to C/EBP sites, but an inhibition of binding to HIV type 1<l3 sites, as tested by 
GMSA (Stein et al., 1993). No C/EBP proteins have so far been characterised in 
Xenopus. 
4.3.2. Speculations on the identity of specific KB binding activities 
detected in embryos. 
As mentioned in the introduction to this section, GMSA using 1d3 site probes 
are likely to detect both rel and non-rel specific 1d3 binding complexes. Non rel family 
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KB specific binding activities include EBPl, HIVEN86A, zinc finger protein H2TF1 
(possibly ubiquitous), and the two related zinc finger proteins aA-CRYBPl and 
AGIE- BPI (Faisst and Meyer, 1992). The work described in the following chapter 
using rel specific dominant negatives suggests that two of the activities detected (at 
least) may involve such proteins (see section 5.5) 
99 
s, Inhibiting XrelA: The design, construction and testing of dominant 
negative interference clones, 
5.1. Introduction: strategies for specific elimination of gene activity in 
Xenopus 
One of the greatest drawbacks of using Xenopus laevis as a model system for 
studying early vertebrate development is the fact that the generation time is too long to 
make mutagenesis screening, or indeed any classical genetics, practical. In addition 
to this, the technology does not currently exist to allow targeted mutagenesis of 
Xenopus genes as it does for mice. This is especially frustrating when one considers 
the range of genes with developmentally significant activities isolated from Xenopus in 
functional screens. 
Many attempts have been made to overcome this problem using methods 
which aim to specifically inhibit gene activity post-transcriptionally. One method 
which initially showed some promise was the use of antisense RNA, thought to block 
transcription specifically by hybridising specifically to its complementary transcript 
(reviewed in Weintraub, 1990). Unfortunately this approach has met with only 
limited success inXenopus. Preliminary experiments withXenopus oocytes showed 
that antisense RNA could be used to eliminate exogenous sense RNA (Harland and 
Weintraub, 1985), but equivalent experiments in embryos were not as successful. 
Initially this was thought to be due to the presence of a double stranded RNA 
unwinding activity in the newly fertilised Xenopus embryo, released from the oocyte 
nucleus during breakdown of the nuclear envelope (Bass and Weintraub, 1987). 
However, this 'unwinding' activity was later shown to be due to an enzyme now called 
double-stranded RNA deaminase, which converts about 25% of the adenosine 
residues in the target RNA duplex to inosines so destabilising the duplex and causing it 
to unwind (Bass and Weintraub, 1988; Polson and Bass, 1994). As such an activity 
acting on mRNA would turn message into nonsense, this activity cannot be 
responsible for the failure of antisense technology in Xe no pus embryos, and the real 
reason remains a mystery. 
Another approach to eliminating specific transcripts involves the use of 
antisense DNA oligonucleotides as primers to direct RNase H activity. As short DNA 
oligos are unstable in vivo due to endogenous exonuclease activities, oligonucleotides 
with modified intemucleoside linkages (e.g.:- to phophoramidate) have to be used 
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(Dagle et al., 1990). Such modified DNA oligonucleotides have been successfully 
used by Janet Heasman and colleagues to deplete pools of specific maternal RNA by 
injection into oocytes which are then subsequently labelled with dye (for identification 
purposes) and matured with progesterone before re-implanting into a primed host 
female (Heasman et al., 1992 and1994). It should be noted, however, that this 
technique depends on the absence of significant stores of maternal protein. 
By far the most popular and successful approach to the elimination of gene 
activity in Xenopus has been the use of dominant negative interference clones to 
inhibit the activity of gene products. This rather complicated sounding term 
(dominant negative for short) is adopted from classical genetics, where dominant 
alleles capable of inhibiting the activity of a wild-type allele of the same gene in a 
heterozygous organism are referred to as dominant negative alleles. The ideal targets 
for such an approach are gene products which are active as dimers, preferably with 
very specific dimerisation activity. Peptide growth factor receptors (PGF-R's) fulfil 
these requirements, and are also of obvious interest developmentally with respect to 
their role in transducing inductive signals. It is therefore not very surprising that the 
most interesting and fruitful work using dominant negatives inXenopus has been their 
use in investigating the nature of inductive signals. PGF-R dominant negatives 
generally have truncations or deletions in the intracellular 'signalling' domain allowing 
them to act either by forming inactive heterodimers with endogenous wild-type protein 
or by sequestering the endogenous receptor's ligand. One of the advantages of PGF-R 
based dominant negatives is that they can be rescued by overexpression of the wild 
type receptor. This control confirms the specificity of the dominant negative, at least 
to the degree that its target(s) are functionally equivalent to the wild type receptor. 
Dominant negative interference clones have also been used to study the role of 
particular signal transduction pathway elements in mesoderm induction. The targets 
for the dominant negatives in this case, the GTP binding protein ras and the ser/thr 
kinase raf, are not dimeric proteins so a different approach is required. Instead the 
dominant negatives are designed so that they are incapable of further transducing the 
signal (e.g.:- in the case of raf, the kinase domain is inactive), but retain the ability to 
bind to upstream activators. When these clones are overexpressed they saturate the 
binding sites on these upstream activators, inhibiting signal transduction. This 
could potentially cause problems with interpretation as such dominant negatives could 
potentially be inhibiting upstream activator(s) with additional targets to their wild-type 
equivalents. 
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5.2. Design of rel family dominant negatives 
XrelA protein can be detected in oocytes at levels approximately equivalent to 
those seen at blastula stages (Bearer, 1994). The relatively low levels of maternal 
XrelA message indicate that there is unlikely to be a rapid turnover of XrelA protein 
prior to MBT. If this is the case, then the pool ofXrelA protein present in oocytes is 
likely to contribute significantly to the localised XrelA protein detected in the blastula. 
These considerations mean that the use of antisense modified DNA oligonucleotides to 
target XrelA protein in the blastula is probably not a viable approach. 
There are a number of possibilities for designing dominant negatives based on 
XrelA. All rel family members, as far as is known, act as dimers, so any mutant 
XrelA capable of forming inactive dimers would be expected to act as a dominant 
negative. Unfortunately, members of the rel family are very promiscuous in their 
dimerisation abilities, so that, with the exception of relB, all known vertebrate 
members of the rel family are capable ofheterodimerisation with each other (see 
introduction, section I.I.I.). Consequently, any XrelA based dominant negative 
would be expected to target the activity of other rel family members if they are present, 
and not just XrelA and Xrel.2. 
The two most obvious ways of producing a rel dominant negative are to 
specifically interfere with either DNA binding or transactivation without inhibiting 
dimerisation. Given the extent of conservation of the rel homology domain between 
relA and XrelA, and the extensive degree to which domains and residues necessary 
for the various activities of re IA have been characterised ( see section 1.1.6. ), the 
design of deletion mutants lacking DNA binding or transactivation activity is 
relatively straightforward. XrelA homodimers have been shown to have the ability to 
activate transcription from an HIV-LTR based reporter (Richardson et al., 1994). By 
analogy with relA one would expect the C-terminal region of the protein outside the 
rel homology domain to be necessary for this activity. A transactivation deficient 
mutant ofXrelA, known as Xre~22 (see figure 25), which lacks the C-terminal 
222 amino acids was constructed, tested and characterised prior to the start of this 
work (Richardson, 1991; Richardson et al., 1994). XrelA6222 is able to inhibit 
transactivation by exogenous XrelA from an HIV-LTR based reporter construct. This 
probably occurs by the saturation of promoter sites by homodimers of XrelA6222. It 
is also possible that Xre~22 could act by forming transactivation deficient 
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FIG. 25:- Summary of deletions ofXrelA and p105. 
XrelA N 
XrelA ~SP 
XrelA ~222 
XrelA ~ SP/222 
p105 N 
p50 
p50iiSP 
I Conserved DNA binding motif (RxxRxRxxC) 
I Essential for dimerisation 
' 
' 
' 
' 
' 
' 
'' I 
----
I Putative transactivation domain 
■ Ankyrin repeat motif 
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527 
C 
heterodimers with XrelA, although this is difficult to prove. Dominant negative 
transcription factors which act by saturating promoter sites have the disadvantage that, 
when expressed at highly non-physiological concentrations, they may interact with 
promoter elements which are not normal targets of the factor to be inhibited. This is 
not a problem which is easily controlled for. For this reason the use of DNA binding 
deficient dominant negatives which act directly on the intended target by sequestering 
it into inactive complexes (DNA binding requires dimerisation) seemed like a safer 
approach. These dominant negatives also have the advantage that their effects on 
endogenous (and potentially identifiable) KB binding activities are testable using 
GMSA's. 
A deletion ofXrelA known as XrelMSP (see figure 25) which was predicted 
to lack DNA binding activity was also constructed before the start of this study, but, 
remained untested. For reasons discussed in chapter 6 (see section 6.2.3.) a double 
deletion ofXrelA lacking both the putative DNA binding and transactivation domains 
was also constructed. This construct was named XrelMSP/222. These deletions are 
summarised in figure 25. 
Because of worries about specificity, it was decided to also make use of a 
previously characterised DNA binding deficient rel family dominant negative, known 
as p50L\SP, a truncated and deleted form of the NFKBl gene (Kieran et al., 1990; 
see section 1.1.6.). Due to difficulties in obtaining the original p50.:\SP clone, it was 
decided to reconstruct the clone from human NFKB 1 (Meyer et al., 1991) which was 
more readily available, in a suitable transcription vector for use inXenopus. This 
deletion is shown schematically in figure 25. 
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5.3. Construction of rel dominant negative clones. 
5.3.1. Transcription vectors. 
In order to carry out overexpression experiments in Xenopus embryos or 
oocytes, it is necessary to be able to consistently produce stable message for 
microinjection. To this end cloning strategies were designed, in order to insert just 
the coding region of each particular deletion/truncation (with a new stop codon if 
necessary} into a modified form of the expression vector pSP64T. pSP64T (see 
Appendix 1 for map) is an expression vector derived from the SP6 RNA polymerase 
based transcription vector pSP64 (Krieg and Melton, 1984). Adjacent to the SP6 
promoter start site it contains the untranslated regions of the Xenopus P-globin gene 
separated by a cloning site, and with the addition of a polyadenylation signal. These 
untranslated regions serve to stabilise transcribed RNA in vivo. One drawback of 
pSP64T as a cloning vector is that it has only one cloning site (Bglll), so to overcome 
this disadvantage a modified version, called pSPJC was constructed by Jonathon 
Cooke (unpublished), with a new multi-cloning site inserted into the existing single 
cloning site, and the deletion of the old multi-cloning site of pSP64 (pSPJC(2) 
construction is detailed in Appendix 1 ). Unfortunately this proved to be extremely 
limiting with respect to the choice of linearisation sites available for making message 
template. To improve this I inserted a new multiple linearisation site into a Pstl site 
near to the terminal poly A. The resulting vector is referred to as pSPJC2L (See 
Appendix 1 for details). 
S.3.2. Construction of a DNA binding deficient variant of NFKBl 
(pSOaSP). 
The starting point for the construction of p50aSP in was a full length cDNA 
clone of human NFKBl in pBluescript called C9 (see Appendix 1). The following 
strategy was used to construct a clone ofp50aSP in pSPJC2L (summarised in figure26 
(b)):-
Primers were designed to the 5' end of the NFKBl ORF and to a position 
equivalent to the start of the C-terminal p105 inhibitory region which is cleaved off to 
produce active p50. The 3' primer (Primer 3) included a 5' extension consisting of a 
stop site followed by an Stul site, then by an EcoRl site and finally by a 4 bp 
clamping sequence to facilitate cleavage at the adjacent site. The 5' primer (Primer 1) 
included a 5' extension containing a Bgl II site with a GC clamp. A further primer 
(Primer 2) was designed to the 3' end of the deletion with a 5' 
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FIG. 26:- (a)Primers for p50ASP construction and cloning into pSPJC2L 
vector. 
PRIMER 1 
PRIMER 2 
PRIMER 3 
Clone 9 11 
Bgl II 
GAC~AGATCTATGGCAGAAGATGAT 
Stu1 
GAC~AGGCC] CAGCAGACCAAGGA 
Stu1 EcoR1 Stop 
GAC~AGGCC~GAATTctCTATAGAAAGAGGTTATCCT 
(b) Cloning strategy for pSOASP 
2 Stop 
- I 
Start Stu 1 
t 
3 
PCR 
2+3 
Clone 
t Stu 1 
.. Ligation 
9 /Stu1 t L 
PCR 1• 3 1 ~iagno~tic & preparative) 
Gel purification 
JC2L /Bgl ll;EcoR1 
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PCR 1+3 
p50 ORF 
fragment 
-~ l Bgl II; Ea>R1 
-------1 .. ► Ligation 
+ 
p50 & p50. SP in pSPJC2L 
extension containing an Stul site (plus clamping sequence) in the same frame as the 
Stul site at the S' end of the intended deletion. The product of a PCR using C9 as a 
target and primers 2 and 3, was cut with Stul and cloned into the target vector 
linearised with Stul and dephosphorylated to prevent re-ligation. Colonies resulting 
from this cloning were screened directly by PCR using primers 1 and 2, and bands of 
a size indicating an insert in the correct orientation were excised from a gel using a 
Geneclean II kit and subsequently digested with Bgl II and EcoRl and cloned into 
pSPJCL digested with EcoRl and Bgl II. Full length 'p50' generated by PCR primers 
1 and 3 was also cloned into pSPJC2L using the same sites. 
5.3.3. Construction of DNA binding deficient deletions of XrelA. 
As already mentioned, a deletion of XrelA called XrelMSP which was 
predicted to be deficient in DNA binding activity, was constructed by Jill Richardson 
(unpublished). This clone was constructed by restriction deletion of a part of the rel 
homology domain between two Sphl sites at 39 and 507 bp from the translational start 
which fortuitously re-ligate in frame (see figure 25). Construction of the double 
deletion, XrelMSP/222 from XrelM222 was complicated by the presence of an 
additional Sphl site in the vector (see map of pSP64T in Appendix 1). Unfortunately 
partial digestion with Sphl leads to the production of a ligatable fragment of about the 
same size as the fragment with the desired deletion making purification by 
fractionation on an agarose gel impossible. To overcome this problem, XrelM222 
was cut to completion with Apa!, which cuts inside the desired deletion, prior to 
partial digestion in order to make fragments containing this region non-re-ligatable. 
Digested product of the predicted correct size was then isolated from an agarose gel 
slice as described in section 2.2.9. and re-ligated as described in section 2.2.12. 
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5.4. Testing the dominant negatives. 
5.4.1. Inhibition of DNA binding activity of XrelA and p50. 
The dominant inhibitory action ofp50dSP, XrelMSP, and XrelMSP222 
was tested in GMSA's using extracts from oocytes co-injected with mRNA encoding 
one of the deletion clones and either XrelA, Xre!Afil22 (used because it gives a 
stronger band in this assay than XrelA) or p50. The results of these experiments are 
shown in figure 27. It is clear from this experiment that all three dominant negatives 
are able to inhibit DNA binding by co-translated XrelA, XrelAA222 and p50, and that 
a ratio of 20: 1 of dominant negative to p50 or XrelAA.222 is sufficient for almost total 
inhibition. However, the fact that faint bands remain in the case of inhibition of 
XrelA binding by XrelMSP and the inhibition of p50 binding by p50dSP suggests 
that heterodimerisation occurs with a higher affinity than homodimerisation in both 
cases. 
A ratio of 10: 1, but not a ratio of 2: 1 of XrelMSP or XrelMSP222 to XrelA 
is sufficient to eliminate detectable binding. The fact that a lower ratio is required for 
inhibition of full length XrelA binding compared to XrelAA.222 binding may be due to 
the differences in DNA binding affinity between the two. Xre1AA222 was 
consistently seen to bind to probe with a higher affinity than full length XrelA, which 
tends to show up as a diffuse band in GMSA's. The reasons for this are obscure. 
These experiments show that the dominant negative clones are capable of 
forming inactive dimers with wild type proteins when co-translated. However, in 
order to inactivate protein translated prior to fertilisation a dominant negative would 
have to be able to displace subunits from existing dimers. As discussed in section 
5.2., this protein may contribute significantly to the pool ofXrelA protein which 
becomes localised to animal and equatorial nuclei in the blastula. 
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FIG. 27:- GMSA to test ability of XrelAASP and pSO~P to inhibit D~A 
binding by co-translated XreIA. XrelAA222, and pSO. 
GMSA were carried out using SKBW probe v.ith extracts from OOC)1es (0.5 
oocyte equivalent per binding reaction) injected v.ith mixtures of mRNA 
species, as indicated. 
A comparison of lane A2 with A4, and lane A3 with AS shows that at a ratio 
of dominant negative to DNA binding protein of 20: I, Xre~P is able to 
completely inhibit DNA binding by p50, and p50~SP is able to completely 
inhibit DNA binding by Xre~22, at least within the limitations of the 
sensitivity of the assay. Inhibition ofXre~22 binding by Xrel.MSP, and 
p50 binding by p50~SP however is not complete at this ratio, as sho\\n by the 
faint bands in lanes A5 and A 7. 
Inhibition of detectable binding by wild-type XrelA is seen at a ratio of I: IO to 
Xrel.MSP and Xrel.MSP222. A ratio of I :2 of XrelMSP to Xre!A. 
however, does not cause detectable inhibition (lane 84). 
Note the markedly stronger DNA binding affinity ofXrelM222 compared to 
full length XrelA, and the fact that XrelA binding produces a diffuse band, 
rather then the relatively tight one produced by the binding ofXrel.M222. 
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GMSA's showing inhibition of DNA binding 
activity of XrelA, Xre1Ad222 and p50 by 
XrelAdSP, XreldSP222 and p50dSP 
A B 
Cl 234 5678 1 2 3 4 C 
, , • • • • • f, • • • • • 
GelA 
C. Control (partly lost on gel) 
1. 4 ng XrelAL1SP 
2. 200 pg p50 
3. 200 pg XrelAL1222 
4. 200 pg p50 + 4ng XrelAL1SP 
5. 200pg XrelAL1222 + 4ng XrelAL1SP 
6. 4ng p50L1SP 
7. 200pg p50 + 4ng p50L1SP 
8. 200pg XrelAL1222 + 4ng p50L1SP 
GelB 
1. 800 pg XrelA 
2. 800 pg XrelA + 4 ng XrelAL1SP 
3. 800 pg XrelA + 4 ng XrelAL1SP222 
4. 800 pg XrelA +800 pg XrelAL1SP 
5. Control 
To test whether the dominant negatives also have this activity oocytes were 
injected with wild type RNA, and then given a second injection, after 24 hours, of 
dominant negative RNA. Protein extracts were then made for testing by GMSA after 
a further 24 hours. The problem with this experiment is that the half lives of injected 
RNA and translated proteins are all unknown. This makes interpretation difficult. 
This experiment did not generate consistent results ( data not shown), possibly because 
of variations in the times of injection and harvesting between experiments and also 
possibly due to injection errors, further complicating any interpretation Whether co-
translation is required therefore still remains uncertain. 
5.4.2. Inhibition of transactivation by exogenous XrelA and p50 in 
embryos. 
A further way of testing the inhibitory capabilities of the dominant negatives is to test 
their ability to inhibit the transactivation activity of XrelA. To test this a reporter 
construct called pLC2R (Herbomel et al., 1984) containing the gene chloramphenicol 
acetyl transferase (CA n under the control of the HIV-L TR enhancer was used. 
Unstimulated transcription from this construct in Xenopus embryos is dependent on 
the presence of both Spl and KB sites within the enhancer (Richardson et al., 1994) 
The ability of full length XrelA to stimulate transcription from this vector in embryos 
has been characterised previously (Richardson et al., 1994 ). 
Batches of embryos were unilaterally injected at the two cell stage with pLC2R 
(250 pg/embryo) and either XrelA message alone (100 pg/embryo), or XrelA message 
in combination with RNA encoding one of the dominant negatives (1 ng/embryo). 
Embryos were checked for signs of necrosis, and healthy embryos were harvested at 
stage 11 as described in section 2.3 .11. Extracts were then assayed for CAT activity 
as described in section 2.3 .11. The level of radioactive product was measured using a 
Molecular dynamics phosphorimager, and then normalised for soluble protein. The 
results of this experiment are shown in figure 28. It is clear from the figure that all the 
dominant negatives were capable of inhibiting transactivation by exogenous XrelA. 
The biggest reductions in XrelA induced CAT activty were seen with Xre~22. 
This may be because it is capable of inhibiting transactivation from this construct by 
endogenous factors. 
The ability of dominant negatives to affect unstimulated levels of transcription 
from pLC2R was tested by repeating the experiment described above, but without co-
injection ofXrelA message. The results of this experiment are shown in figure 29. 
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The problem with experiments of this type is that there is considerable variation in the 
level of unstimulated transcription from reporter constructs measured between batches 
of embryos (although not in repeated assays from the same extract), even within the 
same experiment. This variation can be as much as+/- 25% (data not shown). This 
may reflect variation in replication of the injected reporter construct, and so the 
problem might feasably be controlled by measuring the amount of reporter DNA 
present by Southern blotting, and normalising the data for this. In the absence of 
such controls this experiment is only useful for measuring large reductions in 
transcription. As can be seen from figure 29, CAT activity normalised for soluble 
protein content in extracts from embryos injected with each of the DNA binding 
deficient dominant negatives fell within this error range. It is therfore not possible to 
conclude whether a proportion of the unstimulated transcription from pLC2R is due to 
rel family dimers (the expected targets of these dominant negatives). XrelM222, on 
the other hand, was able to repeatably reduce transcription levels to around 10% of 
control levels. The reason for the greater efficiency of XrelM222 in inhibiting 
unstimulated transcription from pLC2R is likely to be due to its ability to inhibit 
transactivation by non-rel family members by saturating KB sites in the promoter. 
5.4.3. Testing dominant negatives for squelching activity. 
Potentially one of the greatest drawbacks of using XrelA based dominant 
negatives is that they may cause general inhibition of activateq transcription, known 
as squelching. The evidence for squelching by wild-type XrelA is discussed in the 
introduction (section 1.1.7.). Given that there is compelling evidence for squelching 
by XrelA, particularly when expressed at high levels, it might seem likely that XrelA 
aSP, which after all contains the complete transactivation domain as well as the 
putative nuclear localisation signal, would have the same activity. That this is not a 
forgone conclusion is illustrated by some work on squelching by serum response factor 
(SRF). Like relA, SRF is able to squelch transactivation by acidic transactivators 
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FIG. 28:- Dominant negative inhibition of transactivation by exogenous 
XrelA in embryos. 
Embryos were injected with a mixture ofRNA's as indicated, plus the lllV-
L TR based reporter construct pLC2R (250 pg/embryo). Protein extracts were 
made from these embryos at stage 11, and assayed for CAT activity, and 
soluble protein concentration. 
(A) Shows the radioactive product, visualised by autoradiography from a TLC 
plate (upper spot). 
(B) Shows a histogram of CAT activity, as assayed using a phosphorimager 
followed by quantification of reaction product using ImageQuant and 
normalisation to soluble protein Activity is expressed as a percentage of 
XrelA induced activity. 
Note that all dominant negatives are able to inhibit transactivation by 
exogenous XrelA. Inhibition by Xre~22 is most complete, presumably 
because it is acting by saturating binding sites on the reporter construct \\ith 
non-transactivating homodimers. 
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FIG. 29:- Experiment to test the ability of domianant negatives to 
inhibit endogenous kB transactivating activity at stage 11. 
Embryos were injected with a mixture of RNA's as indicated, plus the 
HIV-LTR based reporter construct pLC2R (250 pg/embryo). Protein 
extracts were made from these embryos at stage 11, and assayed for 
CAT activity and soluble protein concentration .. 
(A) Shows the radioactive product, visualised by autoradiography 
from a TLC plate (upper spot). 
(B) Shows a histogram of CAT activity, as assayed using a 
phosphorimager followed by quantification of reaction product using 
ImageQuant, and normalisation to soluble protein. Activity is 
expressed as a percentage of XrelA induced activity. 
Experimental errors were very high in this experiment. Variation in 
CAT activity in extracts from uninjected embryos, even within the 
same experiment, varied over a range of approximately +/- 25%. 
However, very little variation was seen when CAT activity was 
measured in the same sample more than once (data not shown). It 
therefore seems likely that the variation is due to differences in 
repilication of the injected reporter construct CAT activity in extracts 
from embryos expressing the DNA binding deficient domainant 
negatives all fell within this error range. Xre~22, on the other 
hand, was able to repeatably lead to reductions in CAT activity to 
around 10% of control levels. It seems likely that this reduction is due 
to Xre~22 saturating binding sites on the reporter construct, and so 
inhibiting all 1d3 dependent transactivation, and not just that due to rel 
family members. 
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such as VP16, but this activity is lost in a range of mutants lacking DNA binding 
activity (Prywes and Zhu, 1992). The same has also been shown to be true of the 
squelching activity of a chimeric protein consisting of the VP16 transactivation 
domain fused to the human oestrogen receptor (Gilbert et al., 1993). lfDNA binding 
activity is a general requirement for transcriptional squelching (I have not found any 
published evidence to the contrary), then XrelMSP would not be expected to have 
squelching activity. 
Further evidence for transcriptional squelching by XrelA comes from a set of 
reporter assay experiments using XrelA to activate transcription of a Chloramphenicol 
Acetyl Transferase (CAT) reporter gene driven by the HIV LTR (Richardson et al., 
t 994). As a control for these experiments a construct was used containing the CAT 
gene driven by the thymidine Kinase (TK) promoter (Edlund et al., 1985), which 
does not contain a 1d3 site. Unexpectedly, high levels ofXrelA (concentrations above 
2 ng/embryo) were shown to dramatically reduce levels of transcription from this 
construct. It seemed likely, therefore that the TK/CAT construct could provide a 
simple test for the transcriptional squelching ability of various deletion clones of 
XrelA. 
To test this, mRNA encoding each of the dominant negative interference 
clones (approximately 2 ng/embryo) was individually co-injected with pTKCAT in to 
two cell embryos. These embryos were harvested at stage 11 and the resulting 
extracts were assayed for soluble protein concentration and CAT activity as described 
in sections 2.3.3. and 2.3.11. respectively. As with the pLC2R reporter there was a 
variation in activity between control extracts of around+/- 25% (the possible reasons 
for this are discussed on page 110). All the activities in extracts from dominant 
negative injected embryos fell within this range (see figure 30). However, injection 
of2 ng ofXrelA RNA per embryo is able to reduce transactivation from pTKCAT 
down to 5% of control levels (Richardson et al., 1994). It is therefore clear from this 
experiment that none of the dominant negatives causes transcriptional squelching to 
the same degree as wild-type protein. A comparatively low degree of transcriptional 
squelching by XrelAASP can not, however, be ruled out. 
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FIG. 30:- Experiment to test transcriptional squelching by dominant 
negatives. 
Embryos were injected with a mixture ofRNA's as indicate~ plus the IITV-
LTR based reporter construct pLC2R (250 pg/embryo). Protein extracts were 
made from these embryos at stage 11, and assayed for CAT activity. 
(A) Shows the radioactive product, visualised by autoradiography from a TLC 
plate (upper spot). 
(B) Shows a histogram of CAT activity, as assayed on a phosphorimager 
followed by quantification of reaction product using ImageQuant. Activity is 
expressed as a percentage ofXrelA induced activity. 
As with the pLC2R reporter there was a variation in activity between control 
extracts of around+/- 25% (the possible reasons for this are discussed on page 
110). All the activities in extracts from dominant negative injected embryos 
fell within this range. However, injection of2 ng ofXrelA RNAper embryo 
is able to reduce transactivation from pTKCAT down to 5% of control levels 
(Richardson et al., 1994 ). It is therefore clear from this experiment that none 
of the dominant negatives causes transcriptional squelching to the same degree 
as wild-type protein. 
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5.4.4. Effects of dominant negatives on endogenous KB binding activities. 
As the range of specificity of the DNA binding deficient dominant negatives 
would be expected to include complexes containing other rel family members, it is 
possible that KB binding complexes which do not contain XrelA will be sensitive to 
their presence. Mapping the distribution of such activities may help in the 
interpretation of dominant negative phenotypes. 
To test this embryos were bilaterally injected with either 4ng or 400 pg of 
mRNA encoding Xrel.AASP or p50.::iSP at the two cell stage.. Embryos were 
harvested at stage 13, a stage at which all the specific binding activities previously 
characterised (see section) can be detected, and the extracts used for GMSA's with 
SKBW probe (as described in section 2.3.1.). The results of this experiment are 
shown in figure 31. In the experiment shown, binding of the fastest migrating xB 
binding complex appeared to be inhibited, or much reduced, by 4 ng injections of 
either of the two RNA's. However, this result was not repeatable, and is probably an 
artefact of the instability of this complex noted previously (see section 4.2.3.). What 
was repeatable, however, was the effect of p50.::iSP on the slowest migrating of the 
three rl3 binding complexes. At the lower concentration of injection ( 400 pg/embryo) 
binding by this complex was inhibited, and the intensity of the non-specifc band 
above it was slightly enhanced. At higher concentrations ( 4 ng/embryo ), binding also 
appears to be inhibited, and a strongly binding complex was seen just above. This 
strong band could represent a separate effect to the inhibition, or could result from 
shifting and enhancement of the lower specific band. It should also be borne in mind 
that this (these) effect(s) may not be direct. For example, the enhanced band could be 
an upregulated gene product. 
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FIG. 31:- GMSA's showing effect of expression of DNA binding 
deficient dominant negatives on endogenous ,cB binding complexes. 
Embryos were bilaterally injected with RNA, as indicated and 
harvested at stage 13 ( a stage at which all the characterised binding 
activities are present) for gel mobility shift assays. All binding 
reactions were carried out with SKBW probe in the presence of 100 
fold excess of mutant competitor, except in one case where wild-type 
competitor was used. The three bands lacking in this lane compared 
with the control lanes are the three specific binding activities, known as 
KB 1, KB2 and KB3 described in section 4.2.3. 
As discussed in this section, l<lB is unstable, leading to significant 
variation in its relative level of binding (compared to other bands) 
between extracts from the same stage. The variation seen in this 
experiment may therefore be artifactual. This is supported by the 
finding that the apparent inhibition seen here with high levels ofXrelA 
RNA injection ( 4ng) was not repeatable. 
A result which was repeatable is the inhibition and/or interaction of p50 
L\SP with the KB 1 complex. This activity was not present in extracts 
from embryos injected with 400 pg of p50L\SP RNA, and the (non-
specific(?)) band above appeared to be slightly enhanced. In extracts 
from embryos injected with higher levels of this RNA (4ng), KBl 
activity also seems to be lost, but the upper band is significantly 
enhanced. This result is difficult to interpret. One possibilty is that 
some interaction with pS0L\SP is shifting the complex, rather than 
inhibiting its activity. On the other hand the enhanced band could 
represent a completely different phenomenon. 
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5.5. Conclusions and discussion. 
5.5.1. All three DNA-binding deficient deletions have dominant negative 
activity. 
It is clear from the experiments detailed in this chapter that XrelMSP, XrelA 
~SP222, and p50~SP are all capable of inhibiting DNA binding by wild type XrelA 
and p50 when co-translated in oocytes. It is not clear whether co-translation is 
necessary for this activity. The only significant difference with respect to the 
dominant negative activities of these three clones is the ratio of dominant negative to 
wild type protein necessary for inhibition. The differences in this respect between pSO 
~SP and XreIMSP reflect the differences in dimerisation affinity of the wild type 
protein, in that heterodimerisation between pSO and XrelA seems to occur with a 
higher affinity than the homodimerisation of either (data not shown). 
5.5.2. Xrel.AASP does not squelch transcription from a thymidine kinase 
promoter. 
Within the limits of experimental error it seems safe to conclude that, even 
though it contains the complete transactivation domain ofXrelA, XrelMSP does not 
non-specifically squelch transcription, as measured by transcription from a thymidine 
kinase promoter driven reporter construct. However, that experimental error is large 
enough to not be able to totally discount the possibility that it is capable of a small 
degree of transcriptional squelching. 
5.5.3. pSO~SP interacts with an endogenous KB binding complex. 
Assuming that XrelA can dimerise with the same range of rel family members 
as relA can (see introduction, page 14 for discussion of this), XrelMSP and pSO~SP 
should be capable of inhibiting DNA binding activity of all the known rel family 
members between them. From the investigation of the effects of the dominant 
negatives on specific KB binding activities it therefore seems safe to conclude that the 
two faster migrating, unaffected activities do not involve rel family members, or at 
least not rel family members with activities like those currently characterised. 
p50~SP, but not XrelMSP, is capable of inhibiting DNA binding by the 
specific KB binding complex KB3 in embryos, although it is by no means certain that 
this is a direct effect. It may be possible to test whether the inhibition requires protein 
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synthesis by incubating injected embryos with cycloheximide. The only characterised 
rel family member which will heterodimerise with p50 and not with p65 is relB 
suggesting that if the inhibition does involve direct interaction of p50ASP with a 
component of the binding complex then a relB homologue is a possible candidate for 
this component. 
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6, Analysis of phenotypes 
6.1. Introduction 
The main reason for constructing dominant negative interference clones was, 
of course, to study the effects of their expression on development. This chapter deals 
with the descriptive analysis of phenotypes resulting from the injection of RNA 
encoding the various DNA binding deficient dominant negative clones at the two cell 
stage. 
6.2. Results 
The phenotypes due to expression of the three dominant negative clones in 
whole embryos were investigated by bilateral 18 injection of a range of concentrations 
of mRNA at the two cells stage. Embryos were observed and scored throughout 
development, and any embryos showing signs of necrosis were discarded to avoid 
artifactual phenotypes. Selected embryos were wax embedded, sectioned and stained 
as described in section 2.5. For every concentration of RNA injected a range of 
phenotypes can be observed. This is most likely due, at least in part, to differences 
in the distribution of injected RNA. In order to correlate phenotypic effects with 
RNA distribution, experiments were carried out involving co-injection of the 
dominant negative RNA with RNA encoding P-galactosidase fused to a nuclear 
localisation signal (nuc.p-gal; see appendix 2 for details). The distribution of this 
gene product is easily assayed by staining with X-gal, as described in section 2.3.10. 
Such experiments, have confirmed that the distribution of injected RNA is highly 
variable. This is illustrated by the experiment shown in figure 3 7. 
6.2.1. Expression ofp50ASP in embryos has no obvious pbenotypic 
effects. 
Expression of p50ASP in embryos had no phenotypic effects, as judged 
externally or by histology, except at very high concentrations of injected RNA 
(approximately 5ng) which produced occasional and inconsistent defects (data not 
18 'Bilateral' injection is possible at this stage because the first cleavage plane defines the plane of 
bilateral symmetry in most embryos (see introduction, page 29) 
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shown). As inhibition of DNA binding by XrelA can be inhibited by only a 20 fold 
excess ofp50ASP (see figure 27), such massively high levels of expression should not 
be needed to inhibit DNA binding by endogenous XrelA. However, it is important to 
note that, as it is unclear whether co-translation is necessary for this inhibitory effect, 
there may be a pool of maternal XrelA protein (and/or other rel family member) whose 
activity remains unaffected by this dominant negative 
6.2.2. The phenotype due to XrelAASP has some similarities to that due 
to the dominant negative FGF receptor XFD. 
Unlike p50ASP, XrelAASP injection produces quite dramatic phenotypic 
effects, although these are only seen when 200 pg or more RNA is injected into each 
embryo. Unless otherwise stated, all the phenotypes described here resulted from 
injection of approximately 1 ng of mRNA per embryo. As with all experiments of 
this type there is a certain amount of phenotypic variation, but the phenotype can 
basically be summarised as follows. All injected embryos exhibited shortening of the 
trunk (to varying degrees), accompanied by ventral 'enlargement', and frequently by 
upward curving of the trunk. A proportion of injected embryos showed splitting of 
dorsal structures of the trunk behind the head around an exposed yolk plug. This was 
always accompanied by loss of an eye on one side of the head and in a minority of 
cases loss of eyes on both sides. If allowed to develop, almost all injected embryos 
showed an inhibition of tail extension. A typical distribution of these defects resulting 
from injections of approximately 1 ng of RNA per embryo is illustrated by the 
experiment scored in figure 34. 
Figure 32 shows a typical embryo at control stage 42, from a batch bilaterally 
injected with approximately Ing ofXrelA~SP mRNA (control shown above). One of 
the most striking things about this phenotype is its similarity, at least externally, to 
that caused by expression of the dominant negative FGF receptor, XFD (see 
introduction, page 42). Both phenotypes usually involve apparent splitting of dorsal 
structures of the trunk around a still open yolk plug, usually immediately behind the 
head. In some cases, and especially at lower concentrations of injected RNA, this 
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FIG. 32:- Comparison of control (above) with XrelAASP injected embryo 
at stage 42. 
The embryo shown is representative of the majority of embryos from a batch 
injected with Ing of XrelMSP RNA per embryo. Note reduction in axis 
extension and inhibition of tail elongation. Most embryos also have an open 
yolk plug behind the head, although this is difficult to see in this embryo. 
Most injected embryos are stage retarded. This can be seen in this case by the 
immaturity of head structues compared to the control. 
Scoring for inhibition of tail extension:-
15/24 - tail extension largely or completely inhibited 
9/24 - tail extension occurs relatively normally (tails are generally shorter than 
controls, but this is probably due to stage retardation). 
FIG. 33:- Comparison ofXFD and XrelMSP injected embryos at control 
stage 15. 
Embryos were injected bilaterally at the two cell stage with XrelMSP RNA (1 
ng per embryo) and fixed at control stage 15 for scoring and photography. 
Note - photograph (B) was provided by Caroline Beck, and is shown for the 
purposes of comparison with the XrelMSP injected embryo. It shows an 
embryo at control stage 15 which had been bilaterally injected with XFD 
mRNA at the two cell stage. 
Scoring:-
lng XrelMSP:-
16/29 - Have large exposed yolk plug still visible; induced neural plate shows 
migration/extension of the dorsal mesoderm is more lateral than animal. 
7 /29 - Have small exposed yolk plug visible, induced neural plate shows that 
migration/extension of the dorsal mesoderm is more animal than lateral. 
6/29 - Blastopore has closed but, due to stage retardation, embryos look like 
normal controls of about stage 13. 
In both XFD (B) and XrelMSP (C) injected embryos epiboly is retarded, 
leaving an exposed yolk plug (YP) still visible at control stage 15 ( control 
shown in (A)). Dorsal mesoderm migrates around the yolk plug in these 
embryos instead of towards the anima pole, as in controls, as evidenced by 
the induced neural plate (NP) around one side of the yolk plug. 
Note -the embryo shown in (C) is not the most extreme example of this 
phenomenon seen with XrelMSP. 
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splitting does not occur. This has also been seen in embryos expressing XFD (Amaya 
et al., 1991), and seems to correlate with ventral, but not dorsal, targeting of RNA 
(Isaacs et al., 1994). In both XFD and XrelMSP expressing embryos the axes which 
do form are severely shortened, suggesting an inhibition of convergent extension. 
Both phenotypes also involve an inhibition of tail extension. The head defects seen in 
some XrelMSP expressing embryos (see below) do not fit with the descriptions found 
in the literature of the XFD phenotype. However head defects in XFD expressing 
embryos are mentioned as unpublished observations in a recent publication (Cornell et 
al., 1995)), and have been observed by other members of the research group (C. 
Beck, per. comm.). 
The similarity of the two phenotypes is also very strong during the gastrula and 
neurula stages. In both cases blastopore closure is inhibited, or in some cases delayed 
until the neurula stages. In the most extreme the extent of blastopore closure is 
roughly equivalent to a stage 10.5/11 control. Except in the minority of cases where 
closure is only slightly delayed, these embryos gastrulate very eccentrically. Instead 
of migrating / extending towards the animal pole the dorsal and anterior mesoderm 
appears to migrate and extend around one side of the exposed yolk plug. This is 
indicated by the induction of a neural plate around one side of the yolk plug which, as 
shown in figure 33, is clearly visible by stage 1519• Blastocoel retention is commonly 
seen in such embryos (data not shown). 
In order to determine whether XrelMSP and XFD expressing embryos were 
similar internally a phenotypic range ofXrelMSP injected embryos (Ing 
RNA/embryo) was embeded in wax, sectioned and stained as in section 2.5. A 
similar phenotypic range ofXrelMSP expressing embryos was also probed for 
expression of Collagen II, a marker for notochord, somites and otic vesicles (Amaya 
et al., 1993), by whole mount in situ hybridisation as described in section 2.2.18. 
These experiments show that, unlike XFD expressing embryos, Xrel.MSP expressing 
embryos form notochord and segmented files of somites, even when the yolk plug 
remains exposed. In these instances the notochord which forms is not split around the 
yolk plug. Instead these embryos have a single set of dorsal axial structures split 
around the open yolk plug so that the notochord and one file of somites are found on 
one side, with more staining material, possibly disorganised muscle, forming on the 
19 Gastrulation ofXFD expressing embryos in this fashion was originally described in Issacs et al., 
1994. 
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FIG. 34:- Collagen II expression in Xre~P injected embryos at 
control stage 32. 
Heterozygous albino embryos (albino9 x pigmented Cl) bilateraly 
injected with approximately 1 ng of XrelMSP mRNA per embryo 
were fixed at control stage 32 and stained for the expression of collagen 
II by in situ hybridisation. 
Scoring. 
Group 1 (11/23):- Shortened trunk but otherwise relatively nonnal, 
although almost all of these (9/12) have notochord over to one side (as 
in figure 35). Head defects were rare in this group, but some of the 
more severely laterally asymmetric had eyes on the notochord side only 
(again as in figure 35) 
Group 2 (12/23):- Shortened trunk split dorsally around open yolk plug 
with dorsal axial tissue split as in (C). Of these most had no eye on the 
other side to the notochord, but 3/12 also showed loss of both eyes. 
A. Control ( cleared) 
Note staining in notochord (N), otic vesicle (OV), and also faint 
staining in the somites. The only other pigment visible (zygotic 
contribution) is in the eye, and in migrating neural crest cells (NCr) 
which can be seen around the somite. 
B. Mildly affected Group 1 type embryos. These embryos are 
relatively nonnal apart from having shortened trunks. The two 
embryos shown are not laterally asymmetric. 
C. Ventral / lateral view of typical group 2 embryo. 
Note the splitting of dorsal axial tissues around the exposed yolk plug 
behind the head with the notochord (N)on one side of the yolk plug 
(YP), and disorganised staining material (possibly muscle(M?) on the 
other side. 
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other side of the yolk plug, as indicated in figure 34. This is also illustrated by the 
sections shown in figure 36, although in the embryo shown there is no obvious muscle 
on the other side of the yolk plug from the notochord. In these embryos the neural 
tube is found on the same side of the split as the notochord, and usually fails to close 
completely (see figure 36). The heads of these embryos frequently lack an eye on the 
side lacking notochord and occasionally lack eyes altogether . The Collagen II 
staining of embryos which do not initially appear to have this 'split axis', frequently 
shows that the notochord is over to one side (see figure 35). This suggests that they 
may be more mildly affected versions of the 'split axis' phenotype where closure of the 
blastopore does finally occur but only after gastrulation around the yolk plug, rather 
than being equivalent to the shortened axis phenotype caused by ventral injection of 
XFD. These embryos also often exhibit head defects on one side, in the form of loss 
of one eye. 
In most of the histologically examined XrelMSP injected embryos the dorsal 
trunk structures are similar in proportion to those in controls. The endoderm, on the 
other hand, is much larger in cross section (see figure 36). This is especially true 
anteriorly, as illustrated by the embryo in figure 35C. 
Although even the most extreme embryos have notochord and somites they 
seem to have reduced amounts of these tissues compared to controls. In order to test 
whether the lack of a complete elimination of these tissues might be due to ( enough) 
injected RNA not reaching them embryos were co-injected with XrelMSP and RNA 
encoding nuclear ~-galactosidase (nuc.~-gal. (10 pg/embryo). These embryos were 
fixed and stained for p-galactosidase activity as detailed in section 2.3.10., and then 
re-fixed overnight in MEMF A before staining for collagen II expression by in situ 
hybridisation. Dilution series experiments with injected nuc.p-gal. RNA show that 
the cut off point for detectable p-galactosidase levels of expression is quite sharp 
(activity is not detectable at injection levels below about 5pg (data not shown). Co-
injection of such low concentrations ofnuc.p-gal RNA should therefore lead only to 
staining of cells that have received a relatively high dose of RNA. Similar 
experiments with XFD injected embryos have shown that, even when injected at 
concentrations which do not cause gastrulation defects, XFD can inhibit muscle 
differentiation as long as the injected RNA reaches its target (Amaya et al., 1993; see 
introduction, page 42). 
The experiments shown in figure 3 7 show that at levels above or below those 
which cause gastrulation defects XrelMSP does not inhibit muscle development, 
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even when the highest levels of RNA, as indicated by X-gal staining, are present in 
the somites as in the two embryos shown. 
6.2.3. A variant of Xrel.AASP lacking the transactivation domain has no 
obvious phenotypic effects. 
The fact that the phenotype observed in XrelMSP expressing embryos is not 
also caused by p50~SP, even though this clone is equally effective at inhibiting DNA 
binding by wild type protein suggests that XrelMSP exerts its phenotypic effects by 
some mechanism other than a dominant inhibitory action against XrelA. This 
interaction could take one of two forms. RelA has recently been shown to interact 
with a number of different transcription factors ( discussed in detail in the final chapter; 
see page 151). It seems plausible to suggest that XrelMSP might be acting by 
sequestering some developmentally important transcription factor. The other form 
that this interaction could take is the sequestering of an essential co-factor for acidic 
transactivation, i.e.:- squelching. 
In order to test whether the transactivation domain was necessary for the 
phenotypic effects of XrelMSP, a deletion clone called XrelA ~SP222 lacking both 
the putative DNA binding and transactivation domains was constructed (see chapter 5, 
sections 5.2. and 5.3.3.) and shown to be able to act as a dominant negative (see figure 
25). Expression of this clone in embryos had no obvious phenotypic effect (data not 
shown). 
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FIG. 35:- Most 'non-split-axis' embryos are laterally asymmetric 
Heterozygous albino embryos (albino9 x pigmented O") bilaterally 
injected with approximately 2ng of XrelMSP RNA were fixed at 
control stage 32 and stained for the expression of collagen II by in situ 
hybridisation. For scoring see legend of figure 34. 
A. Control. 
Note clear staining of somites. 
B. and C. Extreme laterally asymmetric embryo from group 1 seen 
from both sides. Note that the notochord and somites are clearly visible 
from one side only and only the notochord side has an eye. This 
embryo also has an upwardly curving trunk which is commonly seen in 
these embryos, and may result from differences in the amount of 
convergent extension occurring in the different germ layers. 
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FIG. 36:- Histological analysis of Xre~SP expressing embryos. 
Embryos bilateraly injected with a total of approximately Ing of XrelA 
~SP RNA were fixed in MEMF A at control stage 32, embedded in 
wax, sectioned and stained. All sections were photographed using a 
10 x objective so direct comparisons of scale can be made between the 
sections shown. 
Scale bar= 100 µm 
A. Mid-trunk section through a control embryo. 
Note detachment of the epidermis is a common artefact of the fixation/ 
embedding procedure used. 
B. Transverse section through the mid-trunk of an Xre~SP 'split-
trunk' embryo. 
Note the large open yolk plug (YP) with somites (S) and a notochord 
(N) on one side. Owing to the curvature of the trunk (see embryo in 
figure 35B and C) a pair of somites can be seen in longitudinal section, 
rather than a single somite in transverse section as in the control. On 
the same side a small, open neural tube {NT) can be seen above the 
notochord. On the other side of the yolk plug there are no obvious 
signs of muscle at this point, just what looks like a very thick layer of 
lateral plate mesoderm. The other main feature of note is how broad 
the endoderm and lateral plate mesoderm are in comparison with the 
control.. By comparison, the dorsal structures remain relatively 
similar in proportion to the controls. 
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C. More anterior trunk section from the same embryo as in (B). 
This section is anterior to the point where the dorsal structures split 
around the yolk plug. Somites are still only clearly visible to one side 
of the notochord, and the neural tube is still open. The large amount 
of lateral plate mesoderm on the right side of the embryo is even more 
striking in this section than in (B). 
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FIG. 37:- Experiment to test ability ofXreIAASP to inhibit muscle 
differentiation, even when embryos gastrulate completely. 
Heterozygous albino embryos (albino9 x pigmented Cf) bilaterally co-injected 
with nuc.~-gal RNA (10 pg/embryo) and XrelMSP RNA (as detailed below) 
were fixed at control stage 32 and stained for ~-galactosidase activity with X-
gal. They were then re-fixed overnight and stained for the expression of 
collagen II by in situ hybridisation. Collagen II expression shows up as a dark 
blue I purple stain in these pictures, whereas X-Gal staining is pale blue. 
A. Control (stage 32) showing strong staining for collagen II in the notochord 
and somites. 
B. Embryo co-injected with nuc.~-gal RNA and XrelMSP RNA (200 
pg/embryo). 
Note - This embryo clearly has XrelMSP RNA in the somites as shown by the 
regular chevron pattern ofX-gal staining (pale blue) in the somites. 
C. Embryo co-injected with nuc.~-gal RNA and XrelMSP RNA (Ing per 
embryo). Preservation of these embryos was poor, but in this case the 
fracturing fortuitously reveals X-gal staining in the somites. 
130 
B 
6.3. Conclusions and Discussion. 
6.3.1. There are only limited similarities between the XrelAL\SP and XFD 
phenotypes 
Expression of Xre!AL\SP in embryos by injection of mRNA at the two cell 
stage results in embryos with a reproducible range of defects. Externally these 
embryos have a number of similarities to the phenotype caused by expression of the 
dominant negative FGF receptor XFD. These similarities may have their origins in the 
eccentric mode of gastrulation, which occurs in both XrelMSP and XFD expressing 
embryos. This involves a failure, or delay, in closure of the blastopore during 
gastrulation (in some embryos closure was not observed until the late neurula stages), 
followed by 'migration' of the dorsal mesoderm around one side of the exposed yolk 
plug. Various potential explanations of this behaviour are discussed later (section 
S.1.1.). At later stages, the outcome of this failure to close the blastopore is a large 
open yolk plug behind the head. Another similarity between the two phenotypes is an 
. inhibition of tail extension. A number of recent reports support a model of tail 
extension as a continuation of gastrulation. For example, expression of Xbra and 
Xnot.2 can be followed from the blastopore lip to distinct cell populations in the 
tailbud (Smith et al., 1991; Gont et al., 1993). This region has also been reported to 
retain potent trunk organising activity until the late stages of development (Gont et al., 
1993). The gastrulation and tail extension defects seen in both XFD and XrelMSP 
embryos could therefore result from inhibition of the same set of 
developmental/molecular processes. 
The similarities between the XFD and XrelMSP phenotypes appear to be 
largely 'mechanical'. Where the effects of these two clones differ significantly is in 
the ability to inhibit tissue differentiation. While XFD can inhibit the differentiation of 
notochord and somites, XrelMSP expressing embryos form these tissues normally, at 
least on one side of the open yolk plug, even from cells receiving the highest dose of 
injected mRNA. Histological analysis ofXFD expressing embryos has revealed that 
in extreme cases no differentiated neural tissue is apparent in the trunk (C. Beck, pers. 
comm-) In XreIMSP embryos, on the other hand, neural tube was always seen along 
the length of the embryo, although it generally failed to close and was smaller than in 
controls. The only ( obvious) complete loss of a major differentiated tissue in XrelM 
SP expressing embryos was the occasional absence of one or both eyes, seen more 
consistently in more severe embryos. Loss of eyes, as well as, more severe head 
131 
7. Analysis of phenotypes - Marker expression 
7.1. Introduction 
One way of testing the FGF inhibition hypothesis is to study the expression of 
various markers whose response to XFD expression has been previously characterised. 
In the event of these experiments failing to uphold the hypothesis they may provide a 
starting point for other models of the origins of the XrelMSP phenotype. Of course, 
it is possible to test for inhibition ofFGF signalling more directly using animal cap 
assays. Unfortunately, this came under the remit of other work being carried out in 
the lab to study the effects of rel dominant negatives on mesoderm induction in general 
over a wide range markers . 
A range of probes was chosen, subject to their availability, based on the FGF 
inhibition hypothesis, and more generally on direct relevance to the phenotype. In 
order to put the data from these experiments into context I have briefly summarised 
what is known about each of the markers used including expression patterns and 
possible developmental role (if models exist). 
7.1.1. Brachyury 
As discussed in the introduction Brachyury is a gene intimately associated with 
mesoderm formation in vertebrates. The Xenopus Brachyury gene (Xbra) is expressed 
throughout the prospective mesoderm in the blastula (its expression is an immediate 
early response to mesoderm induction), but during gastrulation it becomes localised in 
the notochord, and later in the tailbud (Smith et al., 1991). Xbra is expressed in 
animal caps in response to induction by both activin (as an immediate early response) 
and bFGF (Smith et al., 1991; LaBonne et al., 1995). Expression of Xbra in 
embryos is dependent on signals inhibited by dominant negative activin and FGF 
receptors (Hemmati-Brivanlou and Melton, 1992; Amaya et al., 1991 ). Xbra itself 
has ventral and lateral type mesoderm inducing activity when overexpressed in animal 
caps (Cunliffe and Smith, 1992; Orielly et al., 1995) 
Unlike most of the other markers which were isolated because of homology to 
developmentally important genes in Drosophila, or in functional screens, the 
phenotype associated with a null allele of Brachyury in mice was known long before 
the gene was cloned (Chesley, 1935). More recently a mutation in zebrafish called no 
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tail has been shown to be due to a mutation in the zebrafish Brachyury gene. 
Zebrafish no tail (Brachyury null) embryos lack notochord completely. This is due to 
failure of its formation during gastrulation, rather than later degeneration. They also 
exhibit deformed somites (although segmentation does take place and muscle fibres 
differentiate, the myotome is block-like rather than chevron shaped). Wild-type cell 
transplantation studies show that this is due to the effects of Brachyury on notochord 
differentiation, rather than a direct effect on muscle differentiation (Halpern et al., 
1993). Halpern et al. interpret this as implying that Brachyury is necessary for a 
subsequent signalling event which occurs between notochord and somitic mesoderm. 
It should be noted that this signal does not appear to be the same as the one secreted by 
notochord required for neural floor-plate differentiation as this structure develops 
normally in no tail embryos (probably due to the presence of undifferentiated 
notochord precursor cells which secrete it). As one would expect from the name, tail 
formation is inhibited in these embryos. This fits well with a model of tail formation 
as a continuation of gastrulation, which would seem to make intuitive sense, as a 
similar arrangement of dorsal mesodermal structures is formed in the trunk during 
gastrulation. In fact, expression of Xbra and a second dorsal mesodermal marker, 
Xnot2, can be followed from the blastopore lip to distinct cell populations in the 
developing tailbud, which interestingly retains potent organiser activity until late 
stages of development (Gont et al., 1993). 
Increasing evidence suggests that the product of the Brachyury gene is a DNA 
binding protein. A consensus binding site has been determined using a PCR selection 
assay starting from a random pool of oligonucleotides. (Kispert and Hermann, 1993) 
7.1.2. Xwnt-8 
Xwnt-8 is a member of the wnt family of signalling proteins related to the 
oncogene int] and the Drosophila gene wingless (wg) (Christian et al., 1991). The 
precise expression pattern of Xwnt-8 appears to be the subject of some dispute. 
According to Smith and Harland (1991), expression begins at stage 9/10 in the whole 
mesoderm, excluding the organiser. During gastrulation the expression becomes 
progressively more ventrally restricted. By the early neurula it is expression is 
restricted to posterior ventral mesoderm. At stage 16 a low level of expression 
remains in the ventral posterior mesoderm and is also seen in two patches lateral to the 
anterior neural plate. Christian and Moon have also detected expression in lateral 
plate mesoderm at the neurula stage (Christian and Moon, 1993). This expression 
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data was obtained from whole mount in situ hybridisation experiments using a 
digoxigenin labelled riboprobe which, due to penetration problems, tends not to 
detect vegetal expression. By hybridising using digoxigenin labelled probes to 
sections Lemaire and Gurdon have detected vegetal expression at stage 10. By 
staining adjacent sections for expression of Xwnt-8 andXbra they showed that dorso-
laterally the expression of Xwnt-8 is almost entirely vegetal whereas ventrally it is also 
present equatorially. 
The possible developmental function of Xwnt-8 and its activities are discussed 
in detail in the introduction (see page 48). 
Xwnt-8 expression in animal caps can be induced by both FGF and activin. 
Like gsc expressionXwnt-8 expression induced by activin in animal caps is not 
inhibited by XFD (LaBonne and Whitman, 1994). 
7 .1.3. goosecoid 
goosecoid (gsc) is a homeobox containing gene related to the Drosophila 
homeobox genes gooseberry and bicoid (Blumberg et al., 1991 ). Its expression is 
restricted to the organiser at stage 10, and during gastrulation becomes restricted to 
the prospective pre-chordal plate (Cho et al., 1991). gsc expression is an immediate 
early response to mesoderm induction by activin in animal caps (Cho et al., 1991), 
although relatively high levels of activin are required compared to those needed to 
induce Xwnt-8 or Xbra expression. Expression is not induced by bFGF, and is not 
inhibited by XFD expression, either in whole embryos, or in animal caps treated with 
activin (Amaya et al., 1993; LaBonne and Whitman, 1994) 
Gsc has the ability to induce secondary trunk formation when injected ventrally 
during early cleavage, and can do so in a non-cell autonomous manner (Cho et al., 
1992; Niehrs et al., 1993), suggesting that gsc can function to induce the expression 
of (trunk) organiser signals. Gsc expression can also effect cell migration during 
gastrulation so that overexpression in dorsal blastomeres causes expressing cells to 
migrate anteriorly and contribute to the pre-chordal plate (Niehrs et al., 1993) 
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7.1.4. Xnot 
Xnot is a homeobox gene which is most closely related (in its homeobox 
domain) to the Drosophila gene empty spiracles (Von Dassow, et al., 1993). It is 
expressed at a low level maternally, and initial zygotic transcription is ubiquitous (at 
stage 9). By stage 10.5 transcripts have become restricted to the organiser, but in non-
involuted tissue at some distance from the lip which may be prospective dorsal trunk 
mesoderm (trunk organiser), and also to a thin belt of cells also some distance from 
the lip, which von Dassow and colleagues speculate may mark the limit of mesoderm 
involution. This gradual restriction of expression is dependent on translation, as 
cycloheximide treated embryos continue to express Xnot ubiquitously at control stage 
12. Later, in the gastrula and neurula stages, expression is limited to the dorsal 
midline in all three germ layers (i.e.:- in the archenteron roof, notochord, and the 
floorplate of the neural tube.) 
Xnot expression can be induced in animal caps by both FGF and activin. In 
whole embryos expression of Xnot in the marginal zone can be induced by Xwnt-8, 
and is inhibited by BMP-4, and by expression of a dominant negative FGF receptor 
(V onDassow et al., 1993). 
7.1.5. Pintallavis 
Pintallavis was originally isolated in a PCR screen for members of the winged 
helix family of transcription factors which includes rat hepatocyte nuclear factor 3 
(HNF-3) and Drosophilaforkhead (Ruiz-i-Altaba and Jessel, 1992). It is expressed 
initially throughout the mesoderm late blastula, but becomes rapidly localised to the 
organiser region (by stage 10½). By stage 12 pintallavis is expressed in all three germ 
layers in the dorsal midline, and at lower levels in the pre-chordal plate (mesoderm 
only). Expression in the midline of the neural plate is restricted to deep layer cells. 
As expression in the ectoderm is not seen in complete exogastrulae it seems likely that 
this expression requires induction by the mesoderm which comes to underlie the 
ectoderm during gastrulation. 
There is currently no published data on what signals can induce the expression 
of pintallavis in animal caps, or on the effects of dominant negative receptors on its 
expression in whole embryos. 
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Two sets of experiments have given some indication of the developmental roles 
ofpintallavis. Expression in animal caps does not induce mesoderm formation, 
however co-expression with Xbra in animal caps leads to the formation of notochord, 
suggesting that pintallavis may be downstream of notochord inducing signals in the 
organiser (Orielly et al., 1995). However, as overexpression is not sufficient to 
induce a second axis, or to produce radially dorsalised embryos it is obviously not 
capable by itself of inducing organiser signals. In fact, overexpression of pintallavis 
by bilateral injection of RNA at the two cell stage produces shortened embryos lacking 
( or having severely reduced) anterior neural structures, but exhibiting an expansion of 
posterior neural structures (Ruiz-i-Altaba and Jessel, 1992). These effects can be 
seen at neurula stages as a lack of formation of normal anterior neural folds. This has 
been taken to imply a role in specification of posterior neural fate, which would fit 
with its neural expression pattern, and the fact that this expression appears to be 
dependent on (vertical) neural inductive signals. 
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7 .2. Results 
In situ hybridisations were carried out to embryos injected with ofXrelMSP 
RNA, as described in section 2.3.9., using antisense probe RNA probes transcribed 
from the appropriate vector (see Appendix 2) Unless otherwise stated, injections 
were carried out bilaterally at the two cell stage with approximately 1 ng (2 x 500 pg 
injections) of RNA per embryo. Where albino embryos were used they were lightly 
stained with Nile blue to make staging easier and to identify embryos showing signs of 
necrosis so that they could be discarded. As a control for non-specific staining, 
uninjected embryos were taken through the in situ process without the addition of 
probe. In some cases non-specific staining was seen in the blastocoel and also 
sometimes in the archenteron (data not shown). Each figure includes descriptive 
scoring of all stained embryos and pictures of representative examples, where 
appropriate. 
7.2.1. Xbra 
Embryos bilaterally injected with 1 ng ofXrelMSP which have been fixed 
and stained for Xbra expression at stage 10 showed the loss of arcs of staining cells, 
as illustrated in figure 38. Loss of some expression could be detected at injection 
concentrations down to 200 pg per embryo (see figure 38). Complete loss of 
expression was rarely observed. 
Xbra in situ hybridisations were also carried out with embryos injected with 
p50~SP RNA, and XrelMSP222 mRNA both at lng of mRNA per embryo. No 
inhibition of Xbra expression was seen in these embryos ( data not shown). 
Unfortunately, because of sensitivity problems it was not possible to carry out 
equivalent experiments in late blastulae in order to see if immediate early expression 
of Xbra was also affected. 
7.2.2. Unlike XFD there is no dorsal-ventral difference in the sensitivity 
ofXbra expression to XrelA~SP. 
Toe expression of Xbra and another pan mesodermal marker, Xcad, is more 
sensitive to inhibition by XFD dorsally than ventrally (Northrop and Kimelman, 
1994). This can not be accounted for by dorsal-ventral differences in expression of 
FGFR-1. The difference in sensitivity may instead result from differences in the 
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FIG. 38:- XrelAASP inhibition of Xbra expression at stage 10 
Albino embryos bilaterally injected with approximately Ing/embryo ofXrelA 
~SP RNA at the two cell stage were fixed at stage IO and stained for the 
expression of Xbra by whole mount in situ hybridisation. 
A. Control (vegetal view), showing strong expression in a ring around the 
equator 
B. Injected (vegetal view) - showing arcs of lost expression. 
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strength of the FGF signal, either due to a variation in the actual concentration of 
secreted FGF or variation in affinity as regulated by proteoglycans. Alternatively the 
difference could be due to the presence of additional factors which can compensate to 
some degree for a diminution, but not an elimination, of the FGF signal. 
In order to study whether a similar dorsal-ventral difference in the inhibition of 
Xbra expression by XrelMSP exists, pigmented embryos were injected 
quadrilaterally at the 4-cell stage with a range of concentrations of RNA and scored 
for dorsal-ventral differences in Xbra expression following in situ hybridisation. The 
results are summarised in the table in figure 39. At no concentration of injected 
XrelMSP message tested were dorsal-ventral differences in the inhibition of Xbra 
expression seen. 
FIG. 39:- Table showing results of experiment to test for dorsal-ventral 
differences in response to XrelA~SP expression. 
Stain Lost:-
RNA Complete Dorsally Ventrally Laterally 
Injected ring of only, or No Stain 
(ng/injection) stain ambiguous 
-
30/30 0/30 0/30 0/30 0/30 
1 0/24 8/24 7/24 5/24 4/24 
0.5 4/29 9/29 10/29 6/29 0/29 
0.2 20/23 0/23 2R/23 lR/23 0/29 
0.1 26/26 0/26 0/26 0/26 0/26 
0 R The affected arc of staining was reduced (i.e.:-still faintly visible) rather than 
completely eliminated in these embryos. 
7.2.3. Pintallavis 
Embryos injected with XrelMSP (Ing/embryo) frequently show loss of most 
or all of the dorsal arc of expression of pintallavis at stage 10.5 (see figure 40). At 
stage 12 injected embryos fell into three groups with respect to pintallavis expression. 
In some embryos expression was completely eliminated ( data not shown). Where 
expressing cells remained they frequently failed to involute (see figure 41 b) showing 
that lack of involution of dorsal cells does not correlate with loss of dorsal expression 
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FIG. 40:- Pintallavis at stage 10½ 
Albino embryos bilaterally injected with approximately Ing/embryo ofXrel.A..:\ 
SP RNA at the two cell stage were fixed at stage IO½ and stained for the 
expression of pintallavis by whole mount in situ hybridisation. 
Scoring:- 4/12 normal, 1/12 normal except staining appears to be on surface 
5/12 reduced to spot, 2/12 staining completely eliminated. 
The figure shows a control embryo (A) and two XrelMSP injected embryos 
(B), one lacking any pintallavis expression (right) and one with a small 
remaining spot of expressing cells. (C) is a comparison of a cleared control 
(left) and a cleared a XrelAASP expressing embryo. The control is seen 
looking down on the vegetal pole and has a broad dorsal arc of expressing 
cells. The injected embryo (right), seen in a dorsal view, has a much reduced 
dorsal arc of expression. 
Note - the blastocoel is outlined in these embryos by the non-specific 
precipitation of stain. This is phenomenon is also frequently seen in negative 
control embryos taken through the in situ hybridisation procedure in the 
absence of probe (data not shown). 
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FIG. 41:- Pintallavis at stage 12 
Albino embryos injected bilaterally with approximately Ing/embryo ofXrelM 
SP RNA at the two cell stage were fixed at control stage 12 and assayed for 
expression of pintallavis by in situ hybridisation. 
Scoring:- 3/13 No visible expression with open yolk plugs, 6/13 small 
disorganised clumps of non-involuted cells on one side of open yolk plug, 4/13 
Involution of expressing cells has occurred and yolk plug almost closed but 
expression seems to be broader and closer to the surface than in controls. 
A. Controls showing expression in the dorsal midline. The domain of 
expression is broader posteriorly and tails off anteriorly. 
B. Injected embryos showing clumps ofnon-involuted expressing cells on one 
side (presumably dorsal, although it is not possible to confirm this) of their 
exposed yolk plugs (YP). 
NB:- The bottom embryo has a second dark patch. This is a forcep mark, nm 
stain. 
C. Injected embryos showing involution of expressing cells. However, 
expression appears broader than in controls, and unlike controls some staining 
appears to be on the surface (staining in the midline of the neural plate at this 
stage is normally restricted to deep layer cells (Ruiz-i-Altaba and Jessel, 
1992). 
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ofpintallavis. When involution of expressing cells did occur the domain of 
expression was laterally broader than in controls, and staining appeared mottled and 
stronger, possibly because some of the staining cells were present in the surface 
ectoderm (figure 41C). This is unlike controls where staining is only present in the 
deeper layer of neural plate cells. 
7.2.4. Xnot 
Embryos injected with 2 ng ofXrelALiSP RNA frequently lose the majority of 
their dorsal expression, leaving a thin ring of equatorial expression of the type seen 
both laterally and ventrally in wild type embryos, around the whole equator (see 
figure 42). In no case was this thin equatorial ring of expression affected by XrelA Li 
SP expression, suggesting that it is controlled by a different mechanism to that 
controlling the dorsal (trunk organiser) expression. 
7.2.5. Goosecoid and Xwnt-8 
Injection of 1 ng per embryo ofXrelALiSP is sufficient for inhibition of both 
Xwnt-8 and Gsc expression. However, whereas Gsc expression was either 
completely inhibited (7/11) as shown in figure 43, or completely unaffected (4/11), 
Xwnt-8 expression was only ever reduced over a small arc (10/13), as shown in figure 
44. 
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FIG. 42:- Xnot at stage 10½ 
Albino embryos bilaterally injected with approximately Ing/embryo of 
XrelMSP RNA at the two cell stage were fixed at control stage 1 O½ 
and stained for the expression of Xnot by whole mount in situ 
hybridisation. 
A dorsal arc of strongly staining cells can be seen in the control (left), 
along with a thin ring of faintly staining cells around the rest of the 
equator (ventral and lateral). In the injected embryos (right) the broad 
dorsal arc of strongly staining cells is lost leaving a thin ring of low 
level expression, as seen ventral and lateral mesodermal cells in the 
control, extending around the circumference of the embryo. 
Scoring:- 5/14 unaffected, 9/14 reduction of dorsal staining to 
lateral/equatorial levels (as in photo). 
FIG. 43:- Gsc expression is inhibited by Xre.lAASP. 
Albino embryos bilaterally injected with approximately Ing/embryo of 
XrelASP RNA at the two cell stage were fixed at stage 10 and stained 
for the expression of Gsc by whole mount in situ hybridisation. 
A dorsal arc of expressing cells (corresponding to the organiser) can be 
seen in the control (left) but is lost in the injected embryo (right). 
Scoring:- Complete inhibition of expression in 7/11 embryos; no 
inhibition of expression in the remaining 4 
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FIG. 44:- Xwnt-8 expression is inhibited by XrelAASP 
Albino embryos bilaterally injected with approximately 1 ng/embryo of 
XrelASP RNA at the two cell stage were fixed at stage 1 O½ and stained for the 
expression of Xwnt-8 by whole mount in situ hybridisation. All the embryos 
shown were cleared before photography. 
Scoring:-
Reduced expression over a small arc in 10/13, the rest were unaffected. 
Interestingly this arc of reduced expression was always ventral (rather than 
lateral), and lateral expression appeared to be stronger than in controls. 
However, too few embryos were tested in this experiment to be able to draw 
definite conclusions from this. 
A. A vegetal view of controls showing the ventral and lateral arc of 
expression in the mesoderm. 
B. Injected embryos, both with a small arc of reduced expression on the 
ventral side. 
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7 .3. Conclusions and Discussion 
Expression of all of the markers tested was reduced by XrelA~SP expression, 
although there was some variation in the degree to which each gene is effected by the 
same concentration of injected XrelMSP RNA. For example, bilateral injection of 1 
ng injected XrelMSP mRNA at the two cell stage is sufficient to completely inhibit 
large arcs ofXbra expression (up to 180°), but only to reduce expression ofXwnt-8, 
and then in relatively small arcs (up to about 60°). The only example seen of 
expression which appeared to be refractory to inhibition by XrelMSP expression is a 
thin equatorial belt of Xnot expression at stage 10.5, which may mark the limit of 
mesoderm involution. This suggests that expression of Xnot in these cells is 
controlled by some different mechanism to that controlling 'trunk organiser' 
expression. There is also subtle variation in the 'type' of inhibition seen. For 
example, inhibition of goosecoid expression at control stage 10 is an all or nothing 
effect, whereas expression of another dorsal lip specific gene, pintallavis, is 
frequently reduced to small, irregular patches of expressing cells. 
Althoughpintallavis expression at control stage 12 was inhibited in a 
proportion of injected embryos, where expressing cells remained their distribution 
was, in all cases, unlike that in controls. In injected embryos where involution has 
failed, patches of non-involuted, expressing cells can be seen. If the ability to inhibit 
pintallavis expression results from a direct (cell autonomous) effect, then this result 
implies that inhibition of involution/blastopore closure may not result from a direct 
effect on the dorsal involuting marginal zone. It would be easy to test whether 
inhibition of expression correlated with the distribution of injected RNA by using co-
injected nuc.pgal. mRNA as a lineage marker (see experiment described on page 125). 
In the more mildly affected stage 12 embryos which have gastrulated relatively 
normally, expression is seen in a uniformly broad band in the midline, which is both 
broader and lacks the anterior posterior differences seen in controls. (see figure 41 C). 
Lateral broadening of expression may be a reflection of a reduction in convergence and 
extension in the dorsal midline cells, i.e. expression may be in the same cells, but 
these cells are more spread out laterally. 
XrelMSP and XFD differ in their effects on mesodermal marker expression. 
For example, although they both inhibit Xbra expression, Xbra expression does not 
exhibit dorsal-ventral differences in sensitivity to XrelA~SP, as it does to XFD. If 
this difference in sensitivity to XFD expression is due to differences in the levels of 
active FGF (and therefore in the strength of the FGF signal), then one would expect an 
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inhibitor ofFGF signalling to show the same dorsal ventral differences in its effects. 
Another illustration of the difference is seen in their effects ongoosecoid expression. 
The inhibition of gsc expression by XrelMSP shows that the phenotype cannot be due 
to an inhibition ofFGF signalling alone, as this marker is unaffected by expression of 
XFD. It is unclear whether the lack of the equatorial domain ofXnot expression 
represents a difference with XFD, as the only mention ofXFD inhibition on Xnot 
expression in the literature (vonDassow et al., 1993) involved scoring at control stage 
12, after this domain of expression is lost. 
It is difficult to reconcile this relatively broad inhibition of marker expression 
with the relatively mild phenotype (no tissue type is absent) characterised in the 
previous chapter. Inhibition of Xbra expression dorsally, for example, would be 
expected to inhibit notochord development (as in the null phenotype in zebrafish). 
One possible solution to this apparent paradox could be that inhibition of expression of 
say, Xbra, is confined to a narrow window. Future work could investigate this 
possibility further. 
If some markers are only inhibited at earlier stages, this is unlikely to be due to 
instability of the message. Experiments carried out to test for the persistence ofXrelA 
A.SP RNA in injected embryos by in situ hybridisation showed that RNA was still • 
present at high levels (seen after seconds in the staining reaction instead of the hours 
(at least) required to detect even abundant endogenous RNA) in the late neurula (data 
not shown). 
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s, Discussion 
8.1. Discussion of dominant negative phenotypes. 
8.1.1. Discussion of the developmental mechanism of action of XrelAASP. 
As discussed in chapter 6, one similarity between XFD and XrelAASP 
injected embryos is a failure, or delay, in closing the blastopore during gastrulation, 
followed by 'migration' of the dorsal mesoderm around one side of the exposed yolk 
plug. The origins of this behaviour in XFD and XrelMSP expressing embryos may, 
or may not be the same, but for convenience I shall deal with various possible 
explanations of this behaviour together. Embryos lacking an animal cap and non-
involuting marginal zone (NIMZ) can succeed in closing the blastopore (Keller and 
Janser, 1992). Failure to close the blastopore in these embryos could therefore be a 
result of a direct effect on cell behaviour in the involuting marginal zone (IMZ). 
However, it also seems plausible to suggest that inhibition of epiboly in the animal 
cap could physically restrain the IMZ cells from performing this task. A number of 
explanations could be proposed for the behaviour of the dorsal mesoderm during 
gastrulation in these embryos. As these embryos frequently exhibit retention of the 
blastocoel, one possibility is that it is an indirect effect of an inhibition ofblastocoel 
collapse (although this could equally be a result, as a cause). There is some evidence 
that blasotceol collapse is an active, rather than a passive process, based on the result 
that overexpression of certain G-protein a-subunits inhibit blastocoel collapse (Otte, 
1992). Interestingly these embryos eventually develop normally, apart from a 'ventral 
blister' due to the retained blastocoel, suggesting that inhibition of blastocoel collapse 
does not inevitably lead to gastrulation around the yolk plug. Another possible 
explanation which has been proposed is that the entire dorsal mesoderm in these 
embryos behaves like the prospective head mesoderm in wild-type embryos, i.e.- it 
actively migrates, but does not undergo medio-lateral intercalation and so does not 
converge and extend (Isaacs et al., 1994). Ray Keller has proposed a model of 
gastrulation which suggests that co-ordinated patterns of mediolateral interacalation 
behaviour (MIB) ofIMZ cells provide the driving force for both blastopore closure 
and convergence and extension of the dorsal mesoderm during gastrulation (Shih and 
Keller, 1992b; Keller et al., 1992). Inhibition of mediolateral intercalation 
behaviour may therefore be an explanation for inhibition of blastopore closure and for 
the eccentric gastrulation of XFD expressing embryos. The one piece of data which 
seems to argue against this model in the case ofXrelMSP embryos is the expression 
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of pintallavis in these embryos at control stage 12. As discussed in section 7.3., 
although expression is inhibited in a proportion of injected embryos, where expression 
remains it is frequently seen in patches of non-involuted cells. If the inhibition of 
expression is a direct effect then it would be problematic to attribute inhibition of 
involution to a direct effect on these cells as well. 
The control of the co-ordinated patterns of cell behaviour which drive 
gastrulation, and the induction of mesoderm may actually involve the same inducing 
factors. Certainly, no gastrulation takes place in embryos where mesoderm induction 
has been blocked by expression of the dominant negative activin receptor /l 1 XAR 1. 
The ability of mesoderm inducing factors to induce animal caps, and individual 
animal cap cells, to display the various morphogenic behaviours associated with IMZ 
cells during gastrulation has been extensively characterised (Howard and Smith, 
1993). Activin can induce massive convergent extension in animal caps, and a 
variety of behaviours in single cells including elongation and spreading on fibronectin. 
FGF alone is able to induce only a subset of these behaviours in single cells, and only 
induces a small amount of convergent extension in whole caps. However, FGF 
signalling is necessary for induction of convergent extension in animal caps by activin, 
as shown by the inhibition of this behaviour by XFD (Cornell and Kimelman, 1994) .. 
XrelA/lSP also has the ability to inhibit activin induced convergent extension of 
animal caps (C.Beck, Personal communication). This supports the suggestion that 
the gastrulation defects in both XFD and XrelMSP expressing embryos are due to a 
direct effect on the behaviour of IMZ cells. 
8.1.2. Discussion of the molecular mechanism of action of Xrel.AaSP. 
The evidence for and a~ainst squelchin~ by XrelAASP, 
The failure of XrelMSP to inhibit transactivation from the thymidine kinase 
promoter, at least to the degree that wild-type XrelA does, is good evidence that 
transcriptional squelching by XrelMSP does not occur. However, the degree of 
experimental error in this experiment means that a lower level of squelching by XrelA 
/lSP than by wild-type protein cannot be ruled out. This result may seem suprising in 
light of the fact that XrelMSP contains the complete transactivation domain and 
nuclear localisation signal of XrelA (presumably transcriptional squelching takes place 
in the nucleus). However, as discussed in section 5.4.3., the squelching activity of a 
number of other transactivating factors has been shown to require the presence of a 
functional DNA binding domain, so this result is not without precedent. The apparent 
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lack of squelching by XrelMSP suggests that, although the transactivation domain is 
also required for the phenotypic effects of XrelMSP expression, these effects are due 
to some interaction which requires this domain, other than with some general 
transactivating factor. 
The inhibition of expression ( albeit to varying degrees), of all the markers 
studied, might seem to support the squelching hypothesis, but it would probably be 
rash to draw such a conclusion on the basis of the analysis of such a limited range of 
markers. Other work carried out with XrelMSP into its effect on mesoderm 
induction in caps also suggests that its effects are more specific than a general 
squelching of transcription (see below). 
One of the more compelling arguments against the squelching hypothesis is 
that the phenotype caused by injection ofXrelMSP mRNA into embryos is less 
severe than might be expected for a general inhibitor of transcription. It is certainly 
less severe than that caused by overexpression of XrelA ( at least at high levels), which 
is probably attributable to squelching. 
What are the potential candidates for interaction with XrelAASP? 
When the dominant negatives used in this work were designed the only known 
interactions ofNF-K13 subunits p50 and p65 were with other rel family members. 
Since then the interaction of p65 and p50 with a number of different transcription 
factors has been characterised. These transcription factors are therefore candidates for 
the factor(s) titrated by XrelMSP inXenopus embryos. 
Both p65 and p50 interact with a number of bZIP type DNA binding proteins 
(see table - figure 45), characterised by the presence of a leucine zipper structure 
adjacent to a basic DNA binding region. One group ofbZIP proteins which have been 
shown to physically interact with p65 and p5020 are the CCAA T /enhancer binding 
protein (C/EBP) family members C/EBPa, CEBP~ (previously known as NF-IL6), 
C/EBPy (previously called Ig/EBP-1) and C/EBPo (Stein et al., 1993). Interactions 
with the C/EBP family, which can occur in the absence of DNA are mediated through 
the rel homology domain, so may also be found for other rel family members, and 
appear to require dimerisation, as the dimerisation deficient relA mutant p65~ is 
20 p50 has only been shown to interact with C/EBPl3. 
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unable to interact. Functionally this interaction appears to serve to inhibit binding to 
KB sites and potentiate binding of the resulting complex to C/EBP binding sites (for 
which (p65)2 and (p50)2 NF-KB alone have no affinity). The ability to inhibit binding 
to NF-KB sites is of obvious interest given the failure of attempts to detect KB binding 
activity attributable to endogenous XrelA. 
Another family ofbZIP containing proteins which has members capable of 
interacting with NF-KB subunits is the ATF/CREB family. Physical interactions with 
NF-KB subunits in the absence of DNA and which also appear to involve the RHO, 
have been detected with ATFa, ATF2 and ATF3 (p50 only), and c-jun (Kaszubska et 
al., 1993). Unlike the interactions with the C/EBP family, these interactions seem to 
function to allow co-operative binding to promoters containing adjacent ATF and KB 
binding sites. 
NF-KB has also been shown to bind co-operatively with the zinc finger 
containing transcription factor Spl, to the HIV-LTR, which contains 2 KB sites 
adjacent to three Spl sites. This interaction has not been shown to occur in the 
absence of DNA (Perkins et al., 1993 and 1994). This interaction also involves the 
RHD. Other possible candidates for titration by XrelMSP are HLH box proteins, for 
which circumstantial evidence of an interaction exists (see introduction, page 27 ), 
and a DSpl homologue (again for which there is circumstantial evidence in 
vertebrates (see introduction page 26). 
Toe range oflikely targets for XrelMSP is somewhat reduced by the finding 
that the C-terminal domain is necessary for XrelMSP to have its phenotypic effects. 
As discussed in the introduction the c-terminal domain is highly divergent from relA, 
so it is difficult to see how any interactions might be conserved. 
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FIG. 45:- Table of interactions between bZIP proteins and NF-KB 
subunits. 
bZIP protein p50 p65 
C/EBPa Unknown + 
C/EBP~ + + 
C/EBPy Unknown + 
C/EBPo Unknown + 
ATFa + + 
ATF2 + + 
ATF3 + No Interaction 
c-Jun + + 
Discussion of the possible effects ofXelAASP expression on FGF si~nalin~. 
From the data presented in Chapters 6 and 7, it is clear that, despite the 
apparent external similarities, XrelMSP and XFD do not have identical phenotypic 
effects. The main similarities are in the method of gastrulation, the shortening of the 
trunk, and the inhibition of tail extension. One potential model suggested by these 
similarities is that XrelMSP somehow inhibits the morphogenic effects ofFGF, but 
not its ability to induce/maintain the formation ofmesoderm. However, the 
inhibition of expression of the early mesodermal markers by XrelAASP, some of 
which at least are thought to have a role in the specification of tissue type, suggests 
that this is not the case. The range of markers whose expression is inhibited by XrelA 
~SP is, if anything, broader than that inhibited by XFD ( at least at the early gastrula 
stages). For example, goosecoid expression is inhibited by XrelAASP, but not by 
XFD (according to the literature at least). 
Work on the effects ofXrelMSP on induction ofmesodermal markers in caps 
has shown that XrelAASP is able to completely inhibit the induction of all mesodermal 
markers in animal caps by FGF, but not by BMP4, or by activin, although the 
induction of~ markers in activin treated caps is reduced compared to controls 
(C.Beck, personal communication). This result is odd in that it is not consistent with 
the effects of XFD, which is able to abolish induction of a number of markers in 
animal caps by activin (LaBonne and Whitman, 1994; Cornell and Kimelman, 
1994). Various potential models which explain this are currently being investigated, 
but these fall beyond the scope of this thesis. While this data supports the idea that 
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the effects ofXrelAL\SP are very specific, and that XrelMSP is an efficient inhibitor 
of mesodenn induction by FGF, it is currently not easy to construct a comprehensive 
model which accounts for both the phenotype in whole embryos and the data from 
animal cap experiments. 
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8.2. The function and control of endogenous XrelA in the blastula. 
8.2.1. Speculations on the mechanism by which nuclear localisation of 
XrelA is controlled in the blastula. 
Any speculations as to the mechanism of nuclear localisation ofXrelA in the 
blastula are necessarily based on purely circumstantial evidence. Hopefully, the 
value of these speculations is that they can provide testable hypotheses. In this 
section two lines of evidence are described which suggest possible links between FGF 
signalling in the blastula and nuclear localisation ofXrelA. 
Models of the mechanism by which the FGF signal is transduced leading to the 
formation ofmesoderm, provide a link with the models of activation ofNF-1eB. FGF 
receptors belong to the tyrosine kinase family of transmembrane receptors. The 
paradigm for the transduction of signals from receptors of this family involves ligand 
dependent dimerisation and autophosphorylation on multiple tyrosine residues. When 
phosphorylated, these tyrosine residues become binding sites for SH2 domain 
containing proteins (reviewed in Cohen et al., 1995). Co-immunoprecipitation 
experiments usingXenopus blastula extracts and an antibody againstXenopus FGFR-1 
identified complexes of this receptor with various SH2 domain containing proteins in 
the blastula including Grb2, as well as a protein known to associate with Grb2 in other 
systems called Sosl (Ryan and Gillespie, 1994). Sosl is a guanine nucleotide 
exchange factor which is known to be an upstream activator of Ras in various systems 
(reviewed in McCormick, 1993). Increasing evidence points to the importance of this 
pathway in the transduction ofmesoderm inducing signals from the FGF receptor. 
Dominant inhibitory forms of ras and raf21 have been shown to inhibit mesoderm 
induction by FGF in caps, and to produce phenotypes very similar to the XFD 
phenotype when expressed in whole embryos (Whitman and Melton, 1992; 
MacNicoll et al., 1993). Overexpression of wild-type ras and raf, however, can 
induce mesoderm formation in animal caps. One of the downstream effects of raf 
activation is the activation of MAP kinase (MAPK) by phosphorylation, via a kinase 
cascade (reviewed in Nishida and Gotoh, 1993). Activation ofMAPK by 
overexpression of a kinase involved in this cascade, called MEK, can also induce 
mesoderm formation in animal caps (LaBonne et al., 1995). The model ofFGF 
21 As discussed in chapter 5 (section 5.1) the targets for these dominant negatives are not ras and raf 
themselves, but their upstream activators (in the case ofraf, one of these at least is ras), so an element 
of caution is required in interpreting results obtained with these clones. 
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signal transduction leading to mesoderm induction resulting collectively from this data 
is shown in figure 46. 
As discussed in the introduction (see figure 2), NF-rl3 activation by a nwnber 
of stimuli is now thought to involve raf acting serially, or in parallel with a pathway 
involving ceramide as a second messenger. Overexpression of an activated form of 
rafhas been shown to be sufficient for activation ofNF-rl3, at least in some cell lines. 
However, the fact that activation of raf does not always lead to activation of NF-KB 
suggests that this effect is limited by context, e.g. cell type or the presence of 
additional, synergising signals. Raf could potentially provide a means by which the 
nuclear localisation of an XrelA containing complex could be controlled by FGF. 
The other piece of circumstantial evidence for FGF control of XrelA nuclear 
localisation is that the predicted distribution of active FGF in the blastula corresponds 
to the pattern of nuclear localisation ofXrelA. The evidence for this predicted pattern 
is discussed in detail in the introduction (see page 44; also see figure 12), but I will 
summarise it again here. Animal caps contain sub-inducing levels of active MAPK, 
which can be inhibited by XFD expression (LaBonne et al., 1995) indicating that 
blastula animal caps contain sub-inducing levels ofFGF. The fact that induction of 
some immediate early genes by activin in animal caps is inhibited by XFD suggests 
that these sub-inducing levels of FGF are required for animal caps to be competent to 
respond to activin. Recently FGF has been shown to be capable of inducing 
mesodenn formation in vegetal explants at levels of treatment which would be sub-
inducing for animal caps (Cornell et al., 1995). This has been interpreted as implying 
that FGF treatment in these experiments is acting as a competence factor for the 
'activin-like' mesoderm inducing factors secreted by vegetal cells. If this is the case 
then exclusion ofFGF from the vegetal hemisphere could be an explanation of why 
the vegetal hemisphere does not induce itself to form mesoderm. 
The hypothesis that FGF signalling is necessary for activation (and therefore 
nuclear localisation) of an XrelA containing complex in the blastula could be easily 
tested by using the antiserum raised by Elaine Bearer to investigate the effects of 
expressing XFD on the nuclear localisation of XrelA protein. 
156 
FIG. 47:- Transduction of mesoderm inducing signals from the FGF 
receptor. 
FGF 
Cytoplasm 
Nucleus 
Mesoderm 
• 
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8.2.2. Potential roles for XrelA in the blastula 
Until it is known whether the dominant negatives pS0..:iSP and XrelA..:iSP222 
are inhibiting the activity of nuclear localised XrelA in the blastula it is not possible to 
conclude whether this protein has any (non-redundant) role in early development. As 
these dominant negatives would not be expected to inhibit nuclear localisation of rel 
proteins which they inhibit, testing this would require the development of an assay for 
the activity of this complex. This has not proved to be straightforward, even though 
the activity of exogenous XrelA (i.e. XrelA homodimer) is detectable by the assay as it 
stands. As discussed in section 4.3.1., the only obvious possibility for such an assay 
which remains to be tested is the use of a urokinase promoter type KB site probe in gel 
mobility shift assays. This probe is capable of detecting p65/Rel homodimers, which 
the HIV-L TR type rl3 site probes used in the experiments described in chapter 4, are 
not. 
Redundancy 
One possibility that may have to be faced is that XrelA in the blastula has no 
developmental function. There is increasing evidence from homologous 
recombination experiments in mice that the expression patterns of many genes are 
broader than necessary for their essential developmental roles, i.e. they have both non 
essential (redundant) and essential (non-redundant) domains of expression (Reviewed 
in Tautz, 1992). It is possible that XrelA in the blastula is a redundant domain of 
expression, although if, by analogy with relA, expression is ubiquitous then, it is the 
localisation event which would be redundant if XrelA has no essential development 
role. 
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Appendix 1 :- Plasmid Vectors, 
·. 
pGEX-2T Expression Vector 
918 947 
I Thrombin • l. I 
I Leu Val p;;-;:,11 1 Gly Sor l 1 
. CTG GTT CCG CGT GGA rec C~G GGA ATT CAT 
I II . 'I I 
BamHI 
t 
pGEX-2T 
4948bp 
Nar I (4286) 
BssH II (4058) 
2, Apa. I (3854) 
BstE II (38281 
Miu I (3647) 
Psll (1897) 
Structure of the expression vector pGEX-2T (Pharmacia) in which proteins can be 
fused to a glutathione S transferase affinity tail. The expressed protein fusion is 
purified using glutathione sepharose and the presence of the thrombin cleavage 
site enables subsequent removal of the protein of interest from the GST tail. 
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pET-3a Expression Vector 
EcoRI 0 
\ C/al 24 EcoRV 190 I Nhel 230 
__ .....__ EcoRV 380 
pET-3a 
(4.6 kb) 
' BamHI 510 
" 
P ~10 
I Nhel 560 
l-Ndel 560 
Bg/11 610 
1000 
pET-3 carries the bacteriophage T7 ~ 10 promotor and terminator. The terminator 
may make the transcripts more resistant to exonucleolytic degradation (Studier 
and Moffatt, 1986). pET-3a is a derivative of pET-3 into which the translation 
start of bacteriophage T7 ~10 with a BamHl site at codon 11 has been inserted. 
The Ndel site (GATATG) is located at the translation start site and can be used to 
construct a plasmid that directs the expression of native proteins. For more 
information see Sambrook et al., 1989. 
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3163,BsrGI . 
3001 ,Nhel . 
2994,XhoIL 
2968,NgoMl. \\ 
2968,Nae( \\ 
2958,SgrAI. \ \\ 
]SP6 
HindIIl,8 
.BglII,60 
[Xholl,60 
l, BstEII,66 
\j :Msll,92 
267 
Accl 
Hincll 
Sall 
Xbal 
BamHl 
Xholl 
2875,Eco47-3 . \\ :: .-· ·· ··· ··· ··· ·················· ···· ········· ················ Aval 
2841,Dsal._ \ 
2807,Spbl._ ·. 
2742,EcoNI. . 
2464,AatII .. 
2348,Sspl .· 
2312,Msll 
2188,Xholl _..-: 
2171,Xholl _.: 
2141,Xmnl 
2024,Scal . 
2500 
1953,Msll :: 
\ 
2000 
/ 
1913,Pvul -'~: 
1794,Msll. ! 
5'UT~'UTR 
3000 
pSP64T 
3242 bps 
1500 
/ 
500 
1000 
-
_. Pvull,475 
_. Sapl,530 
.. Afllll ,653 
\"Xholl,1294 
Xholl,1305 
\ Xholl,1391 
1766,Fspl 
1631 ,Gsul 
Xholl,1403 
Eaml 105,1541 
Bsal,1613 
The transcription vector pSP64T allows transcription of stable mRNA, using SP6 
RNA polymerase, for injection into Xenopus oocytes or embryos. It was originally 
derived from transcription vector pSP64, as described in Krieg and Melton (1984) 
and contains the 5' and 3' UTR oftheXenopus {3-globin transcript, separated by a 
Bgl II site to allow subcloning of the desired ORF. 
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SmaT 
Xmal 
cll 36 
Sacl 
Apol 
CORI 
297 
58 
Bglll 
Hindlll 
Acct 
3163,BsrGI 
2968,NgoMI. 
2968,Nael( SP6 .Sse8387,286 Hincll 
2958,SgrAI. l :··········· ··· ··· ··;.11stl;1g', ··· ·· ···· ··· ···· ··· ··· ···· ·· ···········--·· Sall 
-1--t---41~1.a f.. BspMl,289 Ndel 2875,Eco47-3.. ··:\ 
2841,Dsal . \ 
2807 ,Sphl. · .. 
2742,EcoNI .. 
2464,Aatll .. 
2348,Sspl 
2024,Scal 
1913,Pvul 
2500 
/ 
5'UTR3'UTR 
\ 
3000 
/ 
500 
pSPJC2 
3248 bps 
1000 
.... 
2000 
1500 
l?66,Fspl : : : iAhdI,1541 
1660,Bgll I: .Eaml 105,1541 
1631,Gsul ·ssal 1613 
' 
.Pvutr,475 
..Sapl,530 
.. Afllll ,653 
pSPJC2 is a derivative of pSP64T (Cooke, unpublished) which lacks the old pSP64 
multi-cloning site as well as the Hind III site adjacent to the SP6 promoter of pSP64T, 
and has a new multi-cloning site between the {3-globin UTR's 
Linker sequence:-
EcoRI Ndel HincII HindIII 
5 1 GATCC~C~~TGTQ}ACC~TA 3 ' 
cGTTA.$TA:l1AcAdcTGGTTCG4ATcTAG 
162 
coRl 
Bst 11 
92 
3199,BsrGI 
3004,NgoMI . 
3004,Nae( 
2994,SgrAI . \ 
SP6 
.BglII,58 
I. Hindlll,64 
\ Accl,70 
:i Hincll,70 
msaU,70 
::!.Ndel,75 
@.EcoRI,80 
!{ :BstEII,92 
293 
Notl 
XmalJI 
Aval 
Xhol 
291 l,Eco47-3 . } 
2877,Dsal. \ 
2843,Sphl .. · .. 
.... .................. ... ... ...................... ...... EcoRV 
· Ec11 36 
2778,EcoNI. . 
\ 
2500,Aatll .. 
2500 
2384,Sspl 
2060,Scal 
5'UTR3'UTR 
3000 
pSPJC2L 
3284 bps 
1500 
/ 
500 
1000 
1949,Pvul 
1802,Fspl 
1696,Bgll : 
1667,Gsul 
1649,Bsal 
\Ahdl,1577 
Eaml 105,1577 
.. PvuII,511 
.. Sapl,566 
.. AtIIII,689 
pSPJC2L is a derivative of pSPJC2 containing a new multi-linearisation site adjacent 
to the /3-globin 3' UTR. 
Linker sequence:-
S' 
Xhol/ 
Notl Aval EcoRV Sacl 
AGOOGCCGQI'CGAGA$TCGGACCTGAGc,tjccTGCA 
ACGTTCG~GAGC'rf2TiJrAGCCTGGAcfrcGAGG 
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3' 
Sacl 
Sse8387 
Pstl 
BspMI 
325 
-.HindIII,8 
[ .Bglll,60 
) ) .Apal,273 
i f, Bspl20J,273 
4763,BsrGI 
4601 ,Nhel 
4568,NgoMI . 
4568,Nae( 
4558,SgrAI.\ 
4475,Eco47-3 . \\ 
4441,Dsal.. :._ :: ---'4-1.__ : . PflMI,411 
4064,Aatll .. 
3948,Sspl. , 
3741 ,Xmnl .. 
3624,Scal 
3513,Pvul 
3366,FspI 
,• 
3260,Bgll / 
3231 ,Gsul .... 
3141 ,Eaml 105 
4000 
AMP-R 
/ 
3000 
6b 
4842 bps 
.. ..Bsu36,505 
1000 
.. PpuMl,985 
1860 
Spel , 1465 Sse8387 
BspMI 
Accl 
Sall 
. Xbal 
... ........... ... .. ................................ BamHI 
/ Aval 
SapI,2130 Smal 
AflIII,2253 Xmal 
Ecll 36 
acl 
EcoRJ 
1897 
6b consists of pSP64T containing the complete ORF ofXrelA subcloned into the 
Bgl II site (Richardson et al. , 1994) 
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Table of probes used for in situ hybridisations. 
Name Vector Linearisation Site Transcribe for Size (Kb) Reference 
Antisense 
Xbra pSP73 EcoRV T7 2.4 Smith et qJ.1991 
Xwnt-8 pGEMl PvuII T7 0.9 Smith and Harland, 1991 
Gsc (pnGsc) pBS KS II Smal T3 0.5 Cho et aJ.1991 ~ 
-
Xnot.2 pBSSK EcoRI T7 1.5 Von Dassow et aJ.,1992 
Collagen II pSP72 Xhol T7 0.5 Amaya et aJ., 1993 
Pintallavis (pF5) pBSKS Xmnl T7 1.8 Ruiz i Altaba and Jessel, 1992 
Table of contructs used to make synthetic mRNA for overexpression experiments. 
Name Description Plasmid Cut Site for SP6 Observed Reference 
Transcription Protein Size 
XrelA Xenopus relA (p65) homologue pSP64T EcoRI 68 Richardson et al., 1994 
Xre1M222 XrelA with transactivation domain pSPJC2 Pstl 38 Richardson et al., 1994 
deleted 
XrelMSP XrelA with deleted DNA binding domain pSP64T EcoRl 46 Richardson et al., 1994 
XrelM222SP XrelA with deleted DNA binding and pSPJC2L EcoRl 18 See Chapter 5 
transactivation domains 
Xre12. Xenopus c-rel homologue pSP64T EcoRl 68 David Tannahill, !8 
unpublished. 
plOS Human NFKBI (pl05) oSPJC2L EcoRV 110 See Chapter S 
050 p50 equivalent, reconstructed from p 105 oSPJC2L EcoRV 63 See Chapter 5 
p50ASP p50 with transactivation domain deleted pSPJC2L EcoRV 38 See Chapter .5 
Nuclear J3-gal nuclear ~-galactosidase pGEM3z Xhol Smith and Harland, 1991 
XFD Truncated Xenopus FGF receptor pSP64T• EcoRl 46 Amaya et al., 1991 
dominant negative. 
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